Towards an understanding of gene-environment interactions between cilia-related genes and folic acid in neural tube defects by Petersen, Juliette R.
 
TOWARDS AN UNDERSTANDING OF GENE-ENVIRONMENT INTERACTIONS 
BETWEEN CILIA-RELATED GENES AND FOLIC ACID IN NEURAL TUBE DEFECTS 
by 
JULIETTE R PETERSEN 
B.S., Harvey Mudd College, 2004 








A thesis submitted to the 
Faculty of the Graduate School of the 
University of Colorado in partial fulfillment 
of the requirement for the degree of 
Doctor of Philosophy 








This thesis for the Doctor of Philosophy degree by 
Juliette R Petersen 
has been approved for the 








Trevor Williams, Chair 






Date: December 16, 2016 
  
 iii 
Petersen, Juliette R (Ph.D., Molecular Biology) 
Towards an Understanding of Gene-Environment Interactions Between Cilia-Related Genes 
and Folic Acid in Neural Tube Defects 
Thesis directed by Professor Lee Niswander 
ABSTRACT 
 Neural tube defects (NTDs) have a complex etiology resulting from genetic and 
environmental causes. The mouse represents an ideal model for mammalian neural tube (NT) 
closure, and >200 mutations have been implicated in NTDs in mice, many of which disrupt 
ciliogenesis. Aberrant cilia function is associated with numerous human inherited disorders, 
called ciliopathies, which can affect most organs and includes NTDs, fetal lethality, and 
kidney, limb, and respiratory defects. Cilia are also required for Sonic hedgehog signaling 
which directs NT patterning, neural fate determination, and neural stem cell proliferation.  
Folic acid (FA) can decrease the NTD risk, however the mechanism by which FA 
affects NT closure is unknown, and surprisingly only a few of the mouse NTD models have 
been tested for FA responsiveness. This thesis shows that 4 out of 6 cilia mutants respond 
detrimentally to long-term FA fortification indicating that dose and duration of FA exposure 
affect the phenotypic outcome. These data suggest that cilia mutations may be a class of 
mutations that benefit from moderate intake of FA, which is supported by in vitro 
experiments using primary mouse and human cell lines. 
Using RNA-Seq and reduced representation bisulfite sequencing (RRBS), we find 
significant gene dysregulation and changes in DNA methylation upon FA fortification. Our 
studies suggest FA affects epigenetic mechanisms, as changes in expression of several 
important developmental genes correlates with differential DNA methylation. The work 
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presented in this thesis highlight the complexity of studying gene-environment interactions as 
well as the importance of such studies for public health. 
The form and content of this abstract are approved. I recommend its publication. 
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The neural tube is the embryonic precursor to the central nervous system and gives 
rise to the brain and spinal cord. Failure of this tube to close results in neural tube defects 
(NTDs), which are the second most common birth defect in the world, affecting between 1 
and 10 in every 10,000 births worldwide. In humans, the process of neural tube closure is 
complete by the end of the fourth week of pregnancy, often before women realize they are 
pregnant. Thus, prevention has been one of the best public health options for reducing the 
incidence of NTDs. NTDs have a complex etiology, and both genetic and environmental risk 
factors have been identified. Folate deficiency has been identified as a strong risk factor for 
NTD-affected pregnancies, and over 70 countries fortify the grain supply with folic acid (FA) 
to ensure that women of child-bearing age are folate-replete. Although the United States has 
been fortifying the grain supply for almost 20 years, and women planning to become 
pregnant have been told for decades to increase their folate intake, we still lack a mechanistic 
understanding of how FA affects the complex process of neural tube closure. This project 
seeks to understand the mechanism by which FA affects neural tube closure in mouse models 
of NTDs, and explores the potential that some genetic defects may respond detrimentally to 
excessive FA, highlighting the importance of optimal FA dosage. 
                                                
1 Portions of this chapter were previously published in Advances in the Care of Children with Spina Bifida, 
published in Advances in Pediatrics (2014, volume 61) and in Genetic, epigenetic and environmental 
contributions to neural tube closure, published in Annual Reviews of Genetics (2014, volume 48) and are 
reprinted with permission of the copyright holders. 
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Neural Tube Defects 
Neural tube development 
Neural tube closure 
 The neural tube (NT) is one of the first embryonic tissues to develop and is the 
precursor of the brain and the spinal cord. Neural tube formation occurs through two 
different processes called primary and secondary neurulation. In primary neurulation, the 
dorsal ectoderm thickens to create the neural plate (or neuroepithelium), which then rolls up 
and fuses across the midline, ultimately becoming the brain and most of the spinal cord. In 
secondary neurulation, which generates the caudal-most part of the spinal cord, mesenchymal 
cells proliferate, condense and undergo epithelialization to form a tube via canalization. 
Secondary neurulation defects do not give rise to open NTDs.  
 In primary neurulation, the neural plate is shaped via convergent extension (CE), a 
highly coordinated combination of collective cell migration and cell intercalation that leads 
to narrowing (or convergence) along one axis and extension along a second axis1. CE is 
regulated by the non-canonical Wnt signaling pathway, also known as the planar cell polarity 
(PCP) pathway. Mutations in PCP pathway genes commonly lead to craniorachischisis, in 
which the neural tube fails to undergo closure anywhere along the anterior-posterior axis. It 
is believed the CE is required to ensure that the folds are apposed in close enough proximity 
for closure to occur.  
Following convergent extension, the neural folds must elevate and bend, which 
requires the formation of hinge points. In the cranial region and rostral spinal cord, the 
medial hinge point (MHP) forms along the midline just dorsal to the notochord, a region 
called the floor plate (Figure 1-1). In fact, it has been shown that signals from the notochord 
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including Sonic hedgehog (Shh) induce formation of the MHP. It is yet unclear whether the 
MHP forms via apical constriction or due to coordination of the cell cycle and interkinetic 
nuclear movement of the nucleus to the basal side of the cell, leading to wedge-shaping of 
cells closest to the notochord2. More posteriorly along the spinal cord, dorsolateral hinge 
points (DLHPs) appear to be the driving force in elevating and bending the neuroepithelium. 
DLHPs form on either side of the developing neural tube, approximately halfway between 
the ventral midline and the neural plate border (Figure 1-1). Interestingly, the MHP does not 
appear to be required for neural tube closure, as mice containing mutations in Shh 
successfully form DLHPs and complete neural tube closure, despite the lack of a MHP3. 
Ectopic or overexpression of Shh results in failure to form DLHPs and ultimately NTDs, 
suggesting that Shh inhibits formation of DLHPs and that DLHP formation is necessary for 
neural tube closure4. 
 
Figure 1-1. Hingepoint formation varies along the anterior-posterior axis. As neurulation 
progresses, the morphology of the neural fold elevation (a) and folding varies along the 
anterior-posterior axis. In the rostral spine (b) bending occurs primarily at the MHP. Further 
along the body axis (c), bending occurs at both the MHP and DLHPs, while in the most 
caudal part of the spine (d), bending occurs only at DLHPs. Reprinted with permission from 
the Nature Publishing Group5. 
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Once the neural folds have elevated and are correctly apposed to one another, they 
must adhere to one another to form the neural tube. This process is called fusion. 
Lamellipodial and/or filipodial projections extend from both folds, interdigitating and 
initiating contact between the two sides. Interestingly, the type of projection that forms 
appears to depend on the location along the anterior-posterior (A-P) axis6. The cells at the 
site of fusion must undergo substantial remodeling, at least in part via apoptosis, to disrupt 
the connection between the neuroepithelium and the non-neural ectoderm (NNE) and 
ultimately establish a continuous neuroepithelium covered by a single layer of NNE cells7 
(Figure 1-2). Fusion occurs at multiple points along the A-P axis (Figure 1-3). In both mice 
and humans, the first closure point, called closure 1, occurs near the hindbrain/cervical 
boundary, and then proceeds by ‘zippering’ rostrally and caudally. In mice, closure 1 occurs 
around embryonic day (E)8 and is followed around E9 by closure 2 and closure 3 in the 
cranial region, at the midbrain/forebrain boundary and at the rostral end of the future 
forebrain, respectively2. Primary neurulation is complete by E10. In humans, the neural plate 
begins to bend and elevate around 17-18 days post fertilization (dpf) and primary neurulation 
is complete by 26-28 dpf2. Interestingly, there appears to be conflicting evidence for closure 
2 in humans, though there is strong evidence for both closures 1 and 3.  
Failure of Closure 1 leads to craniorachischisis. Failure of Closure points 2 or 3, or 
disruption of zippering from Closure 1 rostrally result in cranial NTDs called exencephaly. 
Exposure of the developing neural tissue to toxins such as urea that build up in the amniotic 
fluid as well as mechanical trauma results in degradation of the tissue, leading to 
anencephaly, the loss of brain tissue. Anencephaly has a 100% mortality rate at or shortly 
after birth9. Disruption of closure caudally from Closure 1 results in spina bifida. Infants born 
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with caudal NTDs such as spina bifida often survive, but have a high probability of having 
severe neurological disability and require lifelong and expensive medical care10-12. 
 
Figure 1-2. Neural tube closure. Schematic transverse sections that illustrate the (a) flat 
neural plate stage, (b) hinge-point formation and neural-fold elevation, (c) apposition of the 
neural folds with the neural ectoderm covered by the non-neural ectoderm (NNE), and (d) 
remodeling of the neural ectoderm and NNE and cohesion to form a closed neural tube 
covered by a single layer of NNE. Reprinted8 with permission from Annual Reviews. 
  
Figure 1-3. Neural tube closure points in the mouse and human embryo. In the mouse (a) and 
human (b), neural tube closure is initiated at Closure 1 at the hindbrain/cervical boundary, 
and then proceeds rostrally and caudally. Failure of Closure 1 results in craniorachischisis. A 
second closure point, Closure 2, occurs in most mouse strains (a), but is thought to be absent 
in humans (b). Closure 3 initiates at the rostral forebrain in both mouse (a) and humans (b). 
Failure of Closure 2 or 3 or failure to complete closure rostrally from Closure 1 result in 
anencephaly, while failure of closure caudal to Closure 1 results in open spina bifida. 
Reprinted from Prenat. Diagn.2 with permission from John Wiley and Sons. 
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Dorsal-ventral patterning of the neural tube 
As the neural tube is closing, the neural progenitor cells are also receiving signals that 
dictate the patterning and formation of the distinct neuronal cell types that comprise the 
central nervous system. Patterning is governed primarily from two main signaling centers. 
Ventral patterning is initially induced by expression of SHH in the notochord, an axial 
mesodermal cell group located just ventral of the midline of the neural tube4. Dorsal 
patterning is governed initially by expression of BMPs from the overlying surface ectoderm, 
and eventually by expression of BMPs from the roof plate of the neural tube. Further 
regulation comes from retinoic acid (RA) produced by somites adjacent to the neural tube. 
Shh is first expressed in the notochord, which induces secondary expression of SHH 
in the most ventral region of the neural tube, called the floor plate. SHH expression from 
both the notochord and the floor plate generates a gradient of SHH, which acts as a 
morphogen to induce specific neuronal cell types in a concentration and temporally-
dependent manner13,14. Shh patterning generates 6 distinct domains of progenitor cells 
(Figure 1-4) termed (from ventral to dorsal) the floor plate (FP), p3, pMN, p2, p1, and p0 
domains. These will ultimately give rise to V0-V3 interneurons and motorneurons (MN).  
 7 
 
Figure 1-4. SHH-induced patterning gives rise to six progenitor domains in the ventral neural 
tube. Schematic of domains of Shh-induced patterning in the ventral neural tube. Expression 
of specific transcription factors in the progenitor domains (left) leads to differentiation into 
specific neuronal subtypes (right, lumen of the neural tube). Adapted and reprinted under the 
Creative Commons Attribution (CC BY) license from PLOS Biology14. 
Modulation of Shh signaling is achieved both via the concentration gradient of the 
morphogen and by positive and negative feedback loops, which can provide additional 
precision in Shh responsiveness and cell-type specification15. In vertebrates, SHH signaling is 
transduced by the primary cilium, a microtubule-based organelle that protrudes from the 
surface of most cells when they are not actively dividing. In the absence of Shh ligand, the 
transmembrane protein Patched1 (Ptc1) localizes to the primary cilium and inhibits entry of 
another transmembrane protein, Smoothened (Smo), to the cilia. In the absence of Smo, the 
Gli family of zinc-finger containing transcription factors is proteolytically cleaved into its 
repressive form (GliR). Shh ligand binds to Ptc1 and relieves the inhibition of Smo, which 
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translocates to the primary cilium and represses the processing of Gli into GliR, allowing the 
translocation of activating Gli (GliA) into the nucleus (Figure 1-5).  
Positive and negative feedback of Shh signaling comes from downstream targets that 
either enhance or inhibit Shh signal transduction. For example, Cdo, Gas1, and Boc are all 
down-regulated in response to Shh, but act cell-autonomously to enhance Shh signaling16-18. 
Conversely, other GliA transcriptional targets such as Ptc1 and Hhip1 are up-regulated in 
response to Shh and these then serve to inhibit Shh signal transduction19,20.  
 
Figure 1-5. SHH signaling in the absence (a) and presence (b) of SHH ligand. (a) In the 
absence of SHH, PTCH prevents ciliary localization of SMO, and GLI is proteolytically 
cleaved to its repressive form (GLIR). (b) In the presence of SHH ligand, SHH binds to 
PTCH, relieving the inhibition on SMO entry into the primary cilium. SMO inhibits 
processing of GLI, and thus the activator form, GLIA, translocates into the nucleus. Reprinted 
from Nat. Med.21 with permission from Nature Publishing Group. 
Although the mechanism by which Shh signaling affects neural tube closure is 
unclear, defective Hh signaling is frequently observed in mouse models of NTDs. 
Interestingly, Shh is not required for NT closure, as mice with null alleles of Shh can 
successfully undergo NT closure22. Nonetheless, Shh is key for neural patterning as loss of 
Shh signaling results in expansion of dorsal cell types ventrally, while ectopic or 
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overexpression of Shh expands the domains of ventral cell types. Given the requirement of 
cilia for Shh signal transduction, it is not surprising that mutations in cilia-related genes also 
result in Shh regulated patterning defects. The role of cilia in Shh signaling will be explored 
further in the next section. 
Primary cilia 
As mentioned above, cilia are microtubule-based organelles that protrude from the 
surface of many vertebrate cells. They can be either motile or non-motile, and their functions 
range from movement of liquid in the lungs and kidneys (motile cilia) to cell signaling 
(primary cilia). Defective cilia formation and/or cilia function have been implicated in a wide 
range of birth defects and human diseases, collectively known as ciliopathies, which can 
affect almost every organ in the body (Figure 1-6)23. Common pathologies include NTDs, 
CNS malformations, cystic kidneys, respiratory and olfactory dysfunction, polydactyly, 
infertility, heart defects, obesity, deafness and retinal degeneration24-32.  
Cilia extend from the cell surface and are anchored to the basal body, also known as 
the mother centriole34-36. The cylindrical core of the cilia is called the axoneme, and is made 
up of polymers of alpha and beta tubulin. Non-motile cilia such as primary cilia are generally 
characterized by a 9+0 symmetry arrangement of nine microtubule doublets that comprise the 
axoneme. Motile cilia have an additional pair of microtubule singlets in the center of the 
axoneme, and thus are referred to as having a 9+2 axoneme. Motile cilia also have accessory 
structures required to generate movement, including inner and outer dynein arms, radial 
spokes, and a dynein regulatory complex37. Defects in motile cilia cause Primary Ciliary 
Dyskinesia (PCD), which is characterized by chronic sinusitis and bronchiectasis resulting 
from failure to clear mucus and bacteria from the lungs, chronic ear infections, and often 
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infertility38. Nodal cilia, a type of motile cilia present very early in development, are required 
for determining left-right asymmetry, and thus people with PCD may have situs inversus in 
which the location of all (situs inversus totalis) or some (situs inversus partialis) internal 
organs are reversed from their normal location, and is frequently associated with congenital 
heart defects. People with PCD also have an increased risk of hydrocephalus as a result of 
defective ependymal cilia in the brain, leading to accumulation of cerebrospinal fluid37. Over 
30 different ciliary genes have been identified as causative in PCD, affecting all aspects of 
motile cilia formation and function, though these are thought to account for only 70% of 
PCD cases38. Although nodal cilia are affected in some of the mouse models that will be 
studied in this thesis, they are primarily considered models of defective primary cilia. 
 
 
Figure 1-6. Ciliopathies have been implicated in diseases affecting almost every organ in the 
body. Reprinted from Nat. Rev. Gen.33 with permission from Nature Publishing Group. 
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Defects in primary cilia are associated with a range of ciliopathies, including 
pleiotropic syndromic diseases such as Joubert and Meckel-Gruber syndromes, as well as 
tissue-specific diseases like polycystic kidney disease (PKD). PKD was one of the first 
diseases directly linked to ciliary dysfunction. It was found that a hypomorphic allele of 
mouse homologue of the ciliary trafficking gene, Ift88orpk, caused polycystic kidneys in mice 
and shortened primary cilia in the developing kidneys39. A targeted null allele of Ift88 
resulted in loss of cilia40. Since then, other genes have been linked to both autosomal 
dominant (polycystin-1 and polycystin-2) and autosomal recessive PKD in humans, and these 
encoded proteins also localize to the primary cilia41. 
Several neurological developmental disorders, including Joubert Syndrome, Meckel-
Gruber syndrome (MKS), and Bardet-Biedl Syndrome (BBS), have also been linked to 
mutations in ciliary genes (Table 1-1). All three of these disorders (and many other 
neurodevelopmental ciliopathies) present with a wide spectrum of phenotypes, though CNS 
and skeletal disorders are common. All genes implicated in Joubert Syndrome localize to 
primary cilia, and over half of the 22+ genes identified are also implicated in other 
ciliopathy-based disorders. Similarly, mutations in genes that cause MKS, which is almost 
always perinatal lethal, are predominantly localized to the primary cilia42. Of the nearly 20 
genes identified that cause Bardet-Biedl syndrome, most localize to a basal body structure 
called the BBSome, which is involved in primary cilia assembly and thought to be a cargo 
adaptor for ciliary trafficking42,43. 
In mouse models, mutations in genes associated with these syndromes lead to 
disrupted Shh23,27 and Wnt/PCP23 signaling as well as abnormal or absent cilia. Recently, 
impaired Shh-dependent cerebellar development was observed in human patients with 
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Joubert and MKS syndrome44, providing evidence for the role of disrupted Hh signaling in 
human ciliopathies. 
Table 1-1. Genes identified in ciliopathies, adapted from Nat. Rev. Neurol42. with permission 
from the Nature Publishing Group. 
 
The complex process of ciliogenesis (formation of cilia) depends on proper 
functioning of numerous proteins, from the formation of the basal body to assembly of the 
microtubule-based axoneme and trafficking of proteins into and out of the cilia via 
intraflagellar transport (IFT) proteins and kinesin and dynein motors. Ciliogenesis begins 
when the centrosome transitions into a basal body, which will nucleate the microtubule 
axoneme of the cilia. Centrosomes/basal bodies act as the microtubule-organizing center 
(MTOC), and comprise a pair of centrioles – a mother centriole and a daughter centriole – 
surrounded by a pericentriolar matrix (PCM) containing g-tubulin45. The centrioles are 
characterized by nine microtubule triplets, and the older of the pair, the mother centriole, can 
Molar tooth sign Oculomotor 
apraxia Encephalocoele Intellectual 
disability Ataxia 
Retinal dystrophy
Corpus callosum hypoplasia 
Encephalocoele
Posterior fossa defects 
Hydrocephalus
Corpus callosum hypoplasia 
Perinatal lethality 
Cerebellar defects Hydrocephalus
Intellectual disability Hypothalamic 
hamartoma* Molar tooth sign* 
Bardet–Biedl syndrome 
ARL6, BBS1 , BBS2 , BBS4, BBS5 , 
BBS7 , BBS10, BBS12 , CCDC28B‡, 
CEP290, MKKS, MKS1, LZTFL1, 
PTHB1 , SDCCAG8 , TMEM67‡, 
TRIM32, TTC8, WDPCP 
Intellectual disability Retinal 
dystrophy Hydrocephalus 
*Only in orofaciodigital syndrome type VI. ‡Reported as a genetic modifier only. 
Meckel syndrome 
B9D1, B9D2, CC2D2A, CEP290, 
MKS1, NPHP3 , RPGRIP1L, 
TMEM67, TMEM216, TMEM237, 
TCTN2 
Orofaciodigital syndromes 
C5Orf42, KIF7 , OFD1, TCTN3, 
TMEM216 
Genetic basis and neurological features of ciliopathies involving the CNS 
Ciliopathy Disease-related genes Neurological features 
Joubert syndrome 
AHI1, ARL13B, C5orf42, CC2D2A, 
CEP41 , CEP290, EXOC8 , INPP5E, 
KIF7, NPHP1 , OFD1, PDE6D, 
RPGRIP1L, TCTN1, TCTN2, TCTN3, 
TMEM67, TMEM138, TMEM216, 
TMEM231, TMEM237, TTC21B‡, 
ZNF423 
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be differentiated from the daughter by the presence of distal and sub-distal appendages34. 
These distal appendages are thought to mediate the initial transition from centrosome to basal 
body when the distal end of the mother centriole is ‘capped’ by ciliary vesicles (Figure 1-7)46. 
The protein C2 calcium-dependent domain containing 3 (C2CD3) localizes to the distal ends 
of centrioles, and has been shown to be required for centriolar distal appendage assembly, 
vesicle docking, and the recruitment of several proteins required for ciliogenesis47. A mouse 
model carrying a mutation in this gene, C2cd3hty, will be studied in chapter 2. The mother 
centriole must then migrate to the plasma membrane of the cell, where it becomes anchored 
to the cell membrane by transition fibers, which ultrastructurally resemble distal appendages. 
These transition fibers are located in what becomes the transition zone (TZ), in which the 
triplet microtubules of the centrioles transition to the doublet microtubules of the axoneme. 
The TZ is characterized by electron-rich Y-shaped structures that span the gap between the 
microtubule doublets and the plasma membrane48. It is thought that the transition fibers and 
other proteins that localize to the TZ regulate ciliary composition by acting as a gate or 
sieve49. For example, in Chlamydomonas reinhardtii, CEP290 localizes to the TZ, and loss of 
CEP290 resulted in loss of attachments between the ciliary membrane and the TZ 
microtubules as well as abnormal protein content in the cilia50. The B9 complex is composed 
of nine proteins that localize to the TZ, including seven ciliopathy gene products and the 
transmembrane proteins Tmem231 and Tmem17. Disruption of this complex alters the 
localization of ciliary membrane proteins and entry of non-ciliary plasma membrane proteins 
into the cilium. Furthermore, disruption of the B9 complex prevents translocation of Smo 
into the cilium in response to Shh ligand, indicating that this TZ complex is required for both 
constitutive and regulated ciliary protein localization51.  
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 No protein synthesis takes place in the cilium, so axoneme elongation is dependent on 
transport of ciliary proteins and tubulin building blocks from the cytoplasm via intraflagellar 
transport (IFT). IFT is the process by which multi-subunit protein cargo is packaged and 
transported from the base of cilia to the tip by kinesin-2 motors and returned to the base by 
dynein motors52,53. IFT particles can be divided into two complexes, IFT-A and IFT-B 
proteins (Table 1-2). The IFT-B complex is required for the anterograde transport from the 
base of the cilium to the distal tip, while the IFT-A complex is required for the retrograde 
transport back to the base. Members of the IFT-B complex, such as IFT88 and IFT52, are 
required for ciliogenesis39,54,55, and null alleles of genes that encode proteins in this complex 
fail to make an axoneme, presumably due to the lack of anterograde transport. Mouse models 
with mutations in both of these IFT-B complex genes will be explored in Chapter 2. In 
contrast, mutations in IFT-A complex or retrograde motor genes often results in formation of 
cilia with abnormal bulges at the distal tip as a result of the accumulation of material that 
cannot be transported back to the cell body56,57. 
Table 1-2. Known components of IFT Complex A and Complex B58. 
 

















Figure 1-7. A schematic model of the four stages of ciliogenesis. Reprinted from Dev. Dyn.53 
with permission from John Wiley and Sons. 
 As mentioned earlier, primary cilia are involved in numerous signaling pathways, and 
these include Shh signaling, non-canonical Wnt/Planar Cell Polarity (PCP) signaling, and 
platelet-derived growth factor (PDGF) signaling. Moreover, there is growing evidence that 
primary cilia are also involved in canonical Wnt signaling in some organisms33. The effect of 
mutations in cilia-related genes on the Shh signaling pathway will be described below. 
Interestingly, roughly 5% of the 240+ genes that have been implicated in NTDs in 
mice affect ciliogenesis and/or cilia function59,60, though cilia-related genes only account for 
~2% of mouse coding genes with GO-annotations (487 genes associated with GO term ‘cilia’ 
out of 24,200 mouse protein-coding genes with GO annotations as of September 2016). 
Mutations in genes required for ciliogenesis can differentially affect Hh signaling. 
Specifically, mutations in genes affecting anterograde IFT, including kinesin motors Kif3a, 
Kif3b and IFT-B complex proteins Ift88 and Ift17240,54,55,61,62, result in failure to form primary 
cilia along with classical loss-of-Hh-signaling phenotypes, including loss of ventral cell types 
in the neural tube and polydactyly (Figure 1-8). Conversely, mutations that affect retrograde 
transport, including the dynein motor Dynch2 and IFT-A complex genes Ift122, Ift139a, and 
Ift14456,61,63-66, generally still assemble cilia, but may show either loss of Hh phenotypes or 
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excessive Hh signaling phenotypes such as expansion of ventral cell types in the NT 
(Figure 1-8). 
 
Figure 1-8. Schematic of neural tube and limb patterning defects in hedgehog and cilia 
mutants. (a) Normal Hh, correctly specified neurons and digits. (b) Complete loss of Hh 
results in failure to specify any ventral cell types and complete syndactyly. (c) Excess Hh 
activity results in expansion of ventral cell types at the cost of dorsal cell types and 
polydactyly. (d) Anterograde IFT (IFTB) and dynein motor mutants fail to assemble cilia, 
leading to expansion of dorsal cell types and polydactyly. The phenotype is not as severe as 
the complete loss of Hh phenotype (b) because the cilia are also required for GLIR 
processing. Dynein motor mutants retain motor neurons in the caudal neural tube. (e) 
Retrograde IFT mutants (IFTA) typically assemble cilia, and phenotypes resemble excess Hh 
activity (as in (c)). (f) Kinesin Kif7 mutations result in partial Hh activation, with less severe 
expansion of ventral cell types than observed in (c) and (e). Reprinted from Nat. Rev. Gen.33 
with permission from the Nature Publishing Group.  
 The data linking cilia and canonical Wnt signaling are conflicting, with some studies 
suggesting that the primary cilium and associated ciliary proteins constrain Wnt signaling, 
while other studies find no effect of disrupted primary cilia on Wnt signaling. Briefly, 
canonical Wnt signaling is induced when a Wnt ligand binds to the dual receptor complex 
comprising LRP5/6 and a member of the transmembrane receptor family Frizzled (Fzd). This 
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leads to stabilization and translocation of b-catenin to the nucleus and subsequent activation 
of downstream target genes. PCP signaling also relies on the Frizzled receptor proteins, but 
does not involve b-catenin. Instead, the PCP pathway affects cell movement and tissue 
polarity via RHO and ROCK activation67. 
 One line of evidence supporting a role for cilia in Wnt signaling comes from a study 
of Inversin. Inversin is mutated in at least one form of nephronophthisis, a ciliopathy disorder 
characterized by renal cysts, situs inversis, and renal failure. Inversin was found to localize to 
primary cilia in renal cells, and to inhibit canonical Wnt signaling by targeting the 
downstream effector protein, cytoplasmic disheveled (Dvl1), for degradation68. It was also 
found to be required for convergent extension during gastrulation in Xenopus laevis 
embryos69. This suggests that primary cilia are important for both canonical Wnt and PCP 
signaling. Further evidence for the role of primary cilia in regulating canonical Wnt signaling 
comes from a study showing that depletion of Bbs4 or Kif3a in mammalian cells results in 
accumulation of b-catenin and Dvl1 in both the cytoplasm and the nucleus, as well as 
significantly increased TCF1/LEF1 transcriptional activity70. Similarly, it was shown that the 
primary cilium restricts canonical Wnt signaling, as loss of the primary cilium in Kif3a 
mutant mouse embryos or mouse embryonic fibroblasts (MEFs) resulted in increased Wnt 
expression and canonical Wnt signaling (TCF1/LEF1 transcriptional activity)71. Evidence 
against a ciliary requirement for Wnt signaling comes from another study using a Kif3a null 
allele (as well as mice with mutations in both IFT-A and IFT-B complex genes). It found that 
primary cilia are not required for canonical Wnt signaling in the developing mouse embryo, 
as b-catenin levels and TCF1/LEF1 transcriptional activity are unaffected by these 
mutations72. Thus, the role of cilia in canonical Wnt signaling is still unclear. 
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 The PCP pathway has also been implicated in ciliogenesis and ciliary function in 
vertebrates. Dishevelled (Dvl), which functions in both canonical Wnt and PCP signaling, is 
required for docking of basal bodies to the apical cell surface to nucleate the microtubule 
bundles that form the core of the cilia and along which signaling molecules and other cargo 
are transported73,74. Dvl works in concert with the PCP effector protein INTURNED (INTU) 
to mediate basal body docking. Disruption of the PCP effector proteins INTURNED and 
FUZZY in Xenopus result in defective ciliogenesis75. Xint and Xfy morphants both result in 
rostral and caudal NTDs. The rostral defects appear to be the result of failed Hh signaling, 
while the caudal NTDs seem to result from defective convergent extension (CE) cell 
movements, providing another link between PCP and ciliogenesis. Both a null and 
hypomorphic allele of Intu are studied in the following chapters. 
Numerous cilia proteins have been shown to affect PCP signaling. The Bardet-Biedl 
Syndrome (BBS) family of proteins are required for correct assembly of basal bodies and 
thus ciliogenesis76, but mice carrying mutations in BBS genes also exhibit classic PCP 
phenotypes including open eyelids and disrupted cochlear stereociliary bundles77. 
Furthermore, the ciliary trafficking protein IFT88 was shown to be required for establishing 
epithelial PCP and CE of the cochlear duct in mice78.  These and other studies have led to the 
now widely accepted concept that cilia are important for both PCP and Hh signaling 
pathways, even though the link to canonical Wnt signaling remains less well-defined. 
Genetics of neural tube defects (NTDs) 
Failure of NT closure results in neural tube defects (NTDs), a very common birth 
defect in humans: ~1 in 1000 incidence in the United States and resulting in 71,000 deaths 
globally in 201079,80. NTDs are considered to be a multifactorial disorder, arising from a 
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complex combination of genetic and environmental factors81. In humans there is a very poor 
understanding of the genetic basis of NTDs. A genetic component for NTDs is suggested by 
the increased recurrence risk for a sibling of an affected individual (2-5%), as well as an 
association of NTDs with several syndromes, including Meckel-Gruber Syndrome (MKS) 
and Joubert Syndrome79,82,83. Chromosomal abnormalities are also associated with NTDs, 
with a higher prevalence of NTDs occurring in conjunction with trisomy 13 and 1880. To 
inform genetic studies in humans, attention has turned to knowledge gained from animal 
models, including mouse where over 200 genes critical for NT closure have been identified60. 
Currently, the emphasis on identifying the genetic risk factors for NTDs in humans fall into 
three main categories: non-canonical Wnt/planar cell polarity (PCP) pathway genes, cilia 
genes, and folate one-carbon metabolism (FOCM) genes.  
Non-canonical Wnt/PCP signaling is required for convergent extension (CE), the 
process by which cells elongate and intercalate along the midline leading to extension along 
the anterior-posterior axis of the body with concomitant narrowing of the mediolateral axis84. 
Genes involved in the PCP pathway have been implicated in NTDs in both humans and mice. 
In humans, mutations in the core PCP gene Celsr1 and the PCP-associated gene Scrib have 
been associated with craniorachischisis, the most severe NTD in which the entire neural tube 
remains open85. However, there is not a strict correspondence between gene and phenotype as 
mutations in Celsr186 and Scrib87 have also been associated with milder forms of NTD, spina 
bifida. Functional studies suggest that the mutations disrupt protein localization to the 
membrane. Several missense mutations in Dact1, which mediates Wnt signaling downstream 
of DISHEVELLED (DVL), were identified in a cohort of stillborn or miscarried fetuses with 
craniorachischisis, including two mutations that appeared to increase DVL2 degradation and 
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alter JNK phosphorylation88. Several variants in core PCP genes VANGL1 and VANGL2 have 
been identified in human cases of both open (myelomeningocele) and closed (tethered cord) 
spina bifida, as well as anencephaly89-94, as have mutations in PRICKLED195. The VANGL1 
Val293Ile variant disrupts binding of VANGL1 with its cytoplasmic partners, 
DISHEVELLED (DVL1, 2 or 3)90. Rare mutations in Dvl2 have been found in NTD cohorts96, 
as have five rare mutations in the Wnt receptor Fzd6, all of which are predicted to affect 
protein function97. Lastly, several mutations have been identified in the PCP effector Fuz in 
cases of myelomeningocele, including at least one substitution, Arg404Glu, that also resulted 
in defective ciliogenesis98. Much of our understanding of the mechanisms underlying PCP 
function and its role in neural tube closure come from animal studies, and mutations in all of 
the genes above as well as other members of the PCP pathway have been implicated in NTDs 
in mice99. Together, the substantial number of PCP genes implicated in human NTDs 
suggests that mutations in the PCP pathway represent a strong genetic risk factor in the 
development of NTDs. 
There is a link between the PCP pathway and ciliogenesis, as highlighted by the Fuz 
mutation above. Meckel-Gruber syndrome is a ciliopathy disorder and is associated with 
NTDs. Several genes have been identified in MKS patients that are linked to human NTDs, 
including Mks1 and Mks3 (Tmem67)100-102, Rpgrip1l26, Tmem216103, Cep290 (Mks4)104, 
B9D1105, B9D2106, and Cc2d2a107. Multiple mutations have been identified in Mks1 and Mks3 
and these account for ~7% of MKS cases101. Functional studies of the aforementioned genes 
in human primary cells, mouse, zebrafish and cell culture have shown all of these genes to be 
required for proper ciliogenesis and cilia function, which in turn is required for correct 
SONIC HEDGEHOG (SHH) signaling27,54,55,103. Moreover, analysis of MKS and Joubert 
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Syndrome fetal samples has shown impaired SHH-signaling44. A large number of genes 
implicated in mouse NTDs are required for ciliogenesis and PCP signaling, suggesting that 
cilia-related genes are excellent targets for future human studies. Indeed, recent whole-
genome copy number variation (CNV) analysis on NTD cases showed a strong association 
between cilia genes and NTDs108. 
Although genetic factors are thought to account for up to 70% of NTDs109, it is known 
that risk factors such as maternal diabetes110, obesity111,112, antiepileptic drugs113,114 and 
maternal folate levels81,82,115-119 also play an important role in the etiology of NTDs. An 
association between folate deficiency and NTDs was first reported in 196560,117. Subsequent 
studies, culminating in a landmark study by the Medical Research Council (MRC) in 1991, 
indicated that periconceptual folic acid (FA) supplementation (0.4 mg/day) could reduce the 
risk of recurrence of a NTD-affected pregnancy by up to 72%82. Since FA fortification of the 
grains in 1998, the NTD risk has decreased ~30% in the general US population9 and this has 
been substantiated by epidemiological studies in other countries following public health 
measures to increase folate levels120. Thus, the search for genetic causes of NTDs focused on 
genes involved in folate metabolism. Over 40 genes involved in FOCM (see Figure 1-9 for a 
schematic of FOCM) have been analyzed as potential risk factors for NTDs in humans 
(reviewed in Greene, 200983). Much attention has focused on the common 677CàT mutation 
in 5,10-methylenetetrahydrofolate reductase (Mthfr), which generates a more thermolabile 
enzyme with significantly reduced activity leading to increased plasma homocysteine 
levels121. Data are conflicting as to whether the T allele in either the mother or patient is as a 
risk factor for NTDs122-130 or not131-137, suggesting a population-specific effect of the 
polymorphism. Recent meta-analyses of the data concluded there is an overall risk associated 
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with the 677CàT allele138,139, and this risk can be reduced with FA supplementation140. A 
second polymorphism identified in Mthfr, 1298AàC, is also implicated as a risk factor for 
NTDs, though meta-analysis indicates that by itself, the polymorphism is not a significant 
risk factor139,141. Similarly, meta-analyses of polymorphisms in methionine synthase reductase 
(Mtrr, 66AàG) and 5-methyltetrahydrofolate-homocysteine S-methyltransferase (Mtr, 
2756AàG) showed no significant increase in risk, although the polymorphism 80AàG in 
reduced folate carrier-1(Slc19a1 or Rfc1) may be associated with increased NTD risk139. 
There appears to be more conclusive evidence for polymorphisms in 
methylenetetrahydrofolate dehydrogenase 1 (Mthfd1), at least in the presence of underlying 
folate deficiency142. Studies that did not take into account maternal folate levels are much less 
conclusive83. A common deletion/insertion polymorphism in the mitochondrial paralogue of 
Mthfd1, Mthfd1l, was recently identified as a risk factor for NTDs, and this may be through 
alternative splicing of MTHFD1L143 and microRNA regulation144. The glycine cleavage 
system, part of mitochondrial FOCM, is also implicated in NTDs. Several non-synonymous 
mutations in aminomethyltransferase (Amt) and glycine dehydgrogenase (decarboxylating) 
(Gldc) were identified and all the NTD-associated Gldc mutations showed reduced 
enzymatic activity, supporting the idea that these mutations are causative145. Despite the 
extensive studies on folate pathway genes and the importance of folate in neural tube closure 
established almost 50 years ago, the data remain inconclusive for most of the FOCM genes, 
highlighting how much we have yet to learn about the role of folic acid in neural tube 
closure. 
Many gene-NTD correlation studies to date fail to investigate the functional importance 
of the variants identified, which limits the power of the findings in revealing true causative 
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mutations. The three pathways discussed above, non-canonical Wnt/PCP signaling genes, 
cilia-related genes and FOCM genes, clearly do not complete our understanding of the genetic 
causes of human NTD, yet the large number of genes within each of these pathways indicates 
their importance in neural tube closure. Animal models still have much to contribute to 
research in this field by providing functional studies of potential risk alleles and through 
continued identification of genes necessary for neural tube closure. Combined efforts of 
developmental biologists, geneticists, epidemiologists, and clinicians will lead to a much 
greater understanding of this complex and multifactorial birth defect. 
Environmental contributions to neural tube closure 
Environmental alteration of the genomic landscape 
Growing evidence now suggests that environmental factors have the ability to alter 
the epigenetic landscape and, therefore, transcriptional activity.  Several lines of study using 
the agouti viable yellow (Avy) mouse have shown that exposure to endocrine disruptors, 
dietary changes, and toxic compounds can cause phenotypic changes in offspring due to 
disrupted DNA methylation146.  Interestingly, gestation appears to be particularly sensitive to 
environmental changes, as maternal folate intake during gestation induces differential DNA 
methylation and phenotypic changes in Avy offspring, but not in their mothers147. Even in 
normal animals, multigenerational exposure to methyl-enriched diets can lead to profound 
changes within the epigenome148. These studies have added to a growing amount of literature 
suggesting that maternal diet is tightly linked to the epigenome of the offspring.  This link is 
not just important for development, however, as rats born from mothers with suboptimal 
nutrition have a significantly increased risk for developing type II diabetes149 and mice born 
from mothers on a low-protein diet show disrupted expression of peroxisomal proliferator-
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activated receptor alpha (Ppara) 150; both phenotypes were shown to be associated with 
alterations in the epigenome.  Together, these data strongly support a significant epigenetic 
role for maternal nutrition in the proper development of offspring. 
Folic acid fortification: Reducing the incidence of NTDs 
Although there is clearly a genetic component to NTDs, numerous environmental 
factors have also been strongly implicated in NTD etiology. One of the earliest records 
correlating environmental risks with NTDs comes from the 18th century midwife, Catherina 
Schrader. Her exceptional records showed two clusters of increased NTD incidence, both 
following unusually poor crop yields, and primarily in lower-class, urban families, 
implicating socioeconomic status, nutrition, and possibly folate deficiency, in the incidence 
of NTDs in 18th century Holland151. Since then, gene-environment interactions have been 
implicated in numerous diseases, including diabetes, metabolic syndrome, neurological 
diseases, and numerous cancers152. As mentioned above, maternal diet can affect the 
developing embryo, and one of the best-studied dietary factors relative to NT closure is 
maternal folate. 
Folate deficiency was suggested as a risk factor for early fetal death in the 1950’s, 
when the folate antagonist, aminopterin, was used to induce therapeutic abortions153,154. 
Women who failed to abort with aminopterin treatment gave birth to babies with numerous 
defects, including NTDs155. Work by Hibbard and Smithells implicated maternal folate 
deficiency as a risk for NTD-affected pregnancies in the 1960’s117, and several landmark 
human trials in the late 1980’s and early 1990’s supported these findings. The Medical 
Research Council Vitamin Study, published in 1991, was the first large, randomized trial to 
show a strong protective effect of folic acid (FA) supplementation. For women who had 
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already had one NTD-affected pregnancy, supplementation with 4 mg/day of FA decreased 
the risk of a second NTD-affected pregnancy by 72% (6/593 NTDs in FA-supplemented 
group vs 21/602 in the unsupplemented group)82. A second large-scale randomized trial in 
Hungary provided evidence that FA supplementation could reduce the risk of a first NTD-
affected pregnancy. Supplementation with 0.8 mg/day of FA for one month prior to 
conception and the first 8 weeks of pregnancy significantly decreased the risk of having a 
first NTD-affected pregnancy (0/2104 NTD cases in the vitamin-supplement group, 
compared to 6/2052 NTD cases in the control group)156.  
 As a result of these studies, the US Centers for Disease Control and Prevention 
(CDC) made the official recommendation that “[a]ll women of childbearing age in the United 
States who are capable of becoming pregnant should consume 0.4 mg of folic acid per day 
for the purpose of reducing their risk of having a pregnancy affected with spina bifida or 
other NTDs157.” This supplementation campaign proved unsuccessful, however, possibly in 
part because physicians and patients were not sufficiently educated on the importance of 
supplementation158, and less than a third of women were reported to be taking a FA 
supplement in 1997, despite increased public awareness159. Given the limited effectiveness of 
the supplementation campaign and the fact that an estimated 50% of pregnancies in the US 
are unplanned160, the US implemented a fortification campaign in 1998 to ensure that all 
women of childbearing age received the daily recommended dose of 400 µg/day161. Since 
fortification, the prevalence of folate deficiency has decreased from 30% to <1%, and the 
NTD incidence in the US has decreased by almost 30% overall9, although there are 
significant differences in the risk depending on ethnic and social backgrounds. Similar 
fortification campaigns in other countries have yielded comparable results. In Canada, where 
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fortification also began in 1998, the overall incidence in NTDs was decreased by 46% (53% 
reduction in spina bifida and 38% reduction in anencephaly). Furthermore, geographical 
differences in NTD rates among the Canadian provinces disappeared116. In Chile, where 
fortification began in 2000, spina bifida and anencephaly rates decreased by 51% and 42%, 
respectively119. Overall, more than 75 countries have implemented mandatory FA 
fortification campaigns, primarily in wheat flour, and it is estimated that FA fortification has 
prevented 15-25% of NTDs worldwide120. Interestingly, the incidence of spina bifida did not 
continue to decline after the initial decrease, though rates of anencephaly have continued to 
decline162. 
Folate is a water-soluble vitamin that is found naturally in many foods, especially 
green, leafy vegetables163. Dietary folates, in the form of tetrahydrofolates (THF), play an 
important role in one-carbon metabolism (OCM) (Figure 1-9).  FA is a synthetic form of 
folate that is more stable than the naturally occurring form. Both FA and folate must be 
reduced by dihydrofolate reductase (DHFR) and then converted to biologically active form, 
5-methyl-tetrahydrofolate (5-meTHF) by serinehydroxymethyltransferase (SHMT) and 5,10-
methylenetetrahydrofolate reductase (MTHFR)164. 5-meTHF is then used in the biosynthesis 
of purines and thymidylate, the synthesis of methionine from homocysteine, and the 
biosynthesis of S-adenosylmethionine (SAM), the universal methyl donor for cellular 
methylation reactions, including DNA and protein methylation165.  
Drugs that act as folate antagonists have continued to be implicated as risk factors for 
NTDs. Women who took folate antagonists in their first trimester were over 6-fold more 
likely to have an NTD-affected pregnancy. These included DHFR-inhibitors such as 
methotrexate, an anti-cancer therapeutic which inhibits the conversion of folate to its active 
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form and the antiepileptic drug, valproic acid (a histone deacetylase (HDAC) inhibitor)166,167. 
 
 
Figure 1-9. Schematic of folate in one-carbon metabolism. Synthetic and dietary folates are 
reduced to tetrahydrofolates (THF), which is converted to the biologically active 5-
methyltetrahydrofolate (5-methyl-THF) by SHMT and MTHFR. 5-methyl-THF acts a methyl 
donor for purine and thymidylate synthesis, as well as to generate the major cellular 
methylation donor, S-adenosylmethionine (SAM). DHFR, dihydrofolate reductase; MTHFD, 
methylenetetrahydrofolate dehydrogenase; SHMT, serine-hydroxymethyltransferase; 
MTHFR, methylenetetrahydrofolate reductase; MTR, methionine synthase; MTRR, 
methionine synthase reductase; MAT, methionine-adenosyltransferase; MT’s, 
methyltransferases; AHCY, S-adenosylhomocysteine hydrolase; SAM, S-
adenosylmethionine; SAH, S-adenosylhomocysteine. Reprinted8 with permission from 
Annual Reviews. 
After the Brownsville Cluster, in which the incidence of NTDs was four- to five-fold 
higher along the Texas-Mexico border than the rest of the US, attention turned to other 
potential environmental risk factors. The Mexican-American population in the region was 
known to consume high levels of corn, and cornmeal samples harvested around the time of 
the Cluster contained high levels of fumonisin contamination. Fumonisin is a mycotoxin that 
inhibits the biosynthesis of sphingolipids, ultimately interfering with the cellular uptake of 5-
meTHF168. In mouse studies, FA supplementation partially rescued fumonisin-induced 
NTDs169,170. Furthermore, much of the population affected in the Brownsville cluster was also 
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folate-deficient, suggesting that fumonisin is more likely to compound folate-deficiency in a 
human population, and less likely to be a significant risk factor in a folate-sufficient 
population. 
Although more than 40 genes involved in OCM have been investigated for genetic 
variation in human NTD samples, very few have been implicated in either human83 or mouse 
NTDs171. Furthermore, folate deficiency in the absence of a genetic insult fails to cause 
spontaneous NTDs in mice. A handful of mouse NTD models have been used for FA 
supplementation studies, with very mixed results (Table 1-3). For some mouse models, FA 
has a preventative effect171-174, while others are non-responsive145,171, much like in the human 
population. Surprisingly, several models have shown a detrimental response to FA, including 
increased NTDs and increased fetal loss175,176. These studies raise an important question: in 
some cases, is the decreased incidence of NTDs due to an increase in early fetal loss, rather 
than a rescue of NTDs, a possibility first raised nearly two decades ago177? It will be 
important to understand which genetic variants are favorably influenced by FA fortification, 
and it is expected that animal models can provide genetic, experimental and mechanistic 
insights into FA-responsive and non-responsive NTDs. Some experts have raised the idea 
that the dose of FA should be increased to try to further decrease the incidence of NTDs in 
the population178. Indeed, FA fortification in conjunction with an increase in vitamin usage 
has resulted in a trend toward higher FA levels throughout the U.S. population179,180. 
However, it is important to note that there will likely be certain genotypes that are resistant to 
FA, and the potential for long-term epigenetic changes remains an important consideration. 
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Table 1-3. Mouse NTD models studied for responsiveness to folic acid. Reprinted8 with 
permission from Annual Reviews. 
Gene Name FA response Process 
 Beneficial Detrimental None  
3poly175  x  Ciliogenesis 
Cart1 null181 x   
Paired-class homeobox domain-containing 
gene, aka Alx1 
Cited2 null182 x   
Required for heart morphogenesis and L-R 
axis determination in mouse development 
Cd mutant at 
Lrp6 gene183 
x   
Receptor or co-receptor (with Frizzled) of 
Wnt; canonical Wnt/b-catenin signaling 
Folr1 
null184,185 
x   
Folate receptor; involved in transport of 5-
MTF into the cell 
Gcn5 
(Kat2a)186 








Involved in actin remodeling, especially 
apical constriction and apicobasal 
elongation 






Transcription factor involved with ear, eye 
and facial development as well as dorsal 
patterning of the neural tube 
Sp mutant at 
Pax3 gene188 
x    
Shmt172,173 x   
Thymidylate biosynthesis pathway; 
choline-resistant; thymidine  
Zic2175 x   
Transcriptional activator and repressor 
involved in organogenesis of the CNS 
Axd 
mutation189 




  x 
Transcription factor; Ct mutation is 
responsive to inositol191 
Frem2m1Nisw 
allele 175 









Grhl3192   x Transcription factor 
Fkbp8 null193   x 
Member of immunophilin protein family; 
involved in D-V patterning of NT; also 
inositol-resistant 
Map3k4194   x MAPK pathway 
Nog null195   x 
BMP antagonist; also resistant to inositol 
and pifithrin-a (cell-death inhibitor) 
SELH/Bc 
strain196 
  x 
Inbred mouse strain with a high frequency 
of non-syndromic NTDs 
Amt null145   x 
Involved in glycine cleavage system 
(GCS), part of the mitochondrial folate 
metabolism; implicated in human and 
mouse NTDs; responsive to methionine 
Mthfd1lz 
allele174 
   
Untested wrt folic acid; partial rescue 





The mechanism by which folic acid affects NT closure is unknown, but as discussed 
above, changes in DNA methylation likely play a role, as well as alterations in synthesis of 
nucleotide precursors. Methylation of the insulin-like growth factor gene differentially 
methylated region (IGF2 DMR) was significantly higher in children whose mothers took FA 
supplements (400 µg/day) than in children of unsupplemented mothers197. In mice, genome-
wide CpG methylation patterns were found to be significantly different in the cerebral 
hemispheres in offspring of wild type dams exposed to a FA-fortified diet compared to non-
fortified controls198. Furthermore, differential methylation of important developmental genes 
was correlated with altered levels of gene expression. Future studies are needed to determine 
what the link may be between FA status, changes in DNA methylation, and NTD incidence. 
Moreover, the OCM cycle also produces nucleotides, which are needed for proliferation, and 
the rate of proliferation needs to be carefully controlled for proper NT closure. Hence, 
adequate folate levels likely play an important role in maintaining sufficient proliferation 
levels during NT closure. 
Maternal diabetes and obesity 
Maternal diabetes has long been identified as a risk factor for congenital birth defects, 
including NTDs199. Single nucleotide polymorphisms (SNPs) in maternal genes related to 
glucose metabolism such as FTO, LEP, TCF7L2, LEPR, GLUT1 and HK1 have been linked 
to an increased risk for NTDs200,201, and potentially informative maternal-fetal SNP 
interactions have also been correlated to altered NTD risk. For example, SNPs in maternal 
ENPP1 and fetal SLC2A2 correlate with increased risk of NTD (2-3.5-fold), while the same 
fetal SLC2A2 SNPs interact with maternal SNPs in LEP to provide a protective effect (0.5-
fold risk)202. Fetal SNPs in SLC2A2 alone do not appear to confer altered risks of NTDs201. It 
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is thought that altered maternal glucose metabolism leads to an altered intrauterine 
environment, which is not tolerated by the developing embryo, as pancreatic function in 
human embryos begins at approximately week 7 of pregnancy. Diabetic embryopathies are 
known to particularly affect the neural tube and heart, both of which form prior to week 7201. 
Animal models have proven invaluable in elucidating the molecular pathophysiology 
of diabetic embryopathies. In mice, high glucose levels cause decreased proliferation and 
increased apoptosis accompanied by increased caspase-3 activation in neural progenitor cells 
in the developing spinal cord, suggesting that excessive cell death plays a role in diabetic 
embryopathies203. Hyperglycemia can activate several related pathways, including altered 
lipid metabolism, increased generation of reactive oxygen species (ROS), and activation of 
apoptotic pathways (reviewed in Reece et al.204). Briefly, hyperglycemia alters arachidonic 
acid metabolism, leading to the generation of altered levels of prostaglandins, which has been 
linked to adverse pregnancy outcomes. Hyperglycemia also leads to increased glucose 
transport into the cell, which activates the polyol pathway, causing increased accumulation of 
sorbitol and ultimately increased ROS levels. Increased sorbitol and the hyperglycemia-
induced stress response in the endoplasmic reticulum (ER) have both been shown to activate 
the JNK1/2 pathway, which has been implicated in diabetes-induced NTDs205,206. Oxidative 
and ER stress have been shown to activate the PKC pathway207, which can also activate the 
JNK1/2 pathway208,209 and induce apoptosis via caspase-8210. Alleviating oxidative stress by 
overexpression of the antioxidant enzyme superoxide dismutase 1 (SOD1) can rescue 
diabetes-induced NTDs coincident with decreased activation of the PKC and JNK1/2 
pathways211-213. Moreover, ROS in mice activates apoptosis signal-regulating kinase 1 
(ASK1), which activates the transcription factor FoxO3a and caspase-8, as well as increasing 
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levels of the apoptosis-promoting adaptor protein, TRADD, which is a direct target of 
FoxO3a. Interestingly, increased ASK1 phosphorylation, decreased phosphorylation of 
FoxO3a, increased TRADD expression and increased cleaved caspase-8 were also observed 
in neural tissue from human NTD-affected fetuses214. 
Intriguingly, a model of transcriptional variability as the underlying cause of partial 
penetrance of disease phenotypes has been proposed, supported by recent data from diabetic 
mouse models. In both a chemically-induced diabetes model and a non-obese diabetic (NOD) 
strain, NTD-affected embryos had significantly higher variability in gene expression 
compared to their non-NTD littermates. Furthermore, the pathways enriched in the class of 
highly variable genes were different than those enriched in the differentially expressed but 
less variable gene sets, suggesting a role for environmentally-induced variable gene 
expression as a mechanism of increased NTD risk215. Mechanistically, this may fit with 
recent data showing that hyperglycemia alters the epigenetic landscape. Shyamasundar et al. 
found that neural stem cells isolated from chemically induced-diabetic pregnancies had 
increased global levels of H3K9 trimethylation, increased DNA methylation, and decreased 
H3K9 acetylation compared to neural stem cells derived from normal pregnancies216. As 
discussed above, disruption of the epigenetic landscape can increase transcriptional 
variability and may be an underlying factor of NTDs. 
Given what is known about the molecular mechanisms involved in diabetes-induced 
NTDs, several measures have been proposed to protect developing embryos. There is 
evidence that nutritional supplements can alleviate the risks. Diabetic mice supplemented 
with trehalose had a much lower incidence of NTD-affected embryos than unsupplemented 
mice (10% vs 28%), in part by reversing diabetes-induced autophagy impairment217. Diabetic 
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rats supplemented with FA showed a decreased incidence of NTDs (supplemented: 6%, 
unsupplemented: 28%)218. However, diabetic mice also showed premature neuronal and 
astrocyte differentiation when given high doses of FA compared to a moderate dose, 
suggesting that too much FA may cause unintended consequences219. Human epidemiological 
data also suggests that FA supplementation may reduce the risk of NTDs in a diabetic 
pregnancy, with a larger protective effect observed against anencephaly than spina 
bifida220,221. 
Maternal obesity, defined as a body mass index (BMI) ³ 30, has also been linked to 
an increased risk for NTDs. Meta-analyses showed an overall 1.7 – 1.8-fold increase in 
NTD-affected pregnancies for women who are obese and 3.1-fold increase for women who 
are severely obese111,222. Maternal obesity has also been linked to an increased risk in the 
child for heart defects, anorectal atresia, hypospadias, limb reduction defects, diaphragmatic 
hernia and omphalocele223,224, although the potentially confounding effect of maternal 
diabetes must be considered. Interestingly, a pre-fortification study in the US showed that the 
risk associated with increased BMI was independent of maternal folate status223,225, a finding 
confirmed in a Canadian study spanning pre-and post-fortification, which showed that FA 
fortification did not alleviate the obesity-related risk of NTDs224,226. 
Maternal hyperthermia 
Maternal hyperthermia can arise from either a febrile illness (fever) or external 
exposure to heat, such as prolonged periods in a hot tub or sauna. Numerous epidemiological 
studies have strongly implicated maternal fever in early pregnancy as a risk factor for NTD-
affected pregnancies. A recent meta-analysis evaluated 46 studies ranging from 1990-2013 
and found that the NTD risk was increased almost 3-fold in cases of maternal fever during 
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the first trimester, as well as increased risk for oral clefts and congenital heart defects227. 
Interestingly, studies of Mexican-American women along the Texas-Mexico border228, a 
more general US population229, and Hungarian women230, indicate that use of anti-fever 
medication can significantly alleviate this risk. Furthermore, the use of either a multivitamin 
or FA supplementation also appears to abrogate the risk associated with maternal febrile 
illness230,231. Surprisingly, animal models of maternal hyperthermia show a mixed response to 
FA supplementation. In the golden hamster, FA supplementation does not appear to rescue 
heat-induced NTDs232, while studies in mice indicate that FA can rescue heat-induced 
NTDs233. 
Early studies linking maternal hyperthermia as a result of prolonged external 
exposure such as in a hot tub or sauna to increased risk for NTDs are mixed. An increased 
risk was found in several studies234,235, while another study found no correlation with sauna 
use and NTD risk in a Finnish cohort236. Data collected from the large, multisite National 
Birth Defects Prevention Study from 1997 to 2005 shows the risk for anencephaly increased 
by 1.7-fold for women who reported using hot tubs during early pregnancy. However, only 
hot tub sessions lasting more than 30 minutes had a significant effect237. Overall, in both 
animal and human models, the key factor appears to be raising the core temperature > 2 °C 
above baseline238. 
The mechanism by which heat may affect the developing embryo is unknown, but 
there appears to be a genetic component. In one study, five different mouse strains were 
exposed to hyperthermic treatment on embryonic day 8.5, just as the neural tube is closing. 
One strain had a 44% incidence of heat-induced NTDs in their offspring, while the other four 
strains showed no more than a 14% penetrance of NTDs239. A follow-up study confirmed 
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these findings and suggested the importance of maternal genotype in susceptibility to heat-
induced NTDs240.  
Research in animal models indicates that heat adversely affects development, likely 
as a result of increased cell death, decreased proliferation, disruption of gene expression, and 
damage to the embryonic vasculature (reviewed in Edwards et al.241). Recent work on mouse 
neural stem cells showed a narrow temperature range of responsiveness to heat shock, 
leading to induction of apoptosis, inhibition of proliferation, and delayed differentiation242. 
These data highlight the importance of maintaining thermal homeostasis during the critical 
period of NT closure. 
Maternal and embryonic exposure to alcohol and drugs 
While there is no question that exposure to alcohol in utero is detrimental to the 
developing fetus, the epidemiology linking maternal alcohol consumption to NTDs is less 
clear. A small Italian study found that mothers of children with spina bifida were 3-times 
more likely to have consumed 0.5 L/day or more of alcohol in the 3 months leading up to and 
immediately following conception243. Two American studies, on the other hand, showed no 
correlation between periconceptional maternal alcohol consumption and NTDs244,245. 
However, both American studies were retrospective, and the authors suggest that the social 
stigma against alcohol during pregnancy may have led to under-reporting. Animal models 
have shown adverse response to ethanol exposure, evidenced by increased NTDs in mice 
injected with ethanol around the time of NT closure246. The authors proposed that ethanol 
interferes with polyamine synthesis in the developing embryo. As polyamines are known to 
regulate cell growth and proliferation, this may be one mechanism by which alcohol disrupts 
embryonic development. Alcohol can also interfere with folate in OCM, although the 
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mechanisms are not well understood (reviewed in Kruman et al.247). Ethanol treatment of pigs 
results in decreased expression of methionine synthase (MS), a key enzyme in OCM, and it 
has been suggested that ethanol-induced inactivation of MS could lead to a pseudo-folate 
deficiency248.   
Maternal smoking and maternal exposure to environmental tobacco smoke (ETS) 
have also been studied epidemiologically with respect to risk for an NTD-affected 
pregnancy, with conflicting conclusions. Some find that smoking shows no correlation and 
some show an increased risk of NTD-affected pregnancies. Recent meta-analyses indicate 
that maternal smoking confers a small increased risk for spina bifida, and a moderately 
increased NTD risk in cases of maternal ETS exposure249,250. Interestingly, the data suggest 
regional differences in susceptibility, with maternal smoking being a higher risk factor in 
Europe than in the US250. Both smoking and ETS are associated with decreased serum folate 
levels251, so it is possible that the increased risk in Europe compared to the US may be related 
to differences in FA fortification policies. It has been proposed that the risk associated with 
maternal smoking may be under-estimated, as there is evidence that both maternal smoking 
and ETS are associated with a significantly increased risk of spontaneous abortion252, and 
early fetal loss is rarely included in retrospective studies. 
Given the prevalence of caffeine use, several studies have looked at whether 
periconceptional caffeine use is a risk factor for NTDs. One US study found no correlation 
between maternal caffeine intake and NTD-affected pregnancy253, while another small study 
suggested that there might be a slightly elevated risk254. Moreover, the susceptibility to 
caffeine as a risk factor varied by maternal race/ethnicity, with non-Hispanic whites showing 
no correlation, while Hispanic and all other ethnicities had a 1.5-2–fold increased risk254. An 
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Italian study, on the other hand, showed a strong association between maternal coffee intake 
(³ 3 cups/day) and spina bifida-associated pregnancy243, but it was a relatively small study, 
and the overall conclusions from the study focused on folate deficiency as the most important 
risk factor. Tea has also been implicated in NTDs, as tea contains catechins that can inhibit 
DHFR activity. In northern China, daily tea consumption was shown to increase the risk of 
NTD-affected pregnancy by over 3-fold255, although most of these women were also FA 
deficient, confounding the interpretation. However, in the US, no correlation was seen 
between tea consumption and NTDs256.  
As has been discussed above, the etiology of NTDs is extremely complex, with 
numerous genetic and environmental risk factors. In the US, we have been fortifying the 
grain supply with FA since 1998 in an attempt to reduce the incidence of NTDs. Although 
the incidence of NTDs has decreased since fortification, we lack an understanding of how FA 
affects the observed population response. Given the prevalence of NTDs and ciliopathies and 
the increase in levels of FA in the population since fortification, the importance of 
understanding how FA affects cilia cannot be overstated. The work presented in this thesis 





 PHENOTYPIC RESPONSE OF CILIA MUTANTS TO SHORT-TERM AND LONG-
TERM FOLIC ACID FORTIFICATION 
 
Introduction 
 The mouse has proven to be an invaluable tool for understanding human development 
and disease, including neural tube closure and NTDs. Over 240 alleles have been identified 
in mice that cause NTDs59,60, with gene products involved in a wide variety of molecular 
processes including ciliogenesis, cell cycle, cytoskeleton, cell migration, cell survival, 
polarity, metabolism, epigenetic regulators, cell adhesion, and signaling pathways like Shh 
and PCP. An updated list of genes implicated in murine NTDs can be found at the following 
website: https://ntdwiki.wikispaces.com. Moreover, NT closure genes identified in mouse 
have greatly informed human studies. 
 Despite the large number of NTD mouse models available and the growing evidence 
of the importance of folic acid in development, very few mouse models have been studied 
with respect to FA responsiveness. In addition, most of the mouse models have been tested 
with only short-term exposure to folic acid using methods ranging from placing the dam on a 
high folic acid diet shortly before mating through dissection to giving FA around the time of 
neural tube closure (embryonic day (E) 8-9) via intraperitoneal injections or gavage60,171.  In 
these short-term exposure studies, eight mutant strains showed a beneficial response to FA 
supplementation, as defined by a decrease in the incidence of NTDs175,181-183,185-188, and seven 
strains were found to be FA-resistant171,189,191-195, showing no change in the incidence of 
NTDs.   
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The effect of long-term, multi-generational FA fortification, which more accurately 
reflects the current status of the United States population, has only been studied in six mutant 
strains of mice.  Of these, one mutant, an allele for Zic2, was found to have a beneficial 
response to FA, while alleles of Frem2 and Shroom3 were FA-resistant175.  It is interesting to 
note, however, that the Shroom3 mutant showed a beneficial response to short-term FA 
supplementation175, suggesting that short-term and long-term exposure to FA are not 
equivalent.  The last three mutant strains studied, 3Poly, Lrp6 null, and a Grhl2 allele, all 
exhibited detrimental responses to long-term FA supplementation175,176. 
The 3Poly mouse line is characterized in part by a failure to assemble primary cilia. 
Based on this result, as well as the fact that nearly 5% of mouse genes implicated in neural 
tube closure are involved in ciliogenesis and/or cilia function, it raised the question of 
whether defective cilia may sensitize a system to respond adversely to FA fortification. To 
address this, mouse models with mutations in cilia genes affecting different aspects of 
ciliogenesis and function were studied with respect to both short-term and long-term 
exposure to FA fortification. The control diet was defined as having 2 ppm (equivalent to 2 
mg/kg) FA, while the fortified diet, referred to hereafter as the supra diet, contained 10 ppm 
(or 10 mg/kg) FA. These diets have been used in other studies of fortification and have been 
shown to accurately reflect pre- and post-fortification levels in the human population175,180. 
Results 
In addition to 3Poly, six additional mouse models with cilia defects were studied: null 
alleles of two IFT-B complex genes, Ift52 and Ift88, a hypomorphic allele of Ift88, a null and 
hypomorphic allele of the PCP effector gene Inturned, and a hypomorphic allele of C2cd3, 
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which is required for ciliary vesicle docking to the mother centriole (one of the initiating 
steps in ciliogenesis).  
Both IFT52 and IFT88 are considered to be part of the IFT-B complex ‘core,’ which 
also contains IFT81/74/46/27/70/25/22257,258. As mentioned above, proteins in the IFT-B 
complex are required for ciliogenesis. In Chlamydomonas, IFT52 localizes to the basal body 
transition fibers259, and it has been shown that IFT52 is central to the formation of the IFT-B 
complex, as it binds directly to at least four other proteins in the complex, including IFT88257. 
IFT88 localizes to basal bodies and the axoneme of cilia, and appears to have roles beyond 
IFT, such as regulating spindle orientation during mitosis260 and establishing epithelial PCP 
and for convergent extension in the murine cochlear duct78. Loss of either Ift52 or Ift88 in 
mice causes failure of ciliogenesis, disrupted Shh signaling, left-right asymmetry defects, and 
exencephaly39,40,54,55. For the studies reported here, a gene-trap allele of Ift52 was used in 
which the C-terminal end of the protein is replaced with the b-Galactosidase (b-Gal) gene. 
This allele will be referred to as Ift52hypo as it was originally called when it was characterized 
in our lab55. A hypomorphic allele of Ift88, Ift88fxo, was identified in a forward genetic screen, 
which shows similar, though milder phenotypes than the Ift88 null allele54. The hypomorphic 
Ift88 allele showed severe breeding problems on the supra FA diet, and hence was not 
studied here. The null allele of Ift88 was engineered to replace exon 2 and part of exon 3 with 
the b-Gal gene40, and will be referred to as Ift88null. 
Inturned is a highly conserved planar cell polarity effector gene first identified in 
Drosophila, and mutations in Intu lead to abnormal hair polarity and formation of multiple 
hairs per cell261. As mentioned above, Xenopus Intu is required for ciliogenesis, and plays an 
important role in embryonic development via mediation of CE and Hh signaling73,75. 
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Similarly, mammalian Intu is required for ciliogenesis and Hh signaling262, but surprisingly 
does not play a role in CE263, suggesting a divergence in function from its Drosophila and 
Xenopus homologues. Mice with null mutations in Intu, Intunull, do not survive past E15.5 and 
present with significant defects such as severe polydactyly, neural tube defects, and abnormal 
SHH signaling262. Mice with a hypomorphic allele, IntuDtm can survive to sexual maturity, but 
still exhibit polydactyly with 100% penetrance, though the severity of the polydactyly is less 
than in the null allele (7-9 digits per limb in Intunull, 6 digits per limb in IntuDtm). IntuDtm mice 
also have a low incidence of the cranial NTD, exencephaly264.  
 In humans, mutations in C2cd3 (C2 Calcium-Dependent Domain Containing 3) have 
been implicated in the ciliopathy orofaciodigital syndrome XIV (OFD14)265. In mammals, 
C2cd3 is required for ciliogenesis and Shh signaling266. C2CD3 localizes to the distal ends of 
the mother and daughter centrioles and is required for the recruitment of several centriolar 
distal appendage proteins. Loss of C2CD3 results in failure to recruit the ciliogenesis 
regulator TTBK2 to the basal bodies as well as failure to remove CP110 from the mother 
centriole, both of which are key steps in ciliogenesis. Furthermore, neither IFT52 nor IFT88 
can be recruited to the basal bodies47. In this study, the C2cd3Hty allele was used. It contains a 
point mutation at the beginning of intron 4 that disrupts splicing, causing either early 
truncation or in-frame deletions. Embryos homozygous for C2cd3Hty exhibit exencephaly, 
defective left-right axis determination, enlarged pericardial sacs, disrupted Shh signaling, and 
a severe reduction in cilia on the embryonic node and in mouse embryonic fibroblasts266.  
Short-term folic acid responsiveness of cilia mutants  
 Most of the previous studies on FA-responsiveness have used short-term exposures, 
either intraperitoneal (IP) injections of FA around the time of NT closure or placing dams on 
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diet shortly before mating or upon observing a vaginal plug. In line with these protocols, we 
also studied the effect of short-term FA fortification on the incidence of NTDs in our mouse 
models to determine if duration of exposure plays a role in FA-responsiveness. Animals were 
maintained on regular mouse chow (Tekland Rodent Diet 2920X) until visualization of a 
vaginal plug, at which time females were placed on either the control (2 mg/kg FA) or supra 
(10 mg/kg FA) FA diet. To ensure that the only difference between control and supra diets 
was the level of FA, both diets were special-ordered from Research Diets, Inc. This also 
avoids potential confounding factors that can arise if the animal facility changes the type of 
mouse chow, as occurred in the Anschutz vivarium in 2010, when the vivarium switched to a 
higher-protein content diet (see Appendix A for diet comparisons). Embryos were collected 
and scored between embryonic day (E) 9.5 and E16.5. Several of the lines used are 
embryonic lethal very soon after neural tube closure and thus had to be scored at E9.5. 
Mutants were often significantly delayed in their development (by somite count) such that it 
was impossible to score whether the cranial NT had closed or not, so embryos that were 
delayed were considered phenotypic. Like 3Poly, which is non-responsive to short-term FA 
fortification, none of the alleles studied responded significantly to FA fortification with 
respect to NTD penetrance (Figure 2-1).  
 Ift52hypo has 100% penetrance of exencephaly on either the control (19/19) or supra 
(25/25) FA diet. The incidence of exencephaly in C2cd3Hty on regular mouse chow, which 
contains slightly more FA than the control diet, has not been reported. On the control diet, 
C2cd3Hty embryos exhibited a 67% incidence of exencephaly (14/21) (Figure 2-1). The 
incidence was slightly higher on the supra FA diet (77%, 24/31), but the difference was not 
significant (p = 0.52). A similar trend was observed in the incidence of exencephaly in 
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IntuDtm embryos which increased from 3.5% (1/29) on the control diet to 14.3% (4/28) on the 
supra diet, but this increase was not found to be statistically significant (p = 0.19). Neither 
Ift88null nor Intunull had a statistically significant response to short-term FA fortification 
(control vs. supra p = 0.21 and p > 0.99, respectively). However, since the penetrance of 
exencephaly decreased from 100% on the control diet for both lines (22/22 Ift88null; 18/18, 
Intunull) to 89% (17/19, Ift88null) and 96% (24/25, Intunull) on the supra diet, it could be argued 
that there was small biologically significant rescue for both Ift88null and Intunull with short-
term FA fortification. As previously shown by Amber Marean, the incidence of exencephaly 
in 3Poly mutants was unaffected by short-term fortification (27%, 3/11 embryos on control 
vs 31%, 5/16 embryos on supra)175. 
 
Figure 2-1. The incidence of exencephaly is unaffected by short-term FA fortification. None 
of the cilia lines tested showed a significant change in the incidence of exencephaly between 







































































Litter size was not significantly affected by diet for any of the lines studied, and the 
distribution of embryo genotypes was Mendelian on both diets, with approximately 25% 
wildtype, 50% heterozygous, and 25% homozygous mutant, suggesting that there was no 
mutant embryo loss (Table 2-1). Furthermore, mutants were roughly 50% male and 50% 
female, with no effect of gender on the incidence of exencephaly. 
Table 2-1. Observed embryo ratio and litter size following short-term FA fortification. 
 
 IntuDtm was the only line in which mutants survive long enough to be scored for 
polydactyly. As mentioned above, IntuDtm mice have an additional digit on all limbs, 
specifically a duplication of digit 1, referred to as double thumb (Figure 2-2). On regular 
mouse chow, the incidence of double thumb is 100% (n > 300)264. Upon short-term exposure 
to the supra FA diet, the double thumb phenotype remains 100% penetrant (17/17). 
Surprisingly, the incidence drops to 77% on the control diet (20/26) (Figure 2-2B). This 
‘rescue’ is not statistically significant (p = 0. 066), though it trends towards significance. 
Furthermore, it can be considered biologically significant, indicating that a moderate dose of 
Ift52hypo +/+ +/mut mut/mut
Short-term Control 24 43 19 3 9.44 (9) None
Short-term Supra 24 63 25 15 8.79 (14) None
C2cd3Hty +/+ +/mut mut/mut
Short-term Control 37 51 21 10 9.08 (12) None
Short-term Supra 35 65 31 14 8.19 (16) None
Ift88null +/+ +/mut mut/mut
Short-term Control 38 68 22 6 9.21 (14) None
Short-term Supra 19 60 19 15 7.54 (13) None
Intunull +/+ +/mut mut/mut
Short-term Control 30 44 21 7 7.82 (11) None
Short-term Supra 40 62 25 25 8.47 (15) None
IntuDtm +/+ +/mut mut/mut
Short-term Control 36 71 29 23 7.68 (19) None
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FA (control diet, 2 mg/kg FA) is more beneficial for this line (submitted September 2016, 
Petersen et al., Developmental Biology267). 
  
Figure 2-2. The double thumb phenotype (A) observed in Intudtm/dtm embryos was rescued on 
the control FA diet (B) (though this did not achieve statistical significance). 
Long-term folic acid responsiveness of cilia mutants 
 In order to evaluate the effect of long-term, multigenerational exposure to FA 
fortification, dams were maintained on either the control (2 mg/kg) or supra (10 mg/kg) FA 
diet throughout pregnancy and their offspring were continuously kept on diet over multiple 
generations; then embryos in the F3-generation were scored for phenotype. Overall, the lines 
studied were either non-responsive or showed a detrimental response to long-term FA 
fortification ( 
Figure 2-3). 
Ift52hypo, C2cd3Hty and IntuDtm were non-responsive to FA fortification. Similar to the 
short-term fortification study, exencephaly in Ift52hypo mutants was 100% penetrant on both 
the control (29/29) and supra (20/20) folate diets. Unlike the short-term study, the incidence 
of exencephaly in C2cd3Hty was slightly higher on the control diet (78%, 21/27) than on the 
supra diet (67%, 20/30), although this was not statistically significant (p = 0.39). IntuDtm had 





























Like our previous studies of the 3Poly line175, both Ift88null and Intunull showed a detrimental 
response to long-term FA fortification. For Ift88null, 90% of mutant embryos were phenotypic 
on the supra diet (66/73), which is comparable to what was observed on the short-term supra 
diet (89%). However, only 77% (57/74) mutant embryos were phenotypic on the control diet, 
a significant reduction (p = 0.043). Similarly for Intunull, 90% (19/21) of homozygous mutant 
embryos showed exencephaly/developmental delay on the supra diet whereas only 64% 
(23/36) showed these phenotypes on the control FA diet (p = 0.033). While not as large a 
response as what was observed in 3Poly (18% NTDs (3/17) on control FA diet versus 58% 
(14/24) on supra FA diet (p= 0.012), it is still significant that two of the lines studied also 
responded detrimentally to FA fortification with respect to NTD incidence when compared to 
NTD incidence on the control diet. 
 Unlike the short-term fortification study, litter size was affected in one line, and 
significant mutant loss was observed in another (Table 2-2). C2cd3Hty had significantly larger 
litters on the supra diet compared to the control diet (average of 8.91 compared to 7.69 
embryos, p = 0.019). Significant mutant loss was observed for Ift88null on both the control 
(24% loss) and high diet (20% loss). It is difficult to explain this mutant loss, as comparable 
loss was observed on each diet, and because only Ift88null was affected, suggesting that it is 
not just an effect of the long-term diet regime. Since the potential for mutant loss has not 
been addressed for this line, it is possible that such mutant loss by E9.5 is typical, though no 
mutant loss was observed in the F1 generation. As it was observed on both control and supra 




Figure 2-3. The incidence of exencephaly in F3-control diet and F3-supra diet mutants.  
Exencephaly was significantly higher in F3-supra diet mutants than F3-control diet mutants 
in 3 of the 6 lines tested. The remaining 3 lines were non-responsive to FA fortification with 
respect to NTDs. 
 
Figure 2-4. The incidence of double thumb was significantly reduced in F3-control diet 
















































































































Long-term Control 25 70 29 9 7.35 (17) None None




Long-term Control 28 56 27 13 7.40 (15) None None




Long-term Control 108 206 74 22 7.69 (29) None 24% loss




Long-term Control 33 86 36 13 9.10 (20) None None




Long-term Control 26 43 30 26 8.11 (19) None None
Long-term Supra 78 138 75 51 8.24 (17) None None
3poly +/+ +/mut mut/mut
Long-term Control 17 45 17 18 7.18 (11) None None
Long-term Supra 42 98 24 13 6.07 (27) None 43%
* some embryos could not be genotyped, but were nonetheless counted in litter size; only genotyped embryos 
were used to calculate embryo loss
Beneficial      
(litter size)
None
Litter Size      
(# of 
litters)
Effect of FA 
Supplementation
% +/mut 
embryo loss Line/Diet Observed Embryo Ratio Resorptions
Detrimental *
% mut/mut 





 Like the short-term studies, IntuDtm responds beneficially to lower levels of FA with 
respect to the double thumb phenotype. Polydactyly is still 100% penetrant on the supra FA 
diet (35/35), but was only observed in 80% of mutants on the control diet (24/30) 
(Figure 2-4). This rescue was found to be statistically significant (p = 0.0072). 
Exploring the possibility of a defect in heterozygous 3Poly adults 
 One of the phenotypes observed by Amber Marean in the 3Poly line was a fertility 
defect in which only 35% of plugged heterozygous females were actually pregnant 
(compared to 95-100% of C57BL/6 and 129S1/SvImJ wildtype mice268). Since 3Poly has a 
cilia defect, and cilia are involved in transport of ova, sperm and embryos in the fallopian 
tube269, we hypothesized that the decreased fertility in 3Poly was the result of a cilia 
phenotype in heterozygous mice. To address this, we first looked at the oviducts, hoping to 
 49 
see cilia number or structural defects in heterozygous females. However, oviducts are 
extremely tough, fibrous tissues to work with, and preliminary data was difficult to obtain. 
Therefore, we next decided to look at cilia function in the nasal/olfactory epithelia in an 
attempt to assay cilia in a more tractable system.  
The olfactory epithelium contains multiciliated olfactory sensory neurons (OSNs) 
required for odorant detection. Although these cilia have the 9+2 microtubule arrangement 
normally associated with motile cilia, they lack the dynein arms required for movement and 
thus are actually immotile cilia270. Odorant receptors are enriched in OSN cilia, and odorant 
detection occurs via activation of adenylyl cyclase type III (ACIII) and increased ciliary 
concentration of cyclic adenosine monophosphate (cAMP). Olfactory cyclic nucleotide-gated 
channels open in response to cAMP binding, causing OSN depolarization270. OSN cilia 
function was measured using electro-olfactograms (EOGs) in the olfactory epithelium, with 
assistance from the lab of Dr. Diego Restrepo, which has a great deal of expertise in 
measuring responses in olfactory sensory neurons (OSNs)271,272. 
 Pregnant F2-control diet and F2-supra diet female mice were used for this study 
following harvesting of their F3 embryos Traditionally, the response of the nasal epithelia to 
various odorants is normalized to the response to exposure to 3-isobutyl-1-methylxanthin 
(IBMX), which inhibits the breakdown of cAMP by phosphodiesterase and activates all nasal 
epithelia downstream of olfactory receptor proteins activation by odorants. When I 
performed this comparison, there was no significant difference in the response to odorants in 
3Poly females on either diet (Figure 2-5A). However, the overall response to IBMX was 
significantly lower in supra diet F2-females than in control diet F2-females (8.89 ± 0.72 on 
the supra diet compared to 15.33 ± 0.81 on control diet, p < 0.0001) (Figure 2-5B), 
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suggesting that olfactory cilia in supra F2-females may have compromised function. It should 
be noted that very few animals were tested (n = 3 for control F2-females and n = 2 for supra 
F2-females, Student’s t-test). Although these preliminary results were interesting and worthy 
of further study, this work was not continued for technical reasons. Given the prevalence of 
human ciliopathies, these data are intriguing as they suggest that FA fortification can have a 
detrimental effect even in the context of a heterozygous mutation of a cilia gene. 
 
Figure 2-5. Odorant responses of F2-control diet and F2-supra diet 3Poly heterozygous 
females (measured by EOG). (A) 3Poly heterozygous females show no responsiveness to FA 
fortification when odorant response is normalized to IBMX response. However, (B) supra-
diet 3Poly heterozygous females show an overall decreased odorant response to IBMX (**** 
p < 0.0001, Student’s t-test).  
Discussion 
The incidence of NTDs has decreased significantly in the US and other countries since 
FA fortification of the grain supply, but the mechanism by which FA affects NT closure is 
not understood. While it is clear that at a population level, FA fortification is beneficial, we 
do not yet know if certain genetic factors may respond to fortification in unexpected (and 
potentially detrimental) ways. The purpose of this study was to extend the finding of one 
genetic mutant, with disrupted ciliogenesis that responded adversely to FA fortification, to a 
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class of defects that respond negatively to FA fortification. Overall, the cilia mutants tested 
were non-responsive to short-term fortification, and four of six lines, Ift88null, Intunull, IntuDtm, 
and 3Poly, had either a detrimental response to long-term fortification or significantly 
benefited from the control FA acid. These data support the findings of Dr. Amber Marean, 
that some genetic defects have a detrimental response to FA fortification175,273. Specifically, 
all the lines I studied affect ciliogenesis, suggesting that mutations affecting at least some 
cilia genes represent a class of mutations that benefit from more moderate levels of FA. 
Given the prevalence of ciliopathies – for example, autosomal dominant polycystic kidney 
disease is estimated to affect 1 in 1000 people – it is even more important to understand the 
interaction of cilia genes and folic acid dose.  
This is the first time that FA and cilia have been linked, and it begs the question of 
how FA and cilia might interact. It is known that FA acts as a methyl donor in the generation 
of S-adenosylmethionine (SAM) via one-carbon metabolism (OCM), and there is evidence 
for a direct link between protein methylation and flagella disassembly in Chlamydomonas. 
Seven proteins are asymmetrically methylated by protein arginine methyltransferase 1 
(PRMT1), which is thought to either disrupt protein-protein interactions and destabilize the 
components of the axoneme, or promote protein-protein interactions leading to retrograde 
transport of these methylated proteins out of the flagellum274,275. Interestingly, two of the 
proteins that are methylated are CCDC40 and CCDC65, which have both been implicated in 
primary ciliary dyskinesia in humans276,277. Another potential link for future study is that 
Prmt1 is activated via phosphorylation, and at least 7 phosphorylation sites are conserved 
between Chlamydomonas and human Prmt1. Thus it is possible that FA directly affects cilia 
stability via protein methylation in mammals.  
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Another possible methylation-dependent mechanism is through effects on the 
epigenome. In one study, multi-generational fortification (six generations total) with methyl-
donors including FA, betaine, methionine and choline significantly altered the epigenetic 
landscape148, though global DNA methylation was not altered. However, exposure to a 
methyl-rich diet caused increased variability of which loci were methylated, and genes 
involved in development were overrepresented in these methylation-variable loci148. Another 
recent study found that maternal serum folate levels affected DNA methylation in infants. 
Over 400 CpG methylation sites (associated with 320 genes) were identified that were 
significantly affected by serum folate levels. Even after multiple comparison analysis 
correction, the methylation state of 48 CpG regions in infants was significantly affected by 
maternal folate status278. Although DNA methylation-gene expression correlations could not 
be made in the infant samples, data from adult samples indicated that differential methylation 
at most of these CpG sites correlates with differential gene expression. Another example of 
FA affecting DNA methylation and gene expression comes from an Alzheimer’s disease 
mouse model. Supplementation with FA significantly increased DNA methylation of genes 
associated with the janus kinase-signal transducer and activator of transcription (JAK-STAT) 
and long-term depression signaling pathways, and this correlated with concomitant decreased 
gene expression279. Therefore, it is possible that the phenotypic responses observed in the 
mouse models of ciliopathies are the result of epigenetic changes leading to altered gene 
expression. This hypothesis is strengthened by the fact that it takes several generations to see 
the phenotypic response, as one might expect from an altered epigenetic landscape280. The 
potential role of differential DNA methylation and gene expression will be explored in 
Chapters 4 and 5. 
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OCM is also involved in the generation of purines and thymidylate, the building 
blocks of DNA and RNA. It is known that folate-deficient diets can reduce the pool of 
available nucleotides281. Recent work from the lab of Dr. James DeGregori has shown that 
long-term (but in this case not multigenerational) exposure to either FA-deficient (0.1 mg/kg 
FA) or a supra-FA (10 mg/kg) diet reduces the nucleotide metabolism in B-progenitor cells 
compared to mice maintained on a control diet (2 mg/kg FA) (Henry et al., submitted). 
Disrupting nucleotide metabolism can affect cell proliferation, which in turn is known to 
affect neural tube closure282,283. Altered cell proliferation will also be explored in Chapter 4 as 
a possible mechanism of the observed phenotypic response.  
Although there is strong clinical and epidemiological evidence for the role of FA in 
reducing the risk of NTDs as well as reducing certain congenital heart defects284, there is also 
growing evidence that too much FA may be detrimental. Embryos from wild type mice 
maintained on diets fortified with very high doses of FA (40 mg/kg FA) or more moderate 
doses of FA (20 mg/kg FA) were significantly developmentally delayed and had thinner 
ventricular walls of the heart compared to those of embryos exposed to a control diet (2 
mg/kg FA)285,286. In post-menopausal women, unmetabolized serum FA was associated with 
significantly reduced natural killer cell cytotoxicity287. High-dose FA supplementation in 
mothers has been associated with a significantly increased risk of infant asthma288, and 
multiple studies have found strong correlations between high maternal FA intake and 
increased risk of allergic disease in offspring in both rodent models and human studies289,290. 
Maternal supplementation with folic acid has been linked to a decreased risk for autism291,292, 
but recent work has also found a correlation between excessively high levels of serum folate 
in mothers and an increased risk of having an autism diagnosis293,294. These studies, along 
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with the phenotypic responses observed in this thesis, strongly indicate the need for a better 
understanding of FA dosage in human health.  
Methods 
Animals 
 The generation and characterization of Ift52hypo, C2cd3Hty, Ift88null, Intunull and IntuDtm 
have been described elsewhere40,55,262,264,266. All five lines were maintained on a C3H/HeN 
background and genotyping was performed as previously published. 3Poly was generated in 
an ENU-mutagenesis forward genetic screen and genotyping was performed using SSLP 
primers to differentiate between wildtype 129S1/SvlmJ background and the mutagenized 
C57Bl/6 DNA region, as described in Amber Marean’s thesis273. Animals were housed at the 
University of Colorado Anschutz Medical Campus in accordance with an IACUC-approved 
protocol. Genomic DNA was isolated using various standard protocols from tail snips 
digested overnight in 100 uL lysis buffer (50 mM Tris HCl pH 8.8, 1 mM EDTA, 0.5% 
Tween20) with proteinase K (50 ug/mL) at 55 °C. Mice were maintained on Tekland Rodent 
Diet (2018S) (~4 mg/kg FA) and timed-mated. Females were checked for vaginal plugs 
(embryos at noon were considered 0.5 days post fertilization, E0.5), and were placed on 
either control diet (2 mg/kg FA) or supra (10 mg/kg) FA diet; all other diet components are 
the same between the control and supra FA diets (Research Diets, Inc.: 2 p.p.m. is 
D05072702; 10 p.p.m. is D05072701; p.p.m. is equivalent to mg/kg of chow and is not based 
on body weight). For short-term FA exposure (control v supra FA diet at E0.5), embryos 
were dissected from timed-matings on E9.5 – E16.5 (called F1 embryos), and scored for 
NTDs, delayed development (by somite count), incorrect heart looping, enlarged pericardial 
sac, and/or polydactyly, as appropriate for the line. For long-term multigenerational FA 
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exposure, mice were maintained on either the control or supra FA diets for 2 generations, 
time-mated and embryos were dissected at E9.5 – E16.5 (F3 embryos) and scored as above. 
Fisher’s Exact Test was used to evaluate the difference in rates of phenotypes observed in 
mutant embryos. Chi squared goodness of fit test was used to assess deviations from 
expected Mendelian ratios (GraphPad Prism 7). 
Electro-olfactograms (EOGs) 
EOGs were performed as previously described by the Restrepo lab271. Briefly, mice 
were killed by CO2 inhalation followed by cervical dislocation. The head was bisected and 
the nasal septum was removed to expose the endoturbinates. The half-head was mounted in 
Ringer’s saline (145 mM NaCl, 5 mM KCl, 20 mM N-2-hydroxyethylpiperazine-Nʹ-2-
ethanesulfonic acid buffer-Hepes, 1 mM MgCl2, 1 mM CaCl2, 1 mM Na pyruvate, and 5 
mM D-glucose (pH 7.2)) in the EOG chamber. Electrodes were placed between the turbinates 
of the nasal epithelium. IBMX (3-isobutyl-1-methylxanthin) and odorants were dissolved in 
Ringers (IBMX, 1 mM; Isoamylacetate, 25 µM; Lilial, 25 µM; 2-heptanone, 25 µM) and 
passed over the turbinates in 6 pulses, of which only the last 4 were used for analysis. 
Between odorants, turbinates were washed with Ringers and allowed to rest for at least 2 
minutes before applying the next odorant. EOG recordings were made using a DC 
potentiometer and analyzed with AxoGraph. Three F2-control diet and two F2-supra diet 
animals were used (a third F2-supra diet animal was found to be the wrong genotype, and 
thus measurements were not included in analysis). Statistical analyses (Student’s t-tests) were 








The mouse is an invaluable system for studying complex developmental processes 
like neural tube closure, but there are advantages to extending our in vivo analyses to simpler 
in vitro or cell culture systems. All of the mouse models studied in this thesis contain 
mutations in genes affecting ciliogenesis and/or cilia function, and we felt that a cell culture-
based system could complement the animal models with respect to exploring possible direct 
effects of FA on ciliogenesis. Specifically, we sought to manipulate folate levels experienced 
by a monolayer of cultured cells to directly study FA effects, thus reducing the number of 
confounding variables found in live organisms. Moreover, this would give us the ability to 
use a simplified system to assay FA responsiveness much more quickly than a 
multigenerational dietary exposure scheme, as well as afford us the opportunity to use cells 
from human patients. We can also genetically manipulate cell lines much more easily and 
more quickly than generating new mouse lines, especially with the advent of CRISPR-Cas9 
technology295, allowing for much faster screening of potential FA effects on mutations 
identified in human patients. 
Mammalian cells are typically cultured in media containing very high concentrations 
of folic acid, ranging from 1000 ng/mL (MEM and RPMI media) to 4000 ng/mL (IMDM and 
DMEM). These levels of folic acid are several orders of magnitude higher than what is 
observed in serum in either mice or humans on fortified diets, in which serum folate levels 
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ranged from 5 ng/mL to 25 ng/mL175,296. Previous work on the Intunull mouse line showed that, 
although cilia were present in vivo as seen in the lumen of Intunull/null embryonic neural tubes, 
mouse embryonic fibroblasts (MEFs) from Intunull embryos grown in regular DMEM failed to 
form cilia262. The authors suggested that there might be factors present in the tissue 
environment that were permissive to ciliogenesis in the absence of Intu. However, based on 
the phenotypic response of Intunull to FA fortification, we hypothesized that another possible 
explanation was the extremely high levels of FA in the culture media was adversely affecting 
ciliogenesis. Thus, we wanted to explore whether this in vitro system allowed us to grow 
cells in lower doses of FA. 
By modulating the level of FA in media, we hoped to create an in vitro system to 
more directly probe the effect of FA on ciliogenesis. In particular, we hoped to assay the 
effect of decreasing (or increasing) the dosage of FA on cilia formation and cilia length in 
cells containing the mutations that were detrimentally affected by folic acid fortification in 
Chapter 2. Also, by developing an in vitro system, we could begin to extend our findings in 
mice to determine the consequences of manipulating FA levels on human ciliopathy patient 
fibroblasts and/or cell lines engineered to contain mutations in other ciliary genes.  
Results 
Experimental determination of appropriate folic acid levels for in vitro cell studies 
In vitro assay: Take 1 
 Initially, we sought to mimic the serum folate conditions found in humans pre- and 
post-fortification, which averaged 5 ng/mL pre-fortification to 15 ng/mL post-fortification 
(the average concentration in the highest quintile was 25 ng/mL FA297). These levels were 
comparable to F2 mice maintained on control or supra FA diets (10.0 ± 3.8 ng/mL and 25.6 ± 
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4.3 ng/mL, respectively)175,296,297. Therefore, we first compared ciliogenesis in media with 
folate levels of 5 ng/mL or 25 ng/mL, to conventional FA culture media (4000 ng/mL). 
Mouse embryonic fibroblasts (MEFs) were isolated from E12.5 – E14.5 F3 Intudtm embryos 
from dams maintained on either the control FA (F3-control, 2 ppm FA) or supra FA (F3-
supra, 10 ppm FA) diets. MEFs isolated from F3-control diet embryos were then cultured in 
media containing either 5 ng/mL FA or 4000 ng/mL FA (normal DMEM), while MEFs 
isolated from F3-supra diet embryos were cultured in media containing 25 ng/mL FA or 4000 
ng/mL FA.  
 
Figure 3-1. Responsiveness of MEFs to very low levels of FA in media. Cilia number in 
wildtype cells from either F3-control diet (dark blue) or F3-high diet (red) was unaffected by 
FA media levels. Intudtm/dtm MEFs had increased cilia number when maintained on lower dose 
FA media. F3-control diet mutant, light blue, was not significant, while F3-supra diet mutant 
had significantly more ciliated cells on 25 ng/mL FA than 4000 ng/mL FA (27 ± 16% v. 8 ± 
8%, respectively, p = 0.02). (Mean ± SD) 
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The preliminary results were striking, as heterozygous or wildtype embryos had comparable 
numbers of ciliated cells at any level of FA, while Intudtm mutant embryos had significantly 
more ciliated cells when maintained on either the 5 ng/mL or 25 ng/mL FA media compared 
to the 4000 ng/mL FA media (Figure 3-1). However, it quickly became apparent that the 
low-dose FA media levels were much too low and it was adversely affecting the cells, as 
evidenced by enormous nuclei and many cells with supernumerary basal bodies and multiple 
cilia in both wildtype and mutant MEFs (Figure 3-2). 
 
Figure 3-2. Multiple cilia and supernumerary centrioles observed in low-FA media. Intudtm 
mutant (left) and wildtype (right) cells displayed multiple cilia and supernumerary centrioles 
when grown on 5 ng/mL (shown here) or 25 ng/mL FA media. (green: g-tubulin, centrioles; 
red: Arl13b, cilia membrane; blue: Hoescht, nuclei) 
In vitro assay: Take 2 
 Once it became clear that physiological levels of FA (based on serum folate) were 
much too low for cell culture, the lowest ‘dose’ was increased to 100 ng/mL FA, and a 
‘middle’ dose of 500 ng/mL was added. Standard DMEM (4000 ng/mL FA) was still used as 
the ‘high’ dose. Due to a lack of F2-control diet females available for breeding at the time of 
this pilot experiment, only the supra FA diet was studied. Again we noted the interesting 
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result that MEFs isolated from Intudtm mutant embryos responded to folate levels in the 
media. Specifically, F3-supra diet mutant MEFs grown at the lowest dosage of FA, 100 
ng/mL FA, had levels of ciliated cells indistinguishable from wildtype MEFs grown at any 
dosage of FA (71 ± 3% compared to 68 – 78% in wildtype cells). Furthermore, the response 
appeared to be dose dependent, such that mutant MEFs grown at 500 ng/mL FA had fewer 
ciliated cells than MEFs grown at 100 ng/mL FA (43 ± 6%), but significantly more ciliated 
cells than MEFs grown at 4000 ng/mL (20 ± 4%) (Figure 3-3A). Basal body numbers did not 
appear to be affected by FA. Cilia length in Intudtm mutant MEFs was also affected by FA 
media level. Average cilia length for mutant MEFs grown in either 100 ng/mL or 500 ng/mL 
FA media was comparable to the average cilia length of wildtype MEFs grown in any FA 
media condition (2.9 ± 0.4 µm on 100 ng/mL FA and 2.6 ± 0.2 µm on 500 ng/mL FA 
compared to 2.9 – 3.2 µm for wildtype, Figure 3-3B). Since cilia length is known to be 
important for cilia function, this result suggests that FA is affecting cilia function by 
modulating both cilia number and cilia length in Intudtm mutants. It should be noted that these 
data came from a single experiment as it was decided to increase the level of the lowest FA 
dosage yet again because cells grown at 100 ng/mL grew extremely slowly. Furthermore, at 
this time cilia length was measured using 2-D measurements in ImageJ, which was not as 
accurate as the 3-D measurement methods used in later experiments. As indicated below, we 
ultimately chose 250 ng/mL FA as our lowest dose. 
In vitro assay: Takes 3 and 4 
 The in vitro system was developed to recapitulate the long-term multigenerational 
diet scheme developed for our mouse studies in Chapter 2, but any patient cell lines or 
immortalized cell lines could not be subjected to a similar scheme of multi-generational 
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exposure to the diet prior to isolation and cell culture. Furthermore, some of the mouse NTD 
models used in Chapter 2 were no longer being maintained on the FA diets. I therefore 
decided to determine whether there was a differential FA effect on MEFs isolated from mice 
maintained on regular mouse chow and then exposed to varying FA levels in the culture 
media. 
 
Figure 3-3. Responsiveness of Intudtm/dtm mutants MEFs to FA levels in media. Intudtm/dtm 
mutant MEFs isolated from F3-supra diet embryos have increased cilia number (A) and cilia 
length (B) when grown in media containing lower levels of FA. Cilia length was measured in 
2-D on a maximum intensity projection of Z-stack images, not in 3-D. (* p < 0.05; ** p < 
0.01; *** p < 0.001; **** p < 0.0001). 
 For lines like Intudtm and 3Poly, generating MEFs was not a problem, as embryos are 
viable at least through E12.5. The other lines are embryonic lethal by E10.5 and this led to 
severe technical difficulties as primary cell lines reach crisis around passage (P) 5-8. E9.5 
and E10.5 embryos do not yield very many cells, and by the time there were enough cells 
from an embryo to split into different FA media conditions, the cells had undergone (or were 


























































































F3-supra wildtype F3-supra mutant
 62 
It was also ultimately decided that if an epigenetic mechanism was at play, it would 
be better to use MEFs isolated from F3-diet embryos. At this time, only the Intudtm, Intunull 
and Ift88null lines were still being maintained on the FA diets, as both Ift52hypo and C2cd3Hty 
had already been found to be non-responsive to multigenerational FA fortification. However, 
MEFs from both Intunull and Ift88null had to be isolated from E9.5 embryos (by E10.5 mutants 
were either dead or approximately 24 hours delayed), which led to the aforementioned 
crisis/senescence difficulties.  
Given these difficulties, we decided to attempt to immortalize the MEFs, with the 
caveat and concern that many changes occur during the immortalization process (either 
spontaneous or induced immortalization), which could confound the results. Cells were 
immortalized at P1 using a retrovirus expressing the oligomerization domain of p53, DDp53, 
which inhibits p53 activity298. Unfortunately, between 10-90% of cells appeared to undergo a 
mesenchymal-to-epithelial transition (MET) upon inhibition of p53, evidenced by a 
morphological change from elongated, spindle-shaped cells to tightly clustered colonies with 
cobblestone morphology. In retrospect, it has been noted that p53 inhibits MET in MEFs299, 
although the DDp53 construct has been used to successfully to immortalize other primary 
cell lines. Attempts were made to isolate only cells with mesenchymal morphology, but these 
were unsuccessful. Ultimately it was decided to abandon attempts to immortalize MEFs and 
to focus on Intudtm MEFs, which can be isolated from E14.5 embryos to yield enough cells 
from one embryo to carry out parallel experiments with differing levels of FA media for 
several passages before assaying for ciliogenesis. 
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A defined method used to test the ciliogenic response of mouse and human cells to folic 
acid levels  
Ciliogenesis is increased in mouse embryonic fibroblasts grown in lower FA-containing 
media 
After the range of troubleshooting efforts above, it was decided to use F3-embryos 
derived from the Intudtm mouse line, with the lowest dose of media set at 250 ng/mL FA. 
Briefly, MEFs were isolated from F3 embryos from dams maintained on either the control 
FA (2 mg/kg) or supra FA (10 mg/kg) diets. In order to mimic the control and supra-FA diet 
conditions during isolation of MEFs, MEFs from F3-control diet embryos were isolated into 
custom prepared DMEM containing 250 ng/mL FA, while MEFs from F3-supra embryos 
were isolated into DMEM containing 4000 ng/mL FA. MEFs from both diets were then 
cultured for 3 passages in DMEM containing 250 ng/mL, 500 ng/mL or 4000 ng/mL of FA. 
On the 4th passage, cells were serum starved for 48h to induce ciliogenesis, and then assayed 
for cilia number and cilia length.  
As expected, the Dtm mutation significantly affected cilia number (p < 0.0001, 3-way 
ANOVA). Following serum starvation, Intudtm/dtm mutant MEFs had significantly fewer 
ciliated cells than wildtype MEFs (25-45% fewer ciliated cells in mutants compared to 
wildtype, p < 0.0005 for all pairings across folate levels in media, 2-way ANOVA followed 
by Bonferroni posttests, (Figure 3-4 and Table 3-1)). This is consistent with previously 
published data on the Intudtm/dtm mutant264 indicating that cells carrying this hypomorphic 
Inturned mutation have defects in ciliogenesis.  
MEFs were significantly responsive to FA levels in media independent of diet or 
genotype (p < 0.0001, 3-Way ANOVA) and surprisingly this was true even for wildtype 
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cells. Focusing first on wildtype MEFs we found that F3-control diet wildtype MEFs had 
>20% more ciliated cells when grown in either 250 ng/mL FA or 500 ng/mL FA compared to 
cells grown in 4000 ng/mL FA (blue significance bars, p < 0.01 for both, 2-way ANOVA + 
Bonferroni posttest). F3-supra diet wildtype MEFs had 46% more ciliated cells when grown 
on 250 ng/mL FA and 28% more when grown on 500 ng/mL FA media, compared to cells 
maintained on 4000 ng/mL media (red significance bars, p < 0.001 and p < 0.01, 
respectively) (Figure 3-4A). Independently, diet was also a significant factor, as F3-control 
diet wildtype MEFs grown in 500 ng/mL and 4000 ng/mL FA media had significantly more 
ciliated cells than F3-supra diet wildtype MEFs (black significance bars, p < 0.01 for both). 
Thus, even wildtype cells show a significant reduction in cilia number as a result of both 
multigenerational dietary levels of FA and media concentrations of FA, suggesting that FA 
may repress ciliogenesis. 
Similarly, MEFs from Intudtm/dtm embryos responded to changes in folate media levels. 
F3-control diet Intudtm/dtm MEFs grown in either 250 ng/mL or 500 ng/mL had significantly 
more ciliated cells than those grown in 4000 ng/mL media (>50% more ciliated cells on 250 
ng/mL and 500 ng/mL FA media compared to 4000 ng/mL media, p < 0.0001, 1-way 
ANOVA, Tukey’s MCT)). When F3-supra diet Intudtm/dtm MEFs were analyzed there was a 
trend to more ciliated cells in 250 ng/mL FA media compared to 4000 ng/mL FA media but 
this was not significant, although there were significantly more ciliated cells in the 500 
ng/mL FA media than the 4000 ng/mL media (>44%, p < 0.05, 1-way ANOVA, Tukey’s 
MCT) (Figure 3-4B and Table 3-1). Furthermore, cell density was not a factor, as the average 
number of cells per field of view was the same for all conditions. Thus, as we observed in 
Chapter 2, better outcomes are obtained with lower FA doses. This also indicates the 
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usefulness of this experimental in vitro system to study the response of cells from cilia 
mutants to alterations in FA levels.  
 
Figure 3-4. FA dosage response of Intu+/+ and Intudtm/dtm MEFs. MEFs maintained on media 
containing lower levels of FA achieve a higher percentage of ciliated cells than MEFs 
maintained on ‘typical’ FA media (4000 ng/mL FA). A) Wildtype MEFs isolated from either 
F3-control diet (blue) or F3-supra diet (red) embryos have significantly more ciliated cells 
when maintained on 250 ng/mL or 500 ng/mL FA media compared to 4000 ng/mL FA 
media. B) Intudtm/dtm mutant MEFs isolated from F3-control diet (blue) and F3-supra diet 
(pink) embryos also have more ciliated cells when maintained in media containing lower 
levels of FA. (* p < 0.05; ** p < 0.01; *** p < 0.001, n = 3 littermate pairs for each diet, > 
400 cells counted for each condition). 
 
Table 3-1. Percentage of ciliated cells: Wildtype and mutant mouse embryonic fibroblasts 
grown in 250 ng/mL, 500 ng/mL and 4000 ng/mL FA media (± SEM). 
 250 ng/mL FA 500 ng/mL FA 4000 ng/mL FA 
F3-control diet wildtype 84% (± 3) 84% (± 1) 69% (± 4) 
F3-control diet mutant 57% (± 2) 58% (± 3) 38% (± 4) 
F3-supra diet wildtype 79% (± 2) 69% (± 4) 54% (± 3) 


























































Moreover, the multigenerational supra FA diet significantly reduced the number of 
ciliated cells independent of genotype or media FA levels (p < 0.0001, 3-Way ANOVA), 
though this effect was more clearly observed in wildtype MEFs. Wildtype MEFs from F3-
control diet embryos had significantly more ciliated cells than MEFs isolated from F3-supra 
diet embryos in both 500 ng/mL and 4000 ng/mL folate media (p < 0.01 for both, 2-way 
ANOVA, Bonferroni posttest). A similar trend was observed in Intudtm/dtm MEFs in that there 
were significantly more ciliated cells between control and supra diet passaged on 250 ng/ml 
folate media. We also measured cilia length under all of these conditions but found that this 
was unaffected by diet or FA levels or genotype (Figure 3-5).  
 
Figure 3-5. Cilia length is unaffected by FA media levels in wildtype or Intudtm mutant MEFs. 
Ciliogenesis in mutant MEFs in low FA media in vitro is rescued to almost wildtype numbers 
Mutant MEFs from either diet passaged on the lower dosage FA media (250 ng/mL 
and 500 ng/mL FA) had numbers of ciliated cells (~60%) relatively similar to wildtype 
MEFs grown in typical culture media (4000 ng/mL FA). Cilia percentage was statistically 
comparable between F3-control diet mutant MEFs grown in either 250 ng/mL or 500 ng/mL 















































supra diet mutant MEFs grown in lower FA media had levels of ciliated cells 
indistinguishable from F3-supra diet wildtype MEFs grown in 4000 ng/mL FA media, but 
significantly fewer ciliated cells than F3-control wildtype MEFs grown in 4000 ng/mL FA 
media. These data also support that diet is a significant factor affecting ciliogenesis. This 
‘rescue’ of ciliogenesis in mutant MEFs grown in low-folate media to relatively normal 
numbers suggests a possible explanation for the lower incidence of the double thumb 
phenotype in F3-control diet Intudtm/dtm embryos (see Figure 2-4).  
 
Figure 3-6. Intudtm/dtm MEFs maintained in media containing low levels of FA have 
proportions of ciliated cells comparable to wildtype MEFs maintained on regular FA media 
(4000 ng/mL). 
Taken together, genotype, diet and media FA levels were all found to be significant 
independent factors affecting cilia number (p < 0.0001). Furthermore, all three factors show a 
significant interaction with each other (p = 0.045, 3-way ANOVA), and there was a 
significant 2-way interaction between genotype and media FA levels (p = 0.03). Overall, the 
data indicate that ciliogenesis is significantly enhanced when MEFs are maintained in media 
containing lower levels of FA than current standard media. 
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Response of human patient fibroblast cells from ciliopathy patients to lower FA levels in 
media: applying the in vitro system to a human cell line 
Since the in vitro system using MEFs showed promise, we started thinking about 
testing primary human fibroblast cells from patients with ciliopathies to see if they respond 
comparably to decreased folate levels. To test the system, we chose human retinal pigmented 
epithelial cells (RPE1), a cell line commonly used to study cilia. As expected, the percentage 
of ciliated cells in wildtype RPE1 cells was unaffected by FA levels in the media, though 
cilia number was affected by whether ciliogenesis was induced via serum-starvation or 
confluence (confluence-induced ciliogenesis), with a higher percentage of cells assembling 
cilia upon serum-starve conditions (overall: serum-starve, 82 ± 2%, compared to confluence-
induced, 47 ± 2%, p < 0.0001, Figure 3-7).  
Given the response observed in MEFs grown in the super-low FA media, we 
hypothesized that some of the response could be related to differences in FA uptake and 
therefore we attempted pilot studies to assess the localization of folate receptor alpha (FRa). 
Initial results were promising, as FRa appeared to localize to the basal bodies and cilia 
(Figure 3-8A), and intriguingly appeared to localize to cilia in RPE1 cells in an FA dose-
dependent manner, though the direction of the trend depended on the method used to induce 
ciliogenesis. Looking specifically at ciliated cells of the RPE1 line, under serum-starvation 
conditions there was a higher percentage of cilia stained for FRa when grown on higher FA 
media. Conversely, when ciliogenesis was confluence-induced, more cilia stained for FRa 
when grown on lower FA media (Figure 3-8B). Unfortunately, the only available FRa 
antibody was from Santa Cruz and, as can be seen in Figure 3-8A, there was high 
background. Furthermore, subsequent aliquots obtained from Santa Cruz did not work at all. 
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A GFP-tagged FRa construct was transfected into RPE1 cells, and did not reproduce these 
localization results. Hence this aspect of the project was not pursued further. 
 
Figure 3-7. RPE1 cells were non-responsive to changing FA media levels. However, method 
of ciliogenesis induction significantly affected cilia numbers (78 – 87% ciliated cells upon 
serum-starvation; 42 – 50% ciliated cells upon confluence-induced ciliogenesis, p < 0.0001). 
  
Figure 3-8. FR colocalizes with Arl13b in RPE1 cells. Preliminary results suggest FRa 
localizes to basal bodies and the ciliary axoneme in a dose-dependent manner. In RPE1 cells, 
A) FRa (green) colocalizes with g-tubulin (basal bodies, magenta; yellow in inset in first 
panel) and Arl13b (ciliary membrane, red). B) Ciliogenesis induced by serum starvation 





















































Ciliopathy patient cell lines are responsive to lower levels of folic acid in culture media 
 We obtained four patient cell lines from the lab of Dr. Joseph Gleeson, a Howard 
Hughes Medical Investigator with labs at both Rockefeller University and the University of 
California, San Diego. Primary fibroblasts were isolated from ciliopathy patients with 
Joubert Syndrome (JBTS), along with fibroblasts collected from two unaffected family 
members. As mentioned in the introduction, JBTS is a ciliopathy characterized by 
neurological and skeletal defects, and all of the genes currently implicated in JBTS localize 
to the primary cilia42. The four ciliopathy patient fibroblast cell lines represented mutations in 
3 genes, TMEM216, TMEM138, and CEP41.  
Interestingly, TMEM216 and TMEM138 are located adjacent to each other on the 
chromosome in a head-to-tail fashion and share a cis-regulatory element located in the 
conserved intergenic region between them that allows their expression to be highly 
coordinated. Although both encode transmembrane proteins that regulate ciliogenesis, they 
do not appear to have sequence homology or share functional domains, suggesting that they 
are non-paralogous, and in fact they appear to have been joined by a highly conserved 
chromosomal rearrangement at the amphibian-to-reptile transition 340 million years ago300. 
TMEM138 localizes primarily to the axoneme and base of the cilia, while TMEM216 
localizes primarily to the basal bodies103,300. CEP41 also localizes to the basal bodies and 
primary cilia, and regulates ciliary entry of the polyglutamylase enzyme TTLL6301.  
The mutations identified in each gene are shown below (Table 3-2). Briefly, the 
TMEM216 mutation changes a single nucleotide (c.218G>T) resulting in an amino acid 
substitution (p.R73L)103. Loss of TMEM216 leads to failure of ciliogenesis103. The TMEM138 
mutation is a c.380C>T base substitution, leading to an alanine to valine change at the 
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protein level (p.A127V)302. Both patient fibroblast cell lines with CEP41 mutations contain 
the same c.33+2T>G mutation, which abolishes a splice-donor site from exon 1, leading to 
loss of CEP41 mRNA, presumably via nonsense-mediated decay301.  
Table 3-2. Mutations in human JBTS fibroblast cells. 
 Sample name DNA change Protein change Normal localization 
TMEM216 MTI-005 c.218G>T p.R73L Basal bodies 
TMEM138 MTI-129 c.380C>T p.A127V Distal appendages 




c.33+2T>G Splice site; 
premature stop 
Centrioles and cilia 
 
Human fibroblasts cell lines were initially grown in normal DMEM (4000 ng/mL 
FA), and then transferred to 250 ng/mL, 500 ng/mL, 1000 ng/mL or 4000 ng/mL media. 
Cells were maintained on the media ‘diet’ for 3 passages and then assayed for ciliogenesis 
and cilia length. Overall, cilia number was not significantly affected in these cell lines by FA 
media levels (2-way ANOVA with Tukey’s MCT). As expected, cells containing the 
TMEM216 mutation had severely compromised ciliogenesis103 (average percentage of 
ciliated cells was 15-22% across all media levels) compared to the control samples (77-82% 
in control samples across all media levels) (Table 3-3 and Figure 3-9A). Ciliogenesis was not 
as severely affected in the cells containing the TMEM138 mutation, though it was still 
reduced relative to control at all FA levels (47-60%). Cilia numbers were lower at 250 ng/mL 
FA than at 500 or 4000 ng/mL FA , which is the opposite of the trend observed in the Intudtm 
MEFs. Cilia number was significantly reduced in the MTI-429-1-4-1 sample when grown at 
1000 ng/mL FA compared to 250 ng/mL FA and 500 ng/mL FA, but this effect was not 
observed at 4000 ng/mL FA. Furthermore,  no effect of FA was observed on cilia number in 
the other CEP41 sample, MTI-429, as might be expected from the published characterization 
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of the CEP41 mutation301, which indicates that ciliogenesis is not greatly affected in the 
CEP41 mutant cell lines (Table 3-3 and Figure 3-9A). The response of the patient fibroblasts 
to FA media levels did not follow any obvious trends, such as increased cilia number with 
increasing or decreasing levels of FA. However, both genotype and FA media levels were 
found to be significant factors affecting cilia number (2-way ANOVA, p < 0.0001 and p = 
0.0012, respectively), and there was a significant interaction between genotype and media 
FA levels (p = 0.013).  
Table 3-3. Average % ciliated cells in human JBTS fibroblast cells at varying FA-media 
levels. 
 250 ng/mL FA 
(± SEM) 
500 ng/ml FA 
(± SEM) 
1000 ng/mL FA 
(± SEM) 
4000 ng/mL FA 
(± SEM) 
Control (♂) 78% (± 4) 72% (± 3) 74% (± 3) 85% (± 2) 
Control (♀) 76% (±4) 91% (± 2) 82% (± 2) 80% (± 3) 
MTI-005 
(TMEM216) 
15% (± 3) 19% (± 3) 15% (± 3) 22% (± 3) 
MTI-129 
(TMEM138) 
47% (± 1) 60% (± 3) 51% (± 6) 60% (± 4) 
MTI-429 
(CEP41) 
77% (± 2) 78% (± 3) 80% (± 4) 83% (±3) 
MTI-429-1-4-1 
(CEP41) 
72% (± 5) 72% (± 2) 60% (± 3) 68% (± 3) 
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Figure 3-9. Cilia number and cilia length of human JBTS fibroblast cells maintained in 
varying FA-level media. Cilia number in human patient fibroblast cells is not affected by FA 
media levels uniformly across samples (A), but cilia length is increased at lower FA media 
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Although cilia number did not appear to be significantly affected by FA media levels, 
cilia length was significantly affected in all but the MTI-129 cell line (containing the 
TMEM138 mutation) (Figure 3-9B). Surprisingly, but consistent with our findings in mouse 
fibroblasts, even one of the unaffected control samples had significantly longer cilia when 
maintained in 250 ng/mL, 500 ng/mL or 1000 ng/mL FA than when maintained in typical 
4000 ng/mL FA media (7.0 ± 0.2 µm, 6.4 ± 0.2 µm, and 6.6 ± 0.2 µm compared to 5.4 ± 0.1 
µm, p < 0.003 for all comparisons, Table 3-4). Cilia length in MTI-005 cells (TMEM216 
mutation) was significantly shorter than control cells (p < 0.0001 for all FA media levels). 
Nonetheless, there was still a dose-dependent effect on cilia length and MTI-005 cells had 
significantly shorter cilia when grown in higher levels of FA. Interestingly, the MTI-429 
samples (CEP41 mutation) showed different responses to FA with respect to length. Cilia 
length in MTI-429 was unaffected by FA concentration in media, while MTI-429-1-4-1 had 
shorter cilia when grown on higher FA media (250 ng/mL FA media (7.3 ± 0.3 µm) and 500 
ng/mL FA media (7.4 ± 0.3 µm) compared to 4000 ng/mL FA media (6.2 ± 0.2 µm), p < 0.05 
for both comparisons). This difference in responsive to FA in culture may arise from the fact 
that, although both patients share great-great grandparents, they are from different branches 
of the family, and thus we may be observing the effects of other genetic factors. The MTI-
129 cells, which showed some differences in cilia number, were unexpectedly non-
responsive to FA levels in the media with respect to cilia length (Table 3-4 and Figure 3-9).  
Overall, both genotype (presence of ciliary mutation) and FA levels in media were 
found to be significant independent factors affecting cilia length (p < 0.0001 for both factors, 
2-way ANOVA). Furthermore, statistical analysis indicates that there is an interaction 
between genotype and FA media levels (p = 0.0008) affecting cilia length. 
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Table 3-4. Average cilia lengths in human fibroblast cells (µm) maintained in varying FA-
level media. 
 250 ng/mL FA 
(± SEM) 
500 ng/ml FA 
(± SEM) 
1000 ng/mL FA 
(± SEM) 
4000 ng/mL FA 
(± SEM) 
Control (♂) 6.9 (± 0.4) 7.5 (± 0.3) 6.7 (± 0.3) 6.9 (± 0.2) 
Control (♀) 7.1 (± 0.2) 6.4 (± 0.2) 6.6 (± 0.2) 5.4 (± 0.1) 
MTI-005 
(TMEM216) 
5.2 (± 0.3) 4.8 (± 0.2) 4.1 (± 0.4) 3.2 (± 0.1) 
MTI-129 
(TMEM138) 
6.6 (± 0.3) 6.9 (± 0.2) 6.9 (± 0.2) 6.6 (± 0.3) 
MTI-429 
(CEP41) 
7.2 (± 0.2) 6.5 (± 0.3) 6.7 (± 0.2) 6.4 (± 0.1) 
MTI-429-1-4-1 
(CEP41) 
7.3 (± 0.3) 7.4 (± 0.3) 6.7 (± 0.2) 6.2 (± 0.2) 
 
Discussion 
Although the concept of developing an in vitro system for studying the effect of 
varying FA levels on ciliogenesis was straightforward, determining suitable FA levels was 
not trivial. Although it is known that cultured cells grown in folate-deficient media have 
increased levels of excision repair and apoptosis303, we needed to find a balance between 
unhealthy cell conditions and low enough doses of folic acid to observe the beneficial 
response on cilia number and length. Also, almost all of the work in this chapter was 
performed on primary cell lines, which are limited in growth potential. However, ultimately a 
system was developed that appears to provide a large enough range of FA levels in the media 
to observe phenotypic responses.  
MEFs generated from Intudtm mice maintained on the control or supra FA diets had an 
increased ability to form cilia in lower FA media. Furthermore, the level of ciliogenesis 
appeared to depend on the original diet of the mouse (control v. supra FA diet) independent 
of the dosage of FA in the media. This ‘memory’ of the originating diet strongly suggests 
that epigenetic changes may be affecting ciliogenesis, especially since this effect was 
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observed in both wildtype and mutant MEFs. Cilia length in the mouse cells was unaffected 
by either diet or FA media levels, although as discussed below changes in cilia length were 
the major FA-responsive phenotype in human cells. 
We were fortunate to receive primary human fibroblasts isolated from ciliopathy 
patients (and unaffected relatives) from the lab of Dr. Joseph Gleeson. The patient cell lines 
contained mutations in one of three genes, TMEM216, TMEM138 and CEP41. Unlike the 
Intudtm MEFs, cilia number was not affected by FA media levels in a clear direction in the 
human patient cell lines. It is important to note that all three mutations identified can be 
considered weaker alleles than those studied in the mice models, as all of the human cell 
lines came from living people, and all but one of the mouse models studied are embryonic 
lethal. Intudtm, which was used for the MEFs studies in the this section, is not embryonic 
lethal, but does cause early lethality (by weaning age)264. 
Cilia length in human fibroblasts was significantly affected by FA media levels, with 
increased cilia lengths observed in cells grown is lower-dosage FA media. Cilia length is 
known to be important in cilia function, although the exact mechanism by which length 
affects function is not well understood304. One possibility is that cilia length can modulate the 
timing of re-entry into the cell cycle. For example, in cells depleted for Nde1, which encodes 
a centrosomal protein, cilia number is unchanged but cilia length is significantly longer than 
wildtype cells, and cell cycle re-entry is significantly delayed. It has been suggested that 
increased ciliary length causes delayed re-entry into the cell cycle, thus slowing cell division 
and reducing proliferation, as was observed in the zebrafish Kuppfer’s vesicle upon 
knockdown of Nde1305. Another possibility is that cilia length is tightly coupled to signaling 
sensitivity and/or signal transduction. Obese mice with leptin deficiency or resistance have 
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significantly shorter hypothalamic neuronal primary cilia than wildtype mice, and treatment 
of cultured hypothalamic neurons with leptin increases cilia length. Furthermore, mice with 
shortened hypothalamic neuronal cilia have impaired anorexigenic response to satiety 
signals, suggesting that cilia length is directly coupled to signal reception306,307. Whatever the 
mechanism, it is clear from the presence of numerous ciliopathies that exhibit either 
shortened or lengthened cilia that cilia length is tightly coupled with cilia function308. The 
effect of FA on cilia length in the human patient cell lines raises interesting questions as to 
whether people with underlying cilia defects may benefit from a more moderate level of FA 
intake. It should also be noted that, unlike the primary MEFs used in the first part of the 
chapter, primary human cell lines are anything but isogenic, and therefore any number of 
confounding genetic interactions could have affected the responsiveness to FA. Given that, it 
is perhaps even more impressive that a response was observed at all in these cells. 
 Now that the system has been developed, we can take advantage of CRISPR-Cas9 
technology to generate isogenic cell lines (in which potentially confounding effects of 
unknown genetic factors can be controlled) containing human ciliopathy mutations and 
mutations identified in human NTD cases and look at the effect of FA dosage on ciliogenesis. 
We can also use this in vitro system to assay the effect of FA on aspects of cilia function, 
such as hedgehog signaling responsiveness or even trafficking of proteins into, along, and out 
of the cilia. Thus, in this chapter we have developed a tool that will prove extremely valuable 
in further work on folate-responsiveness and the mechanistic basis of this response. 
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Methods 
Cell culture media 
FA-free DMEM was made from 10X FA-free, low-glucose DMEM (SigmaAldrich 
Cat. # D2429) to which was added additional glucose (10% soln, final concentration 4.5 g/L; 
Sigma Aldrich, Cat. # G8644), L-glutamine (200 mM; Gibco/Invitrogen, Cat. # 25030-081, 
final concentration 4 mM), and NaHCO3 (7.5% solution, Gibco/Invitrogen Cat. #25080-094, 
final concentration 3.7 g/L). 250 ng/mL, 500 ng/mL, and 1000 ng/mL FA media was made 
by combining FA-free DMEM and regular DMEM (4000 ng/mL FA, Invitrogen, Cat. # 
11995-073) in the following ratios: 250 ng/mL FA DMEM = 15 parts FA-free DMEM, 1 part 
regular DMEM; 500 ng/mL FA DMEM = 7 parts FA-free DMEM, 1 part regular DMEM; 
1000 ng/mL FA DMEM = 3 parts FA-free DMEM, 1 part regular DMEM. 
Mouse embryonic fibroblasts 
Mouse embryonic fibroblasts were isolated from E14.5 embryos using standard 
methods309. Briefly, viscera were removed from embryos before cells were dissociated by 
passing through 16G needles and incubating in 0.25% Trypsin-EDTA for 8-10 minutes. Cells 
were plated in 6-well tissue culture dishes in DMEM (250 ng/mL or 4000 ng/mL FA for F3-
CD and F3-HD, respectively) supplemented with 10% dialyzed fetal bovine serum (FBS, to 
eliminate any FA from FBS). Once cells reached confluency, equal numbers of cells were 
plated into DMEM with 250 ng/mL, 500 ng/mL or 4000 ng/mL FA, supplemented with 10% 
dialyzed FBS. Cells were maintained on the given FA media for 3 passages, at which time 
2.5 x 105 cells from each condition were plated in quadruplicate (24-well plate). After 24 
hours (to allow cells to re-adhere to the plates), the media was removed and cells were 
washed briefly with PBS before adding serum-starve media (0.5% dialyzed FBS in FA-
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specific DMEM). Cells were serum-starved for 48 hours to induce ciliogenesis, fixed with 
cold 100% MeOH, and used for immunofluorescence (Figure 3-10). All experiments were 
completed by Passage 5. 
 
Figure 3-10. Overview of experimental design to assay MEFs for FA responsiveness. 
RPE1 cells 
RPE1 cells were grown and maintained in DMEM + 10% FBS, 1% pen-strep. For FA 
responsiveness assays, equal numbers of cells from each line were plated in 250 ng/mL FA, 
500 ng/mL FA, 1000 ng/mL FA or 4000 ng/mL FA DMEM supplemented with 10% 
dialyzed FBS and 1% pen-strep. Cells were maintained on the given FA media for at least 3 
passages. For serum-starvation induced ciliogenesis assays, 2.5 x 105 cells from each 
condition were plated in quadruplicate onto 12-mm round glass coverslips (in a 24-well 
plate). After 24 hours (to allow cells to re-adhere to the plates), the media was removed and 
cells were washed briefly with PBS before adding serum-starve media (0.5% dialyzed FBS in 
FA-specific DMEM). Cells were serum-starved for 48 hours to induce ciliogenesis, fixed 
with 4% PFA in PBS, and used for immunofluorescence. For confluence-induced 
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ciliogenesis assays, cells were plated in the same manner (2.5 x 105 cells on glass coverslips), 
and the cells were allowed to adhere for 24 hours and then grown in regular media for an 
additional 24 hours before fixation in 4% PFA. 
Human patient fibroblasts 
Six cell lines were obtained from the lab of Dr. Joseph Gleeson, two controls (Father 
and Mother, though it is not known whose father or mother), MTI-005, male, TMEM216 
mutation; MTI-129, male, TMEM138 mutation; MTI-429 and MTI-429-I-4-1, both males, 
CEP41 mutation. Patient fibroblasts cells were initially grown in DMEM + 20% FBS, 1% 
pen-strep to create frozen stocks. For FA responsiveness assays, equal numbers of cells from 
each line were plated in 250 ng/mL FA, 500 ng/mL FA, 1000 ng/mL FA or 4000 ng/mL FA 
DMEM supplemented with 10% dialyzed FBS and 1% pen-strep. Cells were maintained on 
the given FA media for 3 passages, at which time 2.5 x 105 cells from each condition were 
plated in quadruplicate (24-well plate). After 24 hours (to allow cells to re-adhere to the 
plates), the media was removed and cells were washed briefly with PBS before adding 
serum-starve media (0.5% dialyzed FBS in FA-specific DMEM). Cells were serum-starved 
for 48 hours to induce ciliogenesis, fixed with 4% PFA in PBS, and used for 
immunofluorescence. 
Immunofluorescence 
MeOH- and PFA-fixed cells were blocked with image-iT FX signal enhancer 
(Molecular Probes) for 30 min followed by 0.3% Triton-X in PBS with 3% NGS (normal 
goat serum). Cells were incubated with primary antibodies in blocking buffer overnight at 
4 °C: Arl13b (Antibodies Inc, Cat. #75-287, 1:500), g-tubulin (SigmaAldrich, Cat. # T6557, 
Clone GTU-88, 1:1000), and polyglutamylated tubulin (AdipoGen, Cat. # AG-20B-0020-
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C100, 1:500), followed by incubation with secondary antibodies (AlexaFluor) for 2 h at room 
temperature, and Hoescht or DAPI (1:1000 in PBS) for 10 minutes. Coverslips were mounted 
with Prolong Diamond Antifade Mountant (ThermoFisher, Cat. #P36961), and fluorescent 
images were obtained on a Zeiss LSM510 Meta or Zeiss LSM780 confocal microscope. Cilia 
quantification and length measurements in MEFs were performed using either ImageJ or 
Imaris software. Quantification and length measurements for the human patient fibroblasts 
were performed in ImageJ using the 3-D length measurement script 
LineScan_Analysis_Part1.ijm, written by Dr. Nick Galati. For MEFs, a minimum of 5 
random fields of view (FoV) were assayed for each sample, with 400-500 cells counted for 
each condition, and there was no difference in average numbers of cells per FoV, indicating 
that cell density was comparable across all conditions. Statistical analyses (2-way or 3-way 




 FOLIC ACID FORTIFICATION DOES NOT ADVERSELY AFFECT SONIC 
HEDGEHOG SIGNALING, PROLIFERATION OR APOPTOSIS2 
 
Introduction 
 In vivo data from chapter 2 shows that multiple mouse models of NTDs due to cilia 
defects respond detrimentally to multigenerational FA fortification. In Chapter 3 I developed 
an in vitro system to assay the effect of FA fortification on cilia number and cilia length, and 
showed that in primary cell lines, even wildtype cells appear to grow more and/or longer cilia 
under conditions of lower FA. Aside from some evidence in Chlamydomonas indicating that 
methylation of cilia proteins is required for flagellar disassembly, however, there is no direct 
evidence linking FA to cilia. The phenotypic response of cilia mutants to FA observed in vivo 
and in vitro raises the question as to how FA might affect NT closure and/or cilia function. 
 FA is known to be a methyl donor in OCM, and its biologically active form, 5-
meTHF, is used in the biosynthesis of purines and thymidylate, the generation of methionine 
from homocysteine, and the biosynthesis of SAM, the universal methyl donor of the cell8. 
Thus, altering levels of FA may affect levels of 5-meTHF, and this could affect cell 
proliferation or gene expression by altering the pools of available nucleotides. Given the 
importance of cilia in Shh signaling, and the importance of Shh signaling in neural 
development, I initially hypothesized that FA might be adversely affecting Shh signaling, 
either by disrupting the ability of cilia to function as efficient signal transducers and/or 
affecting the number of cilia, or by altering gene expression within the Shh pathway. I also 
                                                
2 Portions of this chapter were submitted for publication in Developmental Biology 
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tested whether FA fortification might affect cell proliferation or apoptosis in the neural tube, 
as it is known that disrupting the delicate balance of cell growth and cell death can lead to 
NTDs59,60. 
Results 
Shh signaling is not affected by folic acid fortification 
Shh pathway gene expression is not affected by folic acid in the developing neural tube  
 Cilia are required for Shh signaling, so initially we hypothesized that FA fortification 
was further disrupting Shh signaling in cilia mutants. Starting with Ift88null, which showed a 
strong response to FA fortification, we used Hedgehog signaling pathway PCR array 
(SABiosciences) that measures gene expression for 84 Hh pathway genes. Using only neural 
tissue isolated from E9.5 embryos, these results were initially promising, as it appeared that 
Shh, Gli1, Rab23, Smo and Sufu were all significantly more dysregulated in F3-supra diet 
mutants than F3-control diet mutants, relative to F3-control diet wildtype embryos. However, 
at about this time, it was recognized that although the embryos were all from E9.5 litters, 
they were not somite-matched, which meant that the gene expression changes could be due to 
age differences rather than a response to diet. To address this, I performed qRT-PCR on 
somite-matched E9.5 neural tissue testing gene expression of just a few key pathway genes, 
Shh, Gli1, and Ptch1, which are direct targets of Shh signaling as well as being involved in 
the pathway. Although all three genes had significantly decreased expression in mutants 
compared to wildtypes, there was no additional effect of fortification on gene expression 
(Figure 4-1). This was confirmed at the protein expression level with immunofluorescence of 




Figure 4-1. Shh pathway gene expression in E9.5 Ift88null neural tissue. Shh, Gli1 and Ptch1 
expression are significantly decreased in Ift88null/null E9.5 neural tissue compared to wildtype 
embryos, but gene expression is not affected by FA fortification. (* p < 0.05; ** p < 0.01; 
*** p < 0.001; **** p < 0.0001) 
 
Figure 4-2. Neural tube patterning markers in E9.5 Ift88null wildtype and mutant rostral spinal 
cord on control FA diet (F1-control diet) and supra FA diet (F3-supra diet). Expression of 































We also examined Shh signaling in Intudtm, using E10.5 neural and limb tissue. 
Starting with the E10.5 neural tissue, surprisingly, qRT-PCR revealed Shh expression was 
significantly higher in mutants than wildtype embryos, not reduced as expected for a cilia 
mutant. However, there was no significant difference between F3-control diet mutants and 
F3-supra diet mutants (Figure 4-3). Similarly, there was no significant difference in Ptch1, 
Gli1 or Wnt1 gene expression between Intudtm F3-control diet versus F3-supra diet embryos. 
Both Ptch1 and Gli1 expression were significantly higher in F3-supra diet mutants compared 
to F3-control diet wildtype, but not significantly higher than in F3-supra diet wildtype 
embryos. Furthermore, there was no change in gene expression between F3-control diet 
wildtype and F3-supra diet wildtype embryos. Wnt1 expression was not significantly affected 
by either the mutation or diet (Figure 4-3).  
 
Figure 4-3. Shh pathway gene expression in E10.5 Intudtm neural tissue. Shh pathway gene 
expression in E10.5 wildtype and Intudtm/dtm neural tissue (F3-control and F3-supra diet). Shh 
expression is increased in Intudtm/dtm compared to wildtype embryos independent of diet. Ptch1 
and Gli1 expression is significantly elevated in F3-supra diet Intudtm/dtm compared to F3-
control diet wildtype. Wnt1 expression is not affected by genotype or diet (* p < 0.05; ** p < 
0.01; *** p < 0.001; **** p < 0.0001). 



























It was tempting at this point to argue that significant difference in gene expression 
observed in F3-supra diet mutants compared to F3-control diet wildtype embryos might be 
the additive effects of genetic and environmental insults, and thus a possible mechanism by 
which FA interacts with this cilia mutation. However, additional phenotypic data reported in 
Chapter 5 as well as immunofluorescence experiments described below and subsequent 
RNA-Seq studies indicated that Shh signaling is not significantly affected by either the Dtm 
mutation or FA fortification. 
 
Figure 4-4. Neural tube patterning markers in E10.5 Intudtm wildtype and mutant rostral spinal 
cord on control FA diet (F3-control diet) and supra FA diet (F3-supra diet). Patterning 
markers are unaffected by genotype or diet. 
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We used immunofluorescence on rostral spinal cord sections to determine if 
patterning of the neural tube was affected in mutants and by manipulation of dietary FA . Not 
surprisingly based on the qRT-PCR data above, in which even statistically significant 
differences were still no more than ~1.5 fold change in expression, patterning in the rostral 
neural tube of Intudtm mutant embryos was not affected by either the Dtm mutation or by FA 
fortification (Figure 4-4). 
Shh pathway gene expression is not affected by FA fortification in the developing limb bud in 
Intudtm 
Given the importance of Shh in limb development and the fact that the extra digit 
phenotype is rescued in a subset of mutant embryos maintained on a moderate FA diet (F3-
control diet) (Chapter 2, Figure 2-4), we next asked if Shh expression was affected by diet in 
the developing limb bud. Shh is normally expressed in the posterior of the limb bud in the 
zone of polarizing activity (ZPA), and acts as a morphogen to pattern the anteroposterior axis 
of the limb (thumb to little finger) 310. In situ hybridization of E10.5 limb buds shows that 
Shh localization is neither expanded nor reduced in Intudtm/dtm mutants on either control or 
supra FA diet, and there is no ectopic expression of Shh outside of the ZPA (Figure 4-5). 
qRT-PCR was used to confirm that Shh expression was unaffected in the E10.5 limb, 
consistent with our earlier studies of the neural tube 264. The lack of a correlation with either 
genotype or diet suggests that altered and/or rescued Shh expression is not responsible for the 
rescue of the double thumb phenotype in F3-control diet mutants. 
Although Shh expression in the limb bud appeared unaltered by the Intudtm mutation 
or by FA fortification, it is possible that gene expression downstream of Shh signaling is 
affected. qRT-PCR was used to measure Shh pathway gene expression in E10.5 forelimb 
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buds. Gli1 expression, a common readout of Shh signaling activity, is slightly though 
significantly reduced in Intudtm/dtm mutants compared to wildtype littermates (FC = -1.3, p < 
0.005 for both F3-control Intudtm/dtm and F3-supra Intudtm/dtm, Figure 4-6C), but there was no 
effect of diet on Gli1 expression (p > 0.05, 2-way ANOVA), nor was expression of Ptch1 
and Gli3 affected by genotype or diet (Figure 4-6B, D). The lack of a change in gene 
expression relative to diet suggests it is unlikely that altered Shh signaling is the mechanism 
by which FA levels are affecting a phenotypic response. 
 
Figure 4-5. Shh expression in the ZPA of the developing limb bud is not affected by Intudtm 
mutation or FA fortification. Wholemount in situ hybridization for Shh (E10.5, 29 – 31 
somites, n = 3 matched littermate pairs/diet). (A, B) Wildtype (A) and mutant (B) F3-control 
diet embryos with close up views of the forelimb bud (A’ and B’, posterior to the left). (C, D) 
Wildtype (C) and mutant (D) F3-supra diet embryos with close up views of the forelimb bud 
(C’ and D’, posterior to the left). 
Fgf signaling in the apical ectodermal ridge (AER) is required for proximal-to-distal 
(shoulder to digits) patterning, and it is known that the ZPA and AER interact to properly 
pattern the limb 311. Specifically, Fgfs produced in the AER are required to maintain Shh 
expression in the ZPA. Fgf8 expression was tested by qRT-PCR, and appears to be slightly 
increased in Intudtm/dtm embryos compared to their wildtype littermates, although the fold 
change is very small (~1.3-fold increase in mutant compared to diet-matched littermate, p < 
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0.05). However, Fgf8 expression was not affected by diet, suggesting that FGF-signaling is 
also not causative of the diet-dependent phenotype. 
 
 
Figure 4-6. Shh pathway and Fgf8 gene expression in E10.5 Intudtm limb buds. Gene 
expression of Shh pathway genes Shh (A), Gli1 (B), Ptch1 (C), Gli3 (D) and Fgf8 (E) in 
E10.5 wildtype and Intudtm/dtm F3-control diet and F3-supra diet limb buds. As determined by 
qRT-PCR, gene expression was not affected by FA fortification, though Gli1 expression was 
slightly decreased in mutants compared to wildtypes (B), and Fgf8 expression was slightly 
elevated in mutants compared to wildtypes (E) (* p < 0.05; ** p < 0.01; *** p < 0.001; **** 












































If cilia number is altered in the limb mesenchyme by either genotype or diet, 
expression of Arl13b, which encodes the ciliary membrane protein ARL13B may also be 
altered. However, transcript levels of Arl13b, were unaffected by diet or genotype 
(Figure 4-7). Reduced folate carrier 1 (Rfc-1/Slc19a1) is required for folate transport in 
mammalian cells and is expressed in the developing limb bud312. We hypothesized that diet 
might affect levels of Rfc-1 and thereby potentially alter folate transport in the developing 
limb. qRT-PCR revealed that Rfc-1 expression was unaffected by either the Intudtm mutation 
or diet (Figure 4-7). 
  
Figure 4-7. Gene expression of Rfc-1 and the ciliary membrane gene Arl13b in E10.5 
wildtype and Intudtm/dtm F3-control diet and F3-supra diet limb buds was not affected by 
genotype or FA fortification as determined by qRT-PCR (2-way ANOVA). 
Canonical and non-canonical Wnt signaling are not affected by folic acid fortification in the 
Intudtm limb bud 
As the Drosophila Inturned homolog was identified as a PCP effector protein, we 
next asked if either non-canonical (PCP) or canonical Wnt signaling was disrupted in 
Intudtm/dtm and if so, was the effect exacerbated by FA fortification. Wnt5a is considered the 
















modulate b-catenin stability via a Siah2/APC dependent pathway. Furthermore, Wnt5a has 
been shown to transcriptionally activate Siah2, making it an ideal readout for Wnt5a activity. 
However, neither Wnt5a nor Siah2 expression were altered by either the Intudtm mutation or 
diet (Figure 4-8A and B), suggesting that this pathway is not implicated in the double thumb 
phenotype nor the diet-dependent change in phenotype (2-way ANOVA). 
 
Figure 4-8. Expression of non-canonical and canonical Wnt-signaling genes in E10.5 Intudtm 
limb buds. Non-canonical and canonical Wnt signaling are unaffected by the Intudtm mutation 
or FA levels in diet. As measured by qRT-PCR, expression of non-canonical Wnt5a (A) and 
WNT5A target Siah2 (B) was not significantly altered by diet or genotype. Canonical WNT 
signaling targets Axin2 (C) and Dkk1 (D) do not show a genetic response when comparing 
wildtype and mutant within diet. Expression of Axin2 in F3-supra diet mutants is slightly, 
though significantly reduced when compared to F3-control diet wildtype (C, dark blue and 
pink bars), while a small but significant change in expression was observed for both Axin2 
and Dkk1 when comparing F3-control and F3-supra diet wildtypes (C and D, dark blue bar 


































Since neither Intudtm nor FA fortification affect Wnt5a expression or expression of the 
downstream target Siah2, we next asked if canonical Wnt signaling was altered. The 
canonical Wnt targets and negative regulators of Wnt signaling, Axin2 and Dkk1, are both 
expressed in the developing limb bud. Overall, there was no effect of genotype on Axin2 
expression, though there was a statistically significant contribution of diet to Axin2 
expression (p < 0.01, 2-way ANOVA), as both F3-supra diet wildtype and mutant limb buds 
showed significantly reduced expression of Axin2. Given the very small fold-change 
observed, however, it is unlikely that altered Axin2 expression can fully explain the rescue 
observed in F3-control diet mutants. Similarly, although Dkk1 expression was higher in F3-
supra diet wildtype than F3-control diet wildtype (p < 0.05, 2-way ANOVA), the fold-change 
is small (1.3-fold increase) and does not explain the phenotypic response observed in the 
mutants, as Dkk1 expression was not significantly different between F3-control diet and F3-
supra diet mutants. 
Cilia number is altered by folic acid fortification in some but not all tissue types in the 
developing embryo 
Moderate FA facilitates ciliogenesis in developing kidneys 
We next asked if cilia number was affected by diet in vivo. We previously showed 
that cilia number is decreased in kidneys in PW6 Intudtm/dtm mice compared to their wild type 
littermates 264. A similar analysis of E14.5 renal cilia revealed that cilia number was further 
reduced in F3 supra diet mutants compared to F3 control diet mutant embryos (Figure 4-9A 
and B; 41% ciliated cells in E14.5 F3 supra Intudtm/dtm embryonic kidneys (n = 3, 2118/4520 
cells), compared to 53% ciliated cells in E14.5 F3 control Intudtm/dtm embryonic kidneys (n = 
2, 1805/3432 cells), p < 0.01, 2-way ANOVA followed by Tukey’s MCT). The percentage of 
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ciliated cells was unaffected by diet in wild type littermates (68% F3-control vs 60% F3-
supra, p > 0.05). Overall, both genotype and diet were found to be significant factors 
affecting the total number of ciliated cells in E14.5 mutant kidneys (p < 0.0001 and p = 
0.0095, respectively, 2-way ANOVA). 
Interestingly, cilia number appeared to be differentially affected depending on 
location within the kidney. Cells outside renal vesicles were stained for ARL13B, a marker 
for the cilia membrane. Ciliogenesis in these cells was unaffected by diet, though the number 
of ciliated cells outside the renal vesicles was decreased in Intudtm/dtm kidneys compared to 
wildtype littermates (Table 4-1 and Figure 4-9, F3-control diet wildtype: 67% compared to 
Intudtm/dtm: 45%, p < 0.001; F3-supra diet wildtype: 64% compared to Intudtm/dtm; 50%, p < 
0.01).  In contrast, cells comprising the primitive collecting ducts (or renal vesicles), which 
stained more consistently with the cilia marker anti-acetylated a-tubulin antibody than 
Arl13b, showed a dramatic response to FA fortification. F3-supra mutant kidneys had 
significantly fewer ciliated cells than their wildtype littermates (p < 0.05, 2-way ANOVA, 
Tukey’s MCT) or Intudtm/dtm F3-control diet (Figure 4-9C). Interestingly, the number of 
ciliated cells in F3-control mutants was similar to that of F3-control wildtype. Consistent 
with the in vitro MEF data, these results suggest that the lower FA diet ‘rescues’ ciliogenesis 
in vivo in the renal vesicles in Intudtm/dtm mice (Figure 4-9). Thus, both genotype and diet are 
significant factors affecting the number of overall ciliated cells in renal vesicles (p < 0.05, 2-




Figure 4-9. Effect of multigenerational FA fortification on cilia number in the developing 
(E14.5) kidney in Intudtm. Multi-generational exposure of Intudtm mutants to moderate folic 
acid facilitates ciliogenesis in developing kidneys. A) Representative sections of E14.5 
kidneys. The boxes in the top panels indicate the regions shown at high magnification in the 
bottom panels. Basal bodies: g-tubulin (magenta); cilia: acetylated a-tubulin (red) and Arl13b 
(green); nuclei: Hoescht (blue). B - D) Quantification of % of ciliated cells overall (B), in 
renal vesicles (C), and outside of renal vesicles (D). Only a genetic effect on cilia number 
was observed in the kidneys overall and for cells outside of renal cysts (B, D) whereas a diet 
dependent effect was seen in the renal vesicles of Intudtm mutants (C). Moreover, cilia number 
in F3-control diet mutant kidney renal vesicles approached wildtype levels, and had 
significantly more ciliated cells than F3-supra diet mutant renal vesicles (C). (* p < 0.05; ** 
p < 0.01; *** p < 0.001; **** p < 0.0001, 2-way ANOVA; n = 2 littermate pairs (wildtype 







Table 4-1. Percentage of ciliated cells in E14.5 developing kidneys (± SEM). 
 F3-control diet F3-supra diet 
 Wildtype Mutant Wildtype Mutant 
Total ciliated cells 67% (± 3) 52% (± 3) 62% (± 2) 46% (± 3) 
Ciliated cells in renal vesicles 68% (± 4) 62% (± 3) 61% (± 4) 44.8% (± 5) 
Ciliated cells outside renal vesicles 65% (± 3) 45% (± 3) 64% (± 2) 51% (± 3) 
 
Cilia number is not altered in the developing limb bud following FA fortification 
The most penetrant phenotype in Intudtm/dtm is polydactyly and this phenotype is 
rescued in a subset of mutants, so we measured the number of ciliated cells in the developing 
limb bud at E10.5. Not surprisingly, there were significantly fewer ciliated cells in F3 
mutants compared to F3 wildtype littermates (Figure 4-10). On both the control and supra FA 
diets, the percentage of ciliated cells was decreased by approximately 30% in mutant 
embryos compared to wildtype littermates (43 ± 3% F3-control mutant versus 64 ± 4% F3-
control wildtype, p < 0.0005; 50 ± 5% F3-supra mutant versus 71 ± 2% F3-supra wildtype, p 
< 0.0005, 1-way ANOVA followed by Tukey’s MCT). The contribution of genotype was 
found to be highly significant by 2-way ANOVA analysis (p < 0.0001). Although there were 
no significant differences when comparing across diet directly (F3-control wildtype v F3-
supra wildtype or F3-control mutant v F3-supra mutant), 2-way ANOVA analysis does 
indicate that there is a significant contribution of diet (p = 0.04), supporting the hypothesis 
that FA may affect ciliogenesis in the developing limb.  
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Figure 4-10. Percentage of ciliated cells in E10.5 Intudtm limb buds following FA-
fortification. Cilia number is reduced in E10.5 Intudtm/dtm mutant limb mesenchyme compared 
to wildtype (blue and red significance bars), but cilia number is not significantly affected by 
diet (black bar, ns) (*** p < 0.001; **** p < 0.0001, 2-way ANOVA, n = 3 somite-matched 
littermate pairs for each diet). 
Proliferation and apoptosis are not altered by folic acid fortification in the developing 
neural tube 
 Altered proliferation and apoptosis have also been linked to NTDs, so we next asked 
if either of these processes were affected by FA fortification. For Intunull, there did appear to 
be a small but significant increase in the number of proliferating cells in the neural tube upon 
FA fortification, as measured by phosphohistone-H3 (PH3) staining, but only in F3-supra 
diet wildtype embryos (Figure 4-11A). This suggests that FA fortification may increase 
proliferation slightly in wildtype cells, but this FA-induced increase is not observed in Intunull 
mutants. Apoptosis was measured using Terminal deoxynucleotidyl (TdT) dUTP Nick-End 
Labeling (TUNEL). Neither loss of Intu nor FA fortification affected apoptosis 
(Figure 4-11B). Similarly, Intudtm did not show alterations in  proliferation (Figure 4-12A) or 
apoptosis (Figure 4-12B) upon FA fortification. 
 
Percentage of Ciliated Cells in E10.5 Limb Bud



























Figure 4-11. Proliferation (A) and apoptosis (B) are not affected by FA fortification in Intunull 
(** p < 0.01). 
 
Figure 4-12. Proliferation (A) and apoptosis (B) in Intudtm are not affected by FA fortification. 
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Discussion 
 The adverse response to FA fortification in cilia mutants suggests that there is a 
specific gene-environment interaction at play. Given the importance of Shh signaling in 
development, and the dependence of Shh signaling on cilia for signal transduction, the initial 
hypothesis tested here was that FA exacerbates the Shh signaling defect. However, 
immunofluorescence for markers of dorsal-ventral patterning in the developing neural tube 
shows no change in expression as a result of FA fortification. Similarly, expression of Shh, 
Gli1 and Ptch1 was unaltered by diet in the NT. This strongly suggests that exacerbation of 
defective Shh signaling is not responsible for the detrimental phenotypic response to FA 
fortification in the cilia mutants tested. 
 Shh signaling is also important in the developing limb. SHH is expressed in the ZPA 
and acts as a morphogen to determine anterior-posterior patterning of the limb bud. The only 
FA-responsive mutants studied that survive to the stages of limb development are Intudtm/dtm. 
Interestingly, the limb phenotype is rescued in 20% of Intudtm/dtm embryos on the control FA 
diet. Examination of expression of Shh pathway genes in the early limb bud (E10.5) showed 
that FA fortification did not affect Shh pathway gene expression nor did it alter expression of 
genes involved in either canonical or non-canonical (PCP) Wnt signaling. In fact, none of the 
genes tested showed any responsiveness to FA fortification. One possible explanation is that 
that FA fortification is not causing a phenotypic response via changes in gene expression in 
any of the key limb regulatory genes, though it does not rule out the possibility that other 
pathways may be FA-responsive. Another possible explanation is that because the penetrance 
of phenotypic rescue is so low, none of the mutant samples assayed were rescued, and thus 
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one would not expect to see changes in gene expression. In order to confirm this, extremely 
large numbers of embryos would have to assayed. 
 I next asked if FA might be directly affecting cilia number, as observed in the in vitro 
system developed in Chapter 3. Using the Intudtm mouse line, in which mutants survive later 
into development than mutants from either the Ift88null or Intunull mouse lines, cilia number 
was assayed in both the developing kidney and limb mesenchyme. Cilia number was 
decreased in E14.5 Intudtm/dtm kidneys, but not in E10.5 limbs as a result of FA fortification. 
Since Intudtm/dtm has a FA-responsive limb phenotype, it is possible that there is a stage-
specific change in number of ciliated cells in the limb and/or a change is only observed upon 
rescue which we may not have assayed as only 20% of mutants show a rescue and this can 
only be determined by examination of digit condensations, which is after the critical time of 
developmental signaling. Nonetheless, the effect on cilia number observed in Intudtm/dtm 
kidneys in vivo and MEFs in vitro suggest that FA can influence ciliogenesis, even in a 
wildtype background, although the mechanism is unknown. The lack of cilia response in the 
E10.5 limb mesenchyme indicates that even if altered cilia number accounts for some of the 
FA-response, it is likely not the only mechanism at play. There is some evidence that cilia 
number may be reduced in the developing NT (data not shown), but it was not possible to 
quantitate cilia number at the current resolution of our confocal microscope. However, 
preliminary images using new Airyscan technology from Zeiss show that it may now be 
possible to resolve individual cilia in the E9.5 and E10.5 neural tube using confocal 
microscopy, making such quantification possible in the very near future. This would provide 
a direct assay of cilia number and cilia length in the developing neural tube, allowing us to 
determine whether FA fortification is affecting cilia in vivo in FA-responsive cilia mutants. 
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Until then, however, the data are still confusing. The in vitro data from Chapter 3 and the in 
vivo cilia number data from E14.5 Intudtm/dtm kidneys suggest that FA might be directly 
affecting ciliogenesis via an unknown mechanism. However, the lack of cilia response in the 
E10.5 limb mesenchyme indicates that even if altered cilia number accounts for some of the 
FA-response, it is likely not the only mechanism at play. 
 As mentioned above, altering the levels of FA could alter nucleotide pools, and thus 
could affect cell proliferation and apoptosis. However, this does not appear to be the case for 
either Intunull or Intudtm, as neither showed altered proliferation or apoptosis in response to FA 
fortification. Similarly, proliferation in the neural tube was not affected in line 3Poly 
mutants273. 
 This chapter explored the ‘usual suspects’ implicated in NTDs – altered Shh pathway 
gene expression, proliferation and apoptosis. None of these appear to be affected by FA 
fortification. This does not mean, however, that gene expression is not affected by FA 
fortification, but rather that we need to take an unbiased approach to fully address this 
question. Such an approach will be explored in Chapter 5.  
It is also possible that FA is altering the OCM cycle in other ways. SAM is required for 
methylation of DNA, RNA, and proteins. It is possible that FA is affecting these cilia 
mutants via post-translational protein modifications or by altering DNA and/or RNA 
methylation. It is known that in Chlamydomonas, several ciliary proteins must be methylated 
prior to flagellar disassembly274,275, so another possible mechanism may involve a direct link 
between methylation and cilia assembly/disassembly or cilia function. As cilia number is 
affected by FA in vitro (Chapter 3) and in the developing kidney, this would be an interesting 
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question to ask using biochemical assays that take advantage of the in vitro system developed 
in Chapter 3.  
Methods 
Immunofluorescence 
Whole E9.5, E10.5 embryos and E14.5 kidneys were fixed in 4% PFA and processed 
for cryopreservation in OCT and sectioning at 10 µm. Rehydrated sections were blocked 
with 0.3% Triton-X in PBS with 3% Normal Goat Serum (NGS) for 30’ and incubated with 
primary antibodies overnight at 4 °C. Antibodies for dorsal-ventral patterning markers were 
obtained from the Developmental Studies Hybridoma Bank and serum was used at a 
concentration of 1:10 – 1:50 in blocking buffer (Islet 1/2, 39.4D5; Nkx2.2, 74.5A5; Pax3; 
Pax6; Pax7). Other antibodies used include Tuj1 (Covance, Cat. #PRB-435P), Neurofilament 
(SigmaAldrich, Cat. #N4142), Arl13b (Antibodies Inc, Cat. #75-287, 1:500), acetylated a-
tubulin (SigmaAldrich, Cat. #T7451, 1:500) and g-tubulin (SigmaAldrich, Cat. # T6557, 
Clone GTU-88, 1:1000). Sections were incubated with secondary antibodies (AlexaFluor, 
Invitrogen) in 0.3% Triton in PBS for 2 hours at room temperature, followed by Hoescht 
(1:1000 in PBS) for 10 minutes, and mounted with Dako Faramount Aqueous Mounting 
Media (Dako, Cat. #S3025) or Prolong Diamond Antifade Mountant (ThermoFisher, Cat. 
#P36961). Fluorescent images were obtained on a LSM510 Meta confocal microscope 
(Zeiss). Cilia quantification of limb buds and kidneys was performed using ImageJ or Imaris 
software with batch processing. Statistical analysis was performed using GraphPad Prism 
Version 7. 
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Whole-mount in situ hybridization 
Whole-mount in situ hybridization on somite-matched E10.5 (29-31 somite) embryos 
was performed as described elsewhere314, with digestion in Proteinase K (10 µg/mL) for 8 
min using an antisense Shh probe from D. Epstein. Bright-field images were obtained using a 
Nikon SMZ18 stereoscope. 
Quantitative PCR 
Embryo heads were dissected from E9.5 Ift88null and E10.5 Intudtm wildtype and 
mutants embryos on both diets. Individual forelimbs were dissected from somite-matched 
E10.5 littermates (Intu+/+ and Intudtm/dtm) within each diet, flash-frozen in liquid nitrogen, and 
stored at -80 °C until use. Somite-matched embryos were used for comparisons across diets. 
RNA was isolated using the Quick-RNA MicroPrep Kit (Zymo Research, Irvine, CA) 
according to the manufacturer’s instructions. cDNA was generated from 350 ng of RNA 
using the Roche Transcriptor First Strand cDNA Synthesis Kit (v. 6.0, Roche Diagnostics). 
Quantitative real-time PCR (qRT-PCR) was performed on a Roche LightCycler 480 II 
thermocycler using the Universal Probe Library (UPL, Roche Diagnostics). Each sample was 
normalized to Gapdh (Vic-labeled Gapdh Assay, Invitrogen). Primers are as follows: Shh [F 
5’ – CCA ATT ACA ACC CCG ACA TC – 3’, R 5’ – GCA TTT AAC TTG TCT TTG CAC 
CT – 3’]; Ptch1 [F 5’ – GAT TGT GGA AGC CAC AGA AAA – 3’, R 5’ – GGG TCA 
AGG GAG GCT GAT – 3’]; Gli1 [F 5’ – AGG AAT TCG TGT GCC ATT G – 3’, R 5’ – 
TCC GAC AGC CTT CAA ACG – 3’]; Gli3 [F 5’- CAC CAA AAC AGA ACA CAT TCC 
A – 3’, R 5’ – GGG GTC TGT GTA ACG CTT G – 3’]; Fgf8 [F 5’ – TCC TGC CTA AAG 
TCA CAC AGC – 3’, R 5’ – TGA GCT GAT CCG TCA CCA – 3’]; Axin2 [F 5’ – CCA 
TGA CGG ACA GTA GCG TA – 3’, R 5’ – GCC ATT GGC CTT CAC ACT – 3’]; Wnt5a 
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[F 5’ – GCG AAC ACC TCT GTG AGG A – 3’, R 5’ – GCC AGC AGA GAG TCC AGA 
AA – 3’]; Siah2 [F 5’ – TGC CGC CAG AAG TTA AGC – 3’, R 5’ – AAC AGC CCG TGG 
TAG CAT A – 3’]; Rfc1 [F 5’ – GCG GTC ACC TCT GTG CTC – 3’, R 5’ – GGC CAA 
GAT GAC ACT CCA C – 3’]; Arl13b [F 5’ – GAG AGG GCT GAA CGA GTC C – 3’, R 5’ 
– CAC TGG TCC CAT CAA GTT CC – 3’]. All experiments were performed with 
biological and technical triplicates, and statistical analysis was performed using either One-




 EVALUATION OF TRANSCRIPTIONAL AND DNA METHYLATION CHANGES 
IN EMBRYOS FROM MULTIGENERATIONAL FOLIC ACID DIETS 
 
Introduction 
 The phenotypic response of the 3Poly, Ift88null, Intunull, and Intudtm mutants to different 
FA diets was not observed until the mouse lines had been maintained on FA fortified diet for 
several generations, which strongly suggests an epigenetic mechanism. In Chapter 5, I 
explore the hypothesis that the detrimental phenotypic response observed in these cilia 
mutants is the result of changes in gene expression, which in turn are correlated to changes in 
DNA methylation. Initially, we hypothesized that FA might be affecting a phenotypic 
response by further disrupting Shh signaling. However, as was seen in Chapter 4, Shh 
signaling is not altered by FA fortification in the developing neural tube. Furthermore, in the 
developing limb bud of Intudtm mutants, neither canonical Wnt signaling nor planar cell 
polarity signaling appeared to be affected by diet. Thus, we decided to use RNA-sequencing 
(RNA-seq) as an unbiased approach to determine what genes are dysregulated by FA 
fortification in three of the FA-responsive lines, Ift88null, Intunull, and Intudtm.  
Given the role of FA in OCM and the fact that the phenotypic response was observed 
following multigenerational exposure to FA fortification, we also hypothesized that 
differential gene expression might be a result of changes in the epigenome, and here we 
specifically focused on DNA methylation. DNA methylation typically refers to the covalent 
addition of a methyl group to a cytosine residue at the 5’ position, and this preferentially 
occurs at CpG dinucleotides (cytosine adjacent to guanine). More than half of the genes in 
 105 
vertebrate genomes are thought to contain short CpG-rich regions, called CpG islands 
(CGIs), which are ~1kb long, while the rest of the genome is depleted for CGIs315. CGIs are 
often surrounded by CpG-poor regions generally within ~2 kb of the CGI, and tissue-specific 
methylation changes of CpGs in these CGI ‘shores’ has been linked to changes in gene 
expression316. CpGs outside of CGIs and even in CpG ‘deserts’ can still be methylated. DNA 
methylation of CGIs near transcriptional start sites (TSS) is generally associated with long-
term gene silencing, such as in X-chromosome inactivation or imprinted genes, while DNA 
methylation at TSS that are relatively CpG-poor is much more dynamic, though methylation 
is still associated with gene silencing315. Interestingly, DNA methylation within gene bodies 
is not associated with transcriptional repression, but rather is positively correlated with gene 
expression317. 
Evidence correlating dietary methyl content with gene-specific methylation and 
transcription have been demonstrated in numerous studies147,318-326. For example, maternal 
supplementation with a methyl-rich diet increased DNA methylation of a transposable 
element in the Agouti gene of viable yellow agouti mice (Avy), silencing the transposable 
element and leading to changes in coat color of the offspring147. Wild-type mice fed a methyl-
enriched diet have been found to be more susceptible to allergic airway disease, and this 
increased sensitivity is heritable trans-generationally. Furthermore, although global 
methylation was not affected, site-specific methylation changes correlated to decreased gene 
transcription and increased disease severity290. Several studies have shown that FA can affect 
gene expression327,328, even in otherwise identical populations290,323. One study of 
lymphoblastoid cells showed that numerous developmental genes were differentially 
expressed upon FA supplementation323, while another recent study found that maintaining 
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wildtype isogenic mice on a methyl-rich diet for one to six generations increased epigenetic 
variation148. As another example, folic acid supplementation has been shown to rescue 
hypomethylation of DNA in a gene specific manner150. 
To study in an unbiased way the transcriptional and DNA methylation profile of 
wildtype and cilia mutant embryos following multigenerational FA diets, I have used RNA-
seq to identify differentially expressed genes in Ift88null, Intunull and Intudtm, relative to 
genotype and diet and I have also used reduced representation bisulfite sequencing (RRBS) 
to assay for changes in DNA methylation in Intunull and Intudtm embryos.  
Results 
Using an unbiased approach to identify diet-dependent changes in gene expression: 
RNA-Seq 
 The goals of this chapter were three-fold. First, to evaluate diet-dependent changes in 
gene expression in the cranial NT. Second, to determine if FA fortification alters DNA 
methylation, and lastly, to determine if differential gene expression correlates with changes 
in DNA methylation. To optimally address these questions required the ability to assess gene 
expression and DNA methylation in individual embryos, rather than pooled samples. 
Furthermore, it was preferable to use DNA and RNA from the same embryo for direct 
expression-methylation correlation. For both Ift88null and Intunull, RNA and DNA were 
isolated from the heads of E9.5 embryos (19-21 somites), cutting from above the first 
branchial arch to just above the otic vesicle (red line, Figure 5-1A). E9.5 was chosen because 
it is just after cranial NT closure. However, the disadvantage to isolating material from this 
stage is that E9.5 embryo heads yield limited amounts of DNA and RNA. By using dual 
isolation kits, I was able to isolate between 300 – 1000 ng of DNA and 1500 – 3000 ng of 
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RNA. This was sufficient for generating high quality RNA-seq libraries, but was on the low 
end of what could feasibly be used for DNA methylation sequencing assays. Technical 
difficulties with Intunull embryos meant that the RNA-seq data in this thesis is from different 
embryos than the DNA used for DNA methylation, however these difficulties were solved 
and RNA-sequencing will be run on the embryo-matched samples in the future. For Intudtm, 
DNA and RNA were isolated from E10.5 (31-33 somites), again from above the first brachial 
arch to just above the otic vesicle (red line, Figure 5-1B). The later stage was chosen in order 
to increase the yield of DNA, and I was able to isolate 12 – 27 µg of DNA and 7-14 µg of 
RNA per embryo head. 
 
Figure 5-1. Cut sites on (A) E9.5 and (B) E10.5 embryos, illustrating the level at which heads 
were isolated from the body for RNA and DNA isolation. (A) E9.5 mouse embryo image is 
reprinted courtesy of Kallayanee Chawengsaksophak, Czech Centre for Phenogenomics at 
phenogenomics.cz. 
 For all three mouse lines, RNA and DNA sequencing libraries were generated from 4 
embryos for each sample group: F3-control diet wildtype, F3-control diet mutant, F3-supra 
diet wildtype, and F3-supra diet mutant. RNA-sequencing libraries were generated from 1 µg 
of input RNA, and we chose to use single-end sequencing for the RNA-seq experiments, as it 
is significantly cheaper than paired-end sequencing. For DNA-methylation sequencing, 
libraries were made from 100 ng of input DNA. However, the libraries are already of lower 
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complexity and thus it was decided that the additional information to be gained from paired-
end reads was worth the cost. 
 For Intunull and Intudtm, the average reads and quality of base calls was high for the 
RNA-seq experiments (at least 95% >= Q30), with 10-24 million reads per sample. For the 
DNA methylation experiments, sample reads ranged from 55 – 100 million reads/sample, 
with an average of 89% mapability, and only an average of 4% PCR duplication. 
Principal component analysis reveals that folic acid fortification alters the transcriptional 
landscape. 
 Principal component analysis of the transcriptional profiles of the samples used for 
RNA-sequencing indicates that wildtype and mutant embryos segregate from each other in 
all 3 mouse lines studied, Ift88null, Intunull and Intudtm (Figure 5-2A and B, Figure 5-3A and B, 
and Figure 5-4A and B), though there were some outliers.  
 For Ift88null, there was one F3-control diet mutant that was an outlier when compared 
to F3-control diet wildtype samples (Figure 5-2A, light blue rectangle). Oddly, a different 
F3-control diet mutant was an outlier when F3-control diet and F3-supra diet mutants were 
compared (Figure 5-2D, light blue rectangle). There also appeared to be more variability in 
mutant samples than wildtype samples based on the spread of samples in the PCA plots 
(Figure 5-2A and B). Interestingly, wildtype Ift88 samples did not segregate well by diet 
(Figure 5-2C), but the mutant Ift88 samples did segregate moderately well by diet 
(Figure 5-2D), possibly indicating that FA fortification does not significantly affect wildtype 
animals, but does alter the transcriptome of mutants. 
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Figure 5-2. PCA of Ift88null E9.5 transcriptional profiles, 19-21 somites. A) F3-control diet 
wildtype (dark blue) versus F3-control diet Ift88-/-(light blue). B) F3-supra diet wildtype (red) 
versus F3-supra diet Ift88-/- (pink). C) F3 control diet wildtype (dark blue) versus F3-supra 
diet wildtype (red). D) F3-control diet Ift88-/- (light blue) versus F3-supra diet Ift88-/- (pink). 
Oval outlines are included only to highlight clustering, and are not significant in and of 
themselves. 
 PCA analyses of Intunull samples also showed that samples segregated by genotype 
along the primary principal component. However, there did not appear to be increased 
variability in mutants compared to wildtype embryos as was observed in Ift88null 
(Figure 5-3A and B compared to Figure 5-2A and B). Also, both wildtype samples and 
mutant samples segregated out by diet (Figure 5-3C and D), although there was more 
variability in transcriptional profiles in F3-control diet embryos compared to genotype-
matched F3-supra diet samples.  
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Figure 5-3. PCA of Intunull E9.5 transcriptional profiles, 20-21 somites. A) F3-control diet 
wildtype (dark blue) versus F3-control diet Intu-/-(light blue). B) F3-supra diet wildtype (red) 
versus F3-supra diet Intu-/- (pink). C) F3 control diet wildtype (dark blue) versus F3-supra 
diet wildtype (red). D) F3-control diet Intu-/- (light blue) versus F3-supra diet Intu-/- (pink). 
Oval outlines are included only to highlight clustering, and are not significant in and of 
themselves. 
 The final mouse line used for RNA-seq was Intudtm. As mentioned in Chapter 2, 
Intudtm/dtm embryos survive much later than either Ift88-/- or Intu-/- embryos, so neural tissue 
was isolated from E10.5 Intudtm embryos. Although this is a full day after cranial neural tube 
closure is complete, the ability to collect much higher amounts of input RNA (and DNA) 
made the tradeoff worthwhile and also provided new information as to the transcriptional 
profile of neural tissue at this embryonic stage. Like the other mouse lines studied, Intudtm 
wildtype and mutant transcriptional profiles segregated along the first principal component, 
although there were more outliers observed in this line than the other lines studied 
(Figure 5-4A-D). In light of these outliers, analyses of both Intunull and Intudtm were performed 
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on both the complete 16-sample set as well as without the outliers. However, for this thesis, I 
will be focusing on the complete sample set analyses. 
 
Figure 5-4. PCA of Intudtm E10.5 transcriptional profiles, 31-33 somites. A) F3-control diet 
wildtype (dark blue) versus F3-control diet Intudtm/dtm (light blue). B) F3-supra diet wildtype 
(red) versus F3-supra diet Intudtm/dtm (pink). C) F3 control diet wildtype (dark blue) versus F3-
supra diet wildtype (red). D) F3-control diet Intudtm/dtm (light blue) versus F3-supra diet 
Intudtm/dtm (pink). Oval outlines are included only to highlight clustering, and are not 
significant in and of themselves. 
 
Increased gene dysregulation in Ift88null F3-supra diet embryos compared to F3-control diet 
embryos 
The primary effect should be the genetic mutation, so I first compared differentially 
expressed genes between F3-control diet wildtype and Ift88-/- embryos and F3-supra diet 
wildtype and Ift88-/- embryos. Using a threshold of False Discovery rate (FDR) < 0.05 and 
Fold change (FC) > 1.25, with average Fragments Per Kilobase of transcript per Million 
mapped reads (FPKM) > 1  for at least one group, I identified 157 differentially expressed 
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genes between wildtype and mutant embryos on F3-control diet (referred to as control-diet 
mutation-dependent-genes), and 968 differentially expressed genes between wildtype and 
mutant embryos on F3-supra diet (supra-diet mutation-dependent-genes) (Figure 5-5). These 
gene lists had a great deal of overlap, and, as expected these overlapping genes were enriched 
for Hedgehog signaling genes, dorsal-ventral patterning genes and developmental regulator 
genes (eg. Shh, Nkx2.9, FoxA2, Emx2, Lhx2, Wnt7b, and Sfrp1), although as will be 
discussed below, Lhx2 was more dysregulated in F3-supra diet mutants than F3-control diet 
mutants. 
 
Figure 5-5. Venn diagram of genes dysregulated in Ift88null mutants compared to wildtypes on 
control and supra diet. Over 6-fold more genes are dysregulated in Ift88-/- compared to 
wildtype on the supra FA diet (pink) than on the control FA diet (blue) (968 compared to 
157). Genes dysregulated independently of diet (113 purple) include Shh pathway genes, 
dorsal-ventral patterning genes, and developmental regulator genes. 
 Pathway analysis of genes only dysregulated on high diet showed enrichment for 
genes linked to mitochondria function, the proteasome complex, mRNA splicing, sterol and 
lipid biosynthesis, ubiquitin-mediated proteolysis and cell cycle/mitosis/cell division. Of 
interest is Mthfd2, which encodes the mitochondrial enzyme methylenetetrahydrofolate 
dehydrogenase 2 (MTHFD2), a necessary component of OCM (one-carbon metabolism). 
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Mthfd2 is increased 2-fold in F3-supra diet mutants compared to F3-supra diet wildtype 
embryos, but only increased 1.6-fold in F3-control diet mutants (compared to F3-control diet 
wildtype), and Mthfd2 did not appear on the control-diet list of dysregulated genes because 
the FDR value was greater than the q > 0.05 threshold. Expression of Mthfd2 is unchanged in 
wildtype embryos on either F3-control or F3-supra diet. This gene is of particular interest 
given the role of folic acid in OCM, as well as recent data linking mitochondrial OCM to 
NTDs174.  
SHH is modified by the addition of a cholesterol group, and this cholesterol moiety is 
required for SHH to act as a morphogen, so it was interesting that genes involved in sterol 
and lipid biosynthesis were enriched in the supra diet gene list (Table 5-1). Of the 29 genes 
involved in sterol/cholesterol biosynthesis that were only dysregulated on the supra FA diet, 
19 were down-regulated (highlighted in red) and 10 were up-regulated (highlighted in green). 
Looking at these genes on the control diet (F3-control diet wildtype compared to F3-control 
diet mutant) revealed that many of the same genes were dysregulated in mutants on the 
control diet (and in the same direction), though to a lesser extent than on the high diet and/or 
with high FDR values. When I compared expression levels of these genes between F3-
control diet mutants and F3-supra diet mutants directly, however, most had comparable 
levels of expression on either diet (FC < ±1.25). Thus it is not clear that changes in sterol 
and/or lipid biosynthesis gene expression accounts for the phenotypic response observed in 
Ift88-/- embryos.  
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Table 5-1. Sterol and lipid biosynthesis genes dysregulated in F3-supra diet Ift88nul mutants. 
 
Identifying differentially expressed genes between F3-control diet and F3-supra diet 
Ift88-/- embryos using typical standards (False Discovery Rate (FDR) q < 0.05, Fold Change 
FC > 1.5) suggests that there are no differences. However, the observed phenotypic response 
from Chapter 2 is significant, so I reanalyzed the data using less stringent cutoffs. 
Specifically, instead of using FDR, I used a p-value cutoff of p < 0.05, and a fold-change 
cutoff of 1.25 (in either direction). This gave a list of 61 differentially expressed genes, of 
Gene Symbol Gene Name
FC on supra diet      
(wildtype v mutant)
FC on control diet        
(wildtype v mutant)
FC control diet 
mutant v supra diet 
mutant
Fdps Farnesyl Diphosphate Synthase -1.83 -1.28 -1.24
Aacs acetoacetyl-CoA synthetase -1.73 -1.35 -1.19
Scd1 Stearoyl-CoA desaturase 1 -1.71 -1.34 -1.21
Ldlr low-density lipoprotein receptor -1.55 -1.36 -1.17
Mvk mevalonate kinase -1.52 -1.24 -1.06
Acat2 acetyl-Coenzyme A acetyltransferase 2 -1.51 -1.16 -1.19
Ptges2 prostaglandin E synthase 2 -1.47 -1.18 -1.07
Fdft1
farnesyl diphosphate farnesyl 
transferase 1
-1.45 -1.12 -1.12
Fasn fatty acid synthase -1.43 -1.34 -1.02
Pmvk phosphomevalonate kinase -1.4 -1.24 -1.15
Scd2 stearoyl-Coenzyme A desaturase 2 -1.4 -1.21 -1.11
Dhcr7 7-dehydrocholesterol reductase -1.38 -1.08 -1.2
Prkag1
protein kinase, AMP-activated, gamma 
1 non-catalytic subunit 
-1.38 -1.14 -1.12






Fads2 fatty acid desaturase 2 -1.35 -1.21 -1.12
Cyp51 cytochrome P450, family 51 -1.34 -1.09 -1.2
Prkab1




TAM41 mitochondrial translocator 
assembly and maintenance homolog 
-1.32 -1.08 -1.15
App amyloid beta (A4) precursor protein 1.27 1.09 1.18
Mtmr3 myotubularin related protein 3 1.38 1.12 1.17
Cln6 ceroid-lipofuscinosis, neuronal 6 1.5 1.48 1.14
Acat1 acetyl-Coenzyme A acetyltransferase 1 1.52 1.38 1.28
Pla2g12a phospholipase A2, group XIIA 1.59 1.58 1.13
H2-Ke6 hydroxysteroid 17-beta dehydrogenase 8 1.6 1.39 1.3
Soat1 sterol O-acyltransferase 1 1.76 1.79 1.03
Acp6 acid phosphatase 6, lysophosphatidic 1.95 1.47 1.34
Scl37a4
solute carrier family 37 (glucose-6-
phosphate transporter), member 4 
2.68 2.51 1.41
Vldlr very low density lipoprotein receptor 7.91 5.89 1.45
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which 53 could be identified using the DAVID Bioinformatics Resources329,330 website 
(hereafter referred to as DAVID; all DAVID pathway analysis was re-run June-September, 
2016). Pathway analysis in DAVID for this list does not indicate significant enrichment for 
any pathways after multiple comparison correction (Benjamini FDR correction). However, 
Lhx2 was the most down-regulated gene in F3-supra diet mutants compared to F3-control 
diet mutants, with a fold change of -1.56 (p = 0.04, q = 0.4). In F3-control diet mutants, Lhx2 
expression is decreased approximately 2-fold compared to wildtype embryos on either F3-
control or F3-supra diet. In F3-supra diet embryos, Lhx2 expression is decreased by 2.6-fold. 
Lhx2 is a LIM homeodomain transcriptional activator that is required for forebrain, eye and 
definitive erythrocyte development331, as well as a regulator of Wnt signaling in the caudal 
forebrain and roof plate signaling332. The most up-regulated genes in F3-supra diet mutant 
embryos compared to F3-control diet mutant embryos were activating transcription factor 5 
(Atf5) and laminin a5 (Lama5) (1.57 and 1.65 FC, respectively). ATF5 is a centrosomal 
protein that is involved in connecting pericentriolar material to the mother centriole, likely 
via direct interactions with polyglutamylated tubulin and pericentrin333. ATF5 expression also 
promotes proliferation of cerebral cortex progenitor cells, while down-regulation permits 
their differentiation. Interestingly, Atf5 expression is stimulated by SHH expression, but Shh 
expression in Ift88null mutants is significantly reduced334. Lama5-/- mice die between E14-19 
and present with multiple developmental defects including exencephaly, syndactyly and 
abnormal placenta335. Lama-/- mice also have decreased cilia number in E16.5 dermal 
mesenchyme336, and mice homozygous for a hypomorphic allele of Lama5 exhibit polycystic 
kidneys, suggesting a possible connection between LAMA5 and cilia. Interestingly, Atf5 and 
Lama5 are not significantly dysregulated in Ift88null mutants compared to their diet-matched 
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wildtypes. Although it is unlikely that Lhx2, Atf5 or Lama5 dysregulation can fully explain 
the phenotypic difference observed, they are important factors worthy of follow-up. 
 Overall, pathway analysis was not very helpful in analyzing diet-dependent changes 
in gene expression. Instead of looking specifically at what genes are dysregulated, we 
decided to think about the number of genes that are dysregulated. As mentioned before, many 
more genes are dysregulated on the supra-diet (968 genes) compared to the control diet (157 
genes) (Figure 5-5). We might expect the effect of diet on individual gene expression to be 
subtle, so perhaps what we are observing is that F3-supra diet Ift88-/- embryos have increased 
variability of gene expression compared to F3-control diet Ift88-/- embryos. This is in 
agreement with several recent papers supporting the idea that increased variability can 
account for changes in phenotypic penetrance. Raj et al. showed that increased variability of 
gene expression in C. elegans caused incomplete phenotypic penetrance337. Kappen et al. 
found that NTD-affected embryos had significantly higher variability in gene expression than 
non-NTD littermates in both a chemically-induced diabetes model and a non-obese diabetic 
(NOD) strain215. Finally, work in the Niswander lab has found that mutations in the 
chromatin modifiers Baf155338 and Gcn5 (Jon Wilde, unpublished) result in highly variable 
gene expression profiles in mutants, suggesting that mutations in these genes removes the 
‘buffering’ ability of the developing embryo, leading to variable phenotypic penetrance. In 
the case of Ift88-/-, it is possible that FA fortification creates increased gene expression 
variability, essentially adding environmental insult to genetic injury and increasing the risk 
for NTD. 
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Identifying differentially expressed genes in Intunull F3-control diet and F3-supra diet mutants 
 For both Intunull and Intudtm, I performed 4 separate comparisons to identify 
differentially expressed genes, which for the sake of simplicity will be referred to as 
comparisons 1-8 (Comp 1-8; Table 5-2).  
Table 5-2. Comparisons for RNA-seq and DNA methylation experiments 
Experiment Mouse line (age) ‘Control’ ‘Treatment’ 
Comp1 Intunull (E9.5) F3-control diet wildtype F3-control diet mutant 
Comp2 Intunull (E9.5) F3-supra diet wildtype F3-supra diet mutant 
Comp3 Intunull (E9.5) F3-control diet wildtype F3-supra diet wildtype 
Comp4 Intunull (E9.5) F3-control diet mutant F3-supra diet mutant 
Comp5 Intudtm (E10.5) F3-control diet wildtype F3-control diet mutant 
Comp6 Intudtm (E10.5) F3-supra diet wildtype F3-supra diet mutant 
Comp7 Intudtm (E10.5) F3-control diet wildtype F3-supra diet wildtype 
Comp8 Intudtm (E10.5) F3-control diet mutant F3-supra diet mutant 
 
 As with the Ift88null mouse line, I analyzed the Intunull RNA-seq data by comparing 
genes dysregulated in mutants compared to wildtype embryos within diet (Comp1 and 
Comp2). Unlike Ift88null, Intunull mutant embryos had comparable numbers of dysregulated 
genes compared to wildtype embryos on the F3-control diet and the F3-supra diet (21 
dysregulated on control diet, 17 dysregulated on supra diet) (Figure 5-6). As expected, most 
of the 7 genes dysregulated independently of diet are implicated in Shh signaling and D-V 
patterning  (Table 5-3). Although Nkx2-9, Foxa2 and Gli1 all appear to be more down-
regulated in F3-supra diet mutants than F3-control diet mutants, the average FPKM values 
were comparable in mutants on either diet. 
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Figure 5-6. Venn diagram of genes dysregulated in Intunull mutants compared to wildtypes on 
control and supra diet. A comparable number of genes were dysregulated between wildtype 
and mutants on both F3-control diet (21, blue) and F3-supra diet (17, pink), with 7 genes 
dysregulated on both diets. 
 
Table 5-3. Genes dysregulated in Intu-/- independent of diet (down-regulated genes are 
highlighted in pink, up-regulated are highlighted in green). 
 
 Since only 24 genes were dysregulated in mutants in what appeared to be a diet-
dependent manner, I manually inspected the raw data to see if these genes are truly 
dysregulated in a diet-dependent manner. As seen in Table 5-4, many genes that were listed 
as only ‘significantly dysregulated’ on either the F3-control (highlighted in blue) or F3-supra 
diet (highlighted in pink) were actually comparably dysregulated between wildtype and 
mutants independent of diet (highlighted in yellow in Table 5-4). However, because some 
statistical filter must be used, and I chose the standard FDR cutoff of q < 0.05, these genes 
Gene Symbol Gene Name
FC on control diet 
(wildtype v mutant)
FC on supra diet 
(wildtype v mutant)
FC control v supra; 
wildtype
FC control v supra; 
mutant
RP23-136M3.5 putative gene -5.6 -11.3 1.32 -1.5
Nkx2-9 NKX homeobox 9 -4.61 -9.19 1.61 -1.24
Shh Sonic hedgehog -4.1 -4.27 1.14 1.09
Foxa2 Forkhead box A2 -3.68 -5.73 1.32 -1.18
Gli1
GLI Kruppel family 
member GLI1




-2.23 -2.26 1.08 1.07
Prss23 protease, serine 23 1.58 1.47 1.05 -1.02
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only appeared on one list. This highlights the challenge of working with large RNA-
sequencing datasets, as FDR testing can filter out biologically relevant information. At the 
time of writing this thesis, I have not yet determined how best to address this problem, 
though one approach will be to re-analyze data using only p-value cutoffs. Because most of 
the genes that are ‘statistically’ dysregulated only in mutants on either the F3-control diet or 
the F3-supra diet appear to actually be comparably dysregulated independently of diet, 
pathway analysis of these genes has not yet been explored. 
Table 5-4. Genes dysregulated in Intunull F3-control diet mutants (blue) and Intunull F3-supra 
diet mutants (pink). 
 
 
Gene Symbol Gene Name
FC on control diet 
(wildtype v mutant) 
(q-value)
FC on supra diet 
(wildtype v mutant) 
(q-value)
RP24-511M8.2 putative gene -7 (0.04) 2.57 (99)
Wnt8b Wnt family member 8b -2.38 (0.04) -1.68 (0.08)
Ptch2 Patched 2 -2.25 (0.03) -1.9 (0.12)
Dmrt3
Doublesex and Mab-3 related 
transcription factor 3
-1.95 (0.03) -1.83 (0.17)
Slit1 Slit guidance ligand 1 -1.67 (0.004) -2.1 (0.07)
Col15a1 Collagen type XV alpha 1 -1.67 (0.04) -1.49 (0.34)
Ascl1
Achaete-scute family bHLH 
transcription factor 1
-1.58 (0.04) -1.65 (0.07)
Bmp7 Bone morphogenic protein 7 -1.32 (0.004) -1.23 (0.17)
Miip
Migration and invasion 
inhibitory protein
1.28 (0.04) -1.03 (99)
Aacs Acetoacetyl-CoA synthetase 1.43 (0.05) 1.02 (99)
Fam213b
Family with sequence 
similarity 213, member B
1.45 (0.04) 1.01 (99)
Fgfbp3
Fibroblast growth factor 
binding protein 3
2.32 (0.004) 1.35 (99)
Gm22442 predicted gene 11 (0.04) 1.48 (99)
Mir6955 putative microRNA 63 (0.004) -1.36 (0.62)
Snora5c Small nucleolar RNA, H/ACA box 5C 1.58 (99) -12 (0.001)
Samd5 Sterile alpha motif domain containi -1.61 (99) -1.69 (0.001)
Ferd3l Fer3-like -4.53 (0.1) -6.56 (0.003)
Gm3764 predicted gene -4.04 (0.1) -4.17 (0.008)
Nkx2-2 Nk2 homeobox 2 -2.27 (99) -2.86 (0.008)
Nkx2-1 Nk2 homeobox 1 -2.48 (0.09) -2.03 (0.01)
Nkx6-1 NK6 homeobox 1 -1.31 (99) -1.82 (0.02)
Lama5 Laminin, alpha 5 1.05 (99) -1.36 (0.04)
C130021I20Rik Putative gene -1.27 (99) -1.46 (0.04)
Rspo1 R-spondin 1 -1.17 (0.5) -1.28 (0.02)
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Comparing gene profiles of F3-control diet Intu-/- and F3-supra diet Intu-/- (Comp4) 
using standard FDR and FC cutoffs (q < 0.05 and FC > 1.5) yielded no results, similar to 
results of the Ift88null line. Using the same lower-stringency cutoffs as before (p < 0.05, FC > 
1.25) revealed 91 genes dysregulated in F3-supra diet mutants compared to F3-control diet 
mutants (of which 75 were identifiable by DAVID). Similar to Ift88 analyses, pathway 
analysis did not reveal significant enrichment for any pathways or gene ontology terms. One 
of the most up-regulated genes is protocadherin 1 (Pcdh1), which was increased by 1.43-fold 
in F3-supra diet mutants compared to F3-control diet mutants. Pcdh1 is a non-clustered 
protocadherin, a family of calcium-dependent adhesion molecules that have been implicated 
in neuronal development339. Fgf17 was also slightly up-regulated in F3-supra diet mutants 
compared to F3-control diet mutants (1.32, p = 0.02). Fgf17 is expressed in the mid-
hindbrain organizer, and loss of Fgf17 results in loss of precursor cell proliferation in the 
developing cerebellar vermis340. However, neither Fgf8 nor Fgf18, which are also expressed 
in the mid-hindbrain organizer, are differentially expressed in the mutant embryos on F3-
supra diet compared to F3-control diet, although Fgf8 is slightly, though not significantly, 
up-regulated in mutant embryos relative to wildtype embryos.  
 The top hits for down-regulated genes include Usmg5 (upregulated during skeletal 
muscle growth 5, -2.12-fold), Cyp26c1 (cytochrome p450, family 26, subfamily c, 
polypeptide 1, -1.92), Ccng2 (cyclin G2, -1.72), and Dlx2 (distal-less homebox 2, -1.64). 
USMG5 localizes to mitochondria and is a member of the ATP synthase complex. Cyp26c1 
is a member of the cytochrome p450 family of proteins and is involved in retinoic acid 
metabolism. Loss of Cyp26c1 does not appear to affect CNS development in mice, though 
Cyp26a1-/-;Cyp26c1-/- embryos have severe exencephaly341. Ccng2 is a cell-cycle regulator 
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that has been shown to inhibit canonical Wnt/b-catenin signaling as well as epithelial-to-
mesenchymal transition (EMT) in epithelial ovarian cancer342. Dlx2, along with its linked 
partner Dlx1, are known to be required for upper teeth and craniofacial development343 as 
well as specification of neuronal subtypes in the forebrain later in development344. As one 
would expect for a distal-less pair, both Dlx2 and Dlx1 showed a similar pattern, although 
Dlx1 did not achieve statistical significance and thus did not make the initial list. Oddly, 
expression levels of Dlx2 and Dlx1 in F3-control diet mutants are comparable to expression 
levels in F3-supra diet wildtype embryos, and expression levels in F3-supra diet mutants are 
comparable to F3-control diet wildtype embryos. The reason for this unexpected pattern is 
still under investigation 
Identifying differentially expressed genes in Intudtm F3-control diet and F3-supra diet mutants 
As with the first two mouse lines studied, RNA-sequencing data for Intudtm was 
initially analyzed with the standard FDR cutoff of q > 0.05 and FC > 1.25. However, even 
when comparing wildtype and mutant embryo gene expression (Comp5 and Comp6, within 
diet: F3-control diet wildtype v mutant; F3-supra diet wildtype v mutant), no genes were 
significantly differentially expressed with these cutoffs. Since exencephaly is relatively rare 
in this line, and none of the samples used for RNA-seq were phenotypic for exencephaly, this 
is not surprising. Nonetheless, the principal component analyses performed on these data sets 
indicates that the transcriptional profiles do segregate moderately well by both genotype and 
diet (Figure 5-4A-D). Therefore, I applied the less stringent criteria previously defined for 
similar genotype diet comparisons and generated lists of differentially expressed genes based 
on p < 0.05, FC > 1.25. These cutoffs yielded 88 differentially expressed genes in F3-control 
diet mutants compared to F3-control diet wildtype embryos, and 1171 differentially 
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expressed genes in F3-supra diet mutants relative to F3-supra diet wildtype embryos. Of 
these, only 8 genes were differentially expressed on both diets (Figure 5-7), however only 4 
of these genes are known genes: Ndufab1 (NADH dehydrogenase (ubiquinone) 1, alpha/beta 
subcomplex 1), which is implicated in fatty acid synthesis in mitochondria; Mrpl48 
(mitochondrial ribosomal protein L48); Nsf (N-ethylmaleimide sensitive fusion protein), 
which is involved in vesicle-mediated trafficking; and Ece1 (endothelin converting enzyme 
1), which has been linked to Hirschsprung disease345. The remaining 4 are predicted and/or 
pseudogenes. In fact, many of the ‘genes’ found to be dysregulated via low stringency 
criteria in F3-supra diet mutant embryos relative to F3-supra diet wildtype embryos (Comp6) 
were putative and pseudogenes. Comparing mutants across diet (Comp8, F3-control diet 
mutant versus F3-supra diet mutant), identified 3390 differentially expressed genes, of which 
many were putative and pseudogenes. Nonetheless, there were some intriguing PCP and 
cilia-related genes, including Vangl2, Axin1, Tuba1b, Ift140, Ctnnb1, Baiap2, Sept2 
(Table 5-5). 
 
Figure 5-7. Venn diagram of genes dysregulated in Intudtm mutants compared to wildtypes on 
control and supra diet. Over 10-fold more genes are dysregulated in Intudtm/dtm compared to 
wildtype on the supra FA diet (pink) than on the control FA diet (blue) (1171 compared to 
88). Only 8 genes were dysregulated independently of diet (8 purple). 
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Table 5-5. Interesting genes dysregulated between F3-control diet and F3-supra diet Intudtm/dtm 
(Comp8).  
Gene ID Gene Name Fold Change P-value Q-value
Axin1 Axin 1 -1.51 0.011 0.211
Baiap2 brain-specific angiogenesis inhibitor 1-associated protein 2 -1.44 0.001 0.179
Ctnnb1 catenin (cadherin associated protein), beta 1 -1.37 0.020 0.221
Ift140 intraflagellar transport 140 -1.3 0.012 0.211
Kif2a Kinesin family member 2a -1.61 0.022 0.221
Kif5c Kinesin family member 5c -1.71 0.016 0.216
Lef1 Lymphoid enhancer binding factor 1 -1.29 0.046 0.237
Pax6 Paired box 6 -1.41 0.042 0.234
Rara Retinoic acid receptor, alpha -1.32 0.033 0.230
Sept2 Septin 2 -1.32 0.001 0.179
Smad2 SMAD family member 2 -1.26 0.010 0.211
Smad4 SMAD family member 4 -1.38 0.035 0.230
Smarce1
SWI/SNF related, matrix associated, actin dependent regulator 
of chromatin, subfamily e, member 1
-1.3 0.040 0.233
Tuba1b Tubulin alpha 1b 1.33 0.025 0.221
Vangl2 Van gogh-like 2 -1.75 0.009 0.211  
Surprisingly, when analysis was re-run on the Intudtm samples excluding the outliers, it 
was possible to compare F3-control diet mutants and F3-supra diet mutants using the more 
stringent statistical cutoff of FDR q < 0.05, which yielded 1975 differentially expressed 
genes (FC > 1.25), and included all of the genes in Table 5-5. Within this gene list are 50 
genes that have already been implicated in NTDs (NTD gene list from 
https://ntdwiki.wikispaces.com/) (Table 5-6). A number of these genes are implicated in 
canonical and non-canonical (PCP) Wnt signaling, Shh signaling, and cilia, and 17 of these 
genes have a fold change ³ 1.5. Although there is a lack of NTD response to FA fortification 
in this line, some of these genes are also involved in limb development where there is a FA-
dependent effect. These results will be discussed further in the Discussion section of this 
chapter.  
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Table 5-6. NTD-associated genes dysregulated in F3-supra diet Intudtm mutants relative to F3-
control diet Intudtm mutants. Genes with FC > 1.5 are highlighted in yellow. 
 
Average FPKM Average FPKM
(F3-control diet mutant) (F3-supra diet mutant)
Abi1 abl-interactor 1 -1.46 0.010 149.69 102.52
Alx3 Aristaless homeobox 3 -1.29 0.031 57.34 44.4
Apaf1 Apoptotic peptidase activating factor 1 1.52 0.033 18.85 28.69
Axin1 Axin 1 -1.69 0.029 181.87 107.39
B9d1 B9 protein domain 1 -1.44 0.046 106.4 74.13
Cecr2 Cat eye syndrome chromosome region, candidate 2 -1.8 0.020 63.65 35.37
Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 -1.34 0.041 26.37 19.68
Crebbp CREB binding protein -1.63 0.012 16.74 10.26
Ctnnb1 Beta catenin -1.55 0.008 1857.54 1196.26
Ctnnbip1 Beta catenin interacting protein 1 -1.42 0.035 89.09 62.59
Dvl3 Dishevelled segment polarity protein 3 -1.57 0.006 77.51 49.48
Enah Enabled homolog (Drosophila0 -1.31 0.013 362.86 277.08
Fkbp1a FK506 binding protein 1a -1.46 0.015 366.15 251.2
Frem2 Fras1 related extracellular matrix protein 2 -1.32 0.042 28.33 21.41
Gadd45a Growth arrest and DNA-damage-inducible 45 alpha -1.54 0.041 30.97 20.11
Gli3 GLI-Kruppel family member GLI3 -1.7 0.006 72.34 42.58
Gnb1
Guanine nucleotide binding protein (G protein), beta 
1
-1.33 0.009 1614.07 1209.71
Gtf2i General transcription factor II I -1.5 0.012 607.45 405.2
Hif1a Hypoxia inducible factor 1 alpha subunit 1.33 0.030 80.15 106.34
Hipk1 Homeodomain interaction protein kinase 1 -1.32 0.022 47.06 35.78
Hipk2 Homeodomain interaction protein kinase 2 -1.7 0.029 65.86 38.81
Ift140 Intraflagellar transport protein 140 (IFTA complex) -1.39 0.040 48.62 35.05
Jarid2 Jumonji, AT rich interactive domain 2 -1.28 0.028 95.29 74.32
Marcks myristoylated alanine rich protein kinase C substrate 2 0.004 229.84 459.32
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ 
dependent) 1-like
-1.35 0.015 46.7 34.65
Numb Numb homolog (Drosophila) -1.54 0.032 46.74 30.29
Pfn1 Profilin 1 -1.36 0.021 1798.42 1326.54
Phactr4 Phosphatase and actin regulator 4 -1.46 0.024 70.95 48.51
Pip5k1c
Phosphatidylinositol-4-phosphate 5-kinase type 1 
gamma
-1.26 0.046 90.9 72.01
Por P450 (cytochrome) oxidoreductase -1.3 0.022 159.39 122.97
Prkaca Protein kinase, cAMP dependent, catalytic alpha -1.27 0.019 163.22 128.19
Ptk7 Protein tyrosine kinase 7 -1.36 0.021 96.28 71.03
Ptpn11 Protein tyrosine phosphatase, non-receptor type 11 -1.33 0.019 106.81 80.07
Rara Retinoic acid receptor, alpha -1.5 0.011 31.32 20.91
Rere Arginine glutamic acid dipeptide (RE) repeats -1.37 0.017 94.83 69.36
Rgma Repulsive guidance molecule family member A -1.3 0.016 90.92 69.96
Scarb1 Scavenger receptor class B, member 1 -1.27 0.025 83.11 65.38
Scrib Scribbled planar cell polarity -1.35 0.017 197.4 145.75
Sec24b Sec24 related gene family, member B (S. cerevisiae) -1.66 0.013 174.19 104.89
Sema4c Semaphorin 4C -1.41 0.027 86.56 61.31
Sfrp2 Secreted frizzled-related protein 2 -1.56 0.011 225.45 144.84
Sirt1 Sirtuin 1 1.5 0.008 27.44 41.05
Smarca4
SWI/SNF related, matrix associated, actin dependent 
regulator of chromatin, subfamily a, member 4
-1.32 0.011 267.33 202.75
Sphk2 Sphingosine kinase 2 -1.43 0.007 40.2 28.13
Sufu Suppressor of fused homolog (Drosophila) -1.63 0.009 87.8 53.78
Tcof1 Treacle ribosome biogenesis factor 1 -1.49 0.021 94.99 63.94
Tgif1 TGFB-induced factor homeobox 1 -1.27 0.042 106.72 83.94
Vangl2 Vang-like 2 (van gogh, Drosophila) -2.14 0.010 97.15 45.36
Vasp Vasodilator-stimulated phosphoprotein -1.35 0.015 119.48 88.42
Zfp385a Zinc finger protein 385a -1.45 0.020 104.06 71.79
Gene Symbol Gene Name Fold Change Q-value
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Folic acid fortification alters DNA methylation in Intunull and Intudtm 
 As discussed in the introduction chapter, FA acts as a methyl donor in the OCM 
cycle, and has been implicated in altering DNA methylation, which in turn plays a role in 
modulating gene expression. From the beginning of my work on this project, I wanted to be 
able to correlate gene expression changes with DNA methylation, but I was severely limited 
by the very low amount of input DNA that can be isolated from an E9.5 mouse embryo head. 
The Broad Institute has been performing whole genome bisulfite sequencing (WGBS) and 
reduced representation bisulfite sequencing (RRBS) on very low-input samples (10 – 300 
ng346) for a number of years, but until very recently, most commercial protocols 
recommended starting with at least 1 µg of high quality input DNA, which is several hundred 
nanograms more than I could consistently isolate from a single E9.5 embryo head. Given 
some of the inherent variability discovered above in the RNA-Seq datasets, I felt it was 
important to assess individual samples, rather than a pooled sample.  
In late 2014, I started working with Agilent Technologies, Inc to see if their as-yet 
unreleased mouse methylation sequencing kit, SureSelect MethylSeq, might provide the 
technological solution to my low-input problem. The SureSelect system allows for a targeted 
sequencing approach, which is much more cost-effective than WGBS (which requires far 
more sequencing to get adequate read-depths). Working closely with Agilent and the 
Genomics and Microarray Core, I procured and tested a low-input DNA kit and protocol, 
called SureSelectXT Methyl-Seq combined with Post-Bisulfite Adaptor Tagging (PBAT). This 
system was designed to work with as little as 100 ng of input DNA for amplification-free 
template preparation, and as little as 30 ng of input DNA with 4 cycles of PCR 
amplification347,348.  The SureSelect platform uses biotinylated cRNA probes to enrich for 
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pre-designed targets. The mouse methyl-seq SureSelect system provides 109 Mb of coverage 
and was designed to include known CpG islands, shores and shelves (defined as ± 4 kb from 
CpG islands), tissue specific DMRs, Ensemble annotated DNase I hypersensitive sites, 
transcription factor binding sites (TFBS) and polymerase binding sites, and Open Regulatory 
Annotation (ORegAnno) promoters, enhancers, TFBS, and regulatory polymorphisms. 
 Since it was a beta test of an early-access system, and we were the first to use the 
mouse version of the kit (and the first in the United States to use any version of the kit), we 
decided to test the protocol with 1 µg of input DNA, rather than push the low-input limits. I 
started with the Intudtm line, because I could consistently isolate 14-25 µg of high quality 
DNA from a single E10.5 embryo head (compared to an average of 300 – 750 ng of DNA 
from an E9.5 embryo head). Unfortunately, starting with 1 µg of input DNA yielded no 
detectable amount of sequencing libraries, even when an Agilent Field Applications 
Specialist re-tested the protocol. Ultimately, Agilent returned the low-input PBAT mouse 
methyl-sequencing protocol to research and development for the foreseeable future until they 
can determine the source of the problem. 
In the meantime, I was put in touch with NuGEN Technologies, Inc., who had 
recently released its own low-input methyl-seq kit, the Ovation® RRBS Methyl-Seq System, 
which was optimized for 100 ng of input DNA. The NuGEN system had several major 
advantages over other potential options. First of all, the commercially available kit had 
already been successfully used, and thus could be vouched for by an end-user not affiliated 
with NuGEN. Secondly, the inherent advantage of RRBS over WGBS is that, like a target 
enrichment system, RRBS requires orders of magnitude fewer sequencing reads to get 
adequate coverage and depth349. Thirdly, the library preparation was very streamlined, so I 
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was able to generate high quality, bar-coded libraries in a single day. Lastly, according to Dr. 
Ken Jones, the bioinformatician who helped me with my data analysis, the NuGEN RRBS 
system generated the highest quality bisulfite sequencing data he had seen to date, with 
~90% mappability and only 3-4% PCR duplicates. Thus, I was able to successfully generate 
high-quality RRBS libraries from 100 ng of input DNA from both Intunull E9.5 heads and 
E10.5 Intudtm heads and correlate differential methylation with the differential gene 
expression identified via the RNA-seq experiments in the first part of this chapter. 
Differentially methylated regions (DMRs) were identified as follows. First, each 
sample group contained 4 biological samples, and to be included in the analysis, at least 3 
samples in a group had to have sequence data for a given locus. Next, a locus had to have 
sequencing reads for 3+ probes, defined as consecutive CpG sites. Using these criteria, 
several hundred DMRs were identified for each comparison group (Table 5-7). There did not 
appear to be any effect of diet on the number of DMRs identified, although there were fewer 
DMRs overall in the Intudtm experiments than the Intunull experiments.  
Table 5-7. Number of DMRs identified for each experimental comparison. 
 Number of DMRs 
Comp1 (Intunull F3-control diet wildtype v mutant) 719 
Comp2 (Intunull F3-supra diet wildtype v mutant) 498 
Comp3 (Intunull F3-control diet wildtype v F3-supra diet wildtype) 602 
Comp4 (Intunull F3-control diet mutant v F3-supra diet mutant) 584 
Comp5 (Intudtm F3-control diet wildtype v mutant) 381 
Comp6 (Intudtm F3-supra diet wildtype v mutant) 211 
Comp7 (Intudtm F3-control diet wildtype v F3-supra diet wildtype) 286 
Comp8 (Intudtm F3-control diet mutant v F3-supra diet mutant) 359 
 
To determine if differential gene expression correlated with DMRs, we used the 
following criteria – expression quantitative trait loci (eQTLs) were identified as significant 
DMRS (p < 0.05) located ±1 Mb of a differentially expressed gene (p < 0.05).  The same 
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comparison groups were used here as with the RNA-sequencing experiments (Comparisons 
1-8, Table 5-2). For Intunull (Comparisons 1-4), I isolated DNA from different embryos than 
the ones used for RNA-seq due to difficulties in dual isolation of RNA and DNA for E9.5 
embryo heads. However, when I isolated DNA, I was also able to isolate RNA, and will be 
re-running the RNA-seq experiment in order to have direct sample-to-sample correlation for 
expression and DNA methylation. For Intudtm I was able to isolate sufficient RNA and DNA 
from a single embryo head, and thus the gene expression and DNA methylation are from the 
same biological samples.  
The analysis of the methylation data is still in very early stages. However, it is 
interesting to note that DMRs associated with differentially expressed genes (i.e. eQTLs) 
were found even in embryos from the same diet (Intunull, Comp1 and Comp2; Intudtm, Comp5 
and Comp6) as well as when comparing across diets (Intunull, Comp3 and Comp4; Intudtm, 
Comp7 and Comp8) (Table 5-8). 
A number of interesting genes have expression that appears to correlate to changes in 
DNA methylation, including genes associated with Wnt signaling (canonical and non-
canonical), cilia and actin regulation. For example, Vangl2 and Ift40 are both down-regulated 
in Intudtm F3-supra diet mutants compared to F3-supra diet wildtype (Comp6), and both show 
strong associations with DMRs. Both of these genes are also significantly down-regulated in 
F3-supra diet mutants compared to F3-control diet mutants (Comp8), although no significant 
associated DMRs were identified for Comp8 near these genes. Two DMRs with significant 
eQTL values were identified near Tuba1b when comparing Intudtm/dtm on F3-control v F3-
supra diet (Comp8). Tuba1b is slightly upregulated in F3-supra diet Intudtm/dtm compared to 
F3-control diet Intudtm/dtm. Several DMRs were also identified both upstream and downstream 
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of Baiap2, which is involved in lamellipodia and filopodia formation as well as neurite 
growth, and which is down-regulated by -1.44-fold in F3-supra diet Intudtm/dtm compared to 
F3-control diet Intudtm/dtm (Comp8). Similarly, at least two DMRs are associated with Nrxn2 
expression, which has been implicated in cell adhesion and autism and is also down-
regulated in F3-supra diet Intudtm/dtm compared to F3-control diet Intudtm/dtm (Comp8, fold 
change = -1.6), though it is slightly up-regulated in Intunull/null F3-supra diet mutants compared 
to F3-control diet mutants (Comp4, fold change = 1.2). As a final example, b-catenin 
expression (Ctnnb1) is lower in Intudtm/dtm F3-supra diet embryos compared to either F3-
control diet mutants (Intudtm/dtm, Comp8, FC = -1.4) or F3-supra diet wildtype (Comp6, FC = -
1.4). Two DMRs are associated with the differential gene expression, including one DMR 
that is located right at the transcriptional start site of b-catenin.  
Table 5-8. Number of eQTLs identified for each comparison with no FC cut-off (first 
column) and with FC > 1.25 (second column). 
 
Number of eQTLs 
(eQTL < 0.05) 
(# genes associated) 
Number of eQTLs 
(eQTL < 0.05, FC >1.25) 
(# genes associated) 
Comp1  
(Intunull F3-control diet wildtype v mutant) 
187 (123) 75 (51) 
Comp2  
(Intunull F3-supra diet wildtype v mutant) 
58 (34) 16 (11) 
Comp3  
(Intunull F3-control diet wildtype v F3-supra 
diet wildtype) 
286 (151) 63 (35) 
Comp4  
(Intunull F3-control diet mutant v F3-supra 
diet mutant) 
82 (41) 19 (9) 
Comp5  
(Intudtm F3-control diet wildtype v mutant) 
45 (27) 17 (11) 
Comp6  
(Intudtm F3-supra diet wildtype v mutant) 
135 (90) 83 (56) 
Comp7  
(Intudtm F3-control diet wildtype v F3-supra 
diet wildtype) 
93 (62) 33 (19) 
Comp8  
(Intudtm F3-control diet mutant v F3-supra 
diet mutant) 
140 (94) 78 (50) 
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As mentioned above, the DNA methylation data analyses are still very preliminary, 
and none of these DMRs have been validated with either Pyromark sequencing or methyl-
specific PCR, yet. However, it is exciting that a number of developmentally interesting 
genes, including b-catenin and Vangl2, appear to be differentially expressed in a 
methylation-dependent manner. 
Dysregulated genes cluster on the genome near regions of differential DNA methylation 
The Skinner lab identified epigenetic control regions (ECRs), that appear to be more 
sensitive to environmental insults than the rest of the genome, as evidenced by clusters of 
DMRs and differentially expressed genes within 2-5 Mb of these ECRs. Importantly, 
different environmental insults cause dysregulation of different genes, but the location of 
differentially expressed genes appears to cluster near these ECRs280,350. Mapping 
differentially expressed genes identified in the above RNA-seq experiments for Ift88null and 
Intudtm to the genome suggests that dysregulated genes are over-represented in clustered 
regions of the genome, as shown on chromosome 10 and 15, below, (outlined in aqua boxes, 
Figure 5-8, all chromosomes and tracks are shown in Appendix C). It should be noted that 
these gene clusters do not correspond to imprinted regions. I then performed preliminary 
statistical analysis on the potential gene clusters using data from Ift88null. Briefly, for the 
chromosomes shown in Figure 5-8, a simulation was run to generate a random distribution of 
dysregulated genes. The mean and standard error for distance between the randomly 
distributed genes was estimated via bootstrapping of the log-transformed data, and this was 
compared to the log-transformed average distance between genes in each cluster. For each 
cluster like those highlighted in aqua boxes in Figure 5-8, the average distance between 
genes within the cluster was significantly smaller than the bootstrap estimated mean 
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difference (p < 6 x 10-58). The gene clusters observed upon increased FA diet suggest there 
may be FA-sensitive chromosomal regions. 
 
Figure 5-8. Clusters of dysregulated genes on chromosomes 10 and 15. Mapping of 
dysregulated genes to their gene position on two representative chromosomes. Prominent 
gene clusters are outlined in aqua boxes. For each chromosome, the top track shows all 
genes expressed at E9.5 (black, generated from E9.5 wildtype embryo RNA-seq data). In 
blue are genes that are dysregulated in F3-control diet Ift88null mutants compared to F3-
control diet wildtype. In pink are genes differentially expressed between F3-supra diet 
wildtype and mutant Ift88null embryos. In purple are genes dysregulated between Ift88null F3-
control diet mutants and F3-supra diet mutants. The next three tracks show genomic CpG 
methylation data from unexposed WT mice (control (F0) in orange) and WT mice fed 
methyl-rich diets for 1 and 6 generations (F1 in dark orange and F6 in red; only 
differentially methylated regions are displayed) from the Li et al experiment with wildtype 
mice maintained on high methyl diets148. Differentially expressed genes and DMRs for each 
of the four Intudtm comparisons are shown next: Comp5 = F3-control diet wildtype versus F3-
control diet mutant; Comp6 = F3-supra diet wildtype versus F3-supra diet mutant; Comp7 = 
F3-control diet wildtype versus F3-supra diet wildtype; Comp8 = F3-control diet mutant 
versus F3-supra diet mutant. CpG islands from UCSC Genome Browser shown in green 
dashes and all genes are displayed in dark blue. 
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 I then attempted to correlate the clusters of dysregulated genes with DMRs. At the 
time I analyzed the Ift88null RNA-seq data, I did not have any DNA methylation data from 
these studies. However, there was published methylation data from a study in which 
wildtype, isogenic mice were maintained on high methyl diets for one or six generations (F1 
and F6). In this study, Li et al found increased variability of methylated loci was observed the 
longer mice were maintained on the high methyl diet148. It must be noted that the diet used in 
this study had extremely high levels of methyl donors: 15 g/kg choline, 15 g/kg betaine, 7.5 
g/kg L-methionine, 15 mg/kg FA, 1.5 mg/kg vitamin B12. Furthermore, the authors only 
validated 9 DMRs, of which only 5 were found to have changes in methylation consistent 
with the initial data. Nonetheless, as a proxy until I could generate my own data, the DMRs 
identified in this study showed an interesting correlation with dysregulated genes identified 
in my RNA-seq experiments. As can be seen in Figure 5-8, clusters of dysregulated genes 
appear to correspond to regions of DMRs (orange, dark orange, and red). Below the wildtype 
methylation data from Li et al148 are genes dysregulated in the Intudtm experiments along with 
the corresponding DMRs. Although DMRs for the Intudtm did not correlate as well with gene 
clusters of dysregulated genes, the gene clusters do appear to correspond to the clusters 
observed in Ift88null. Although not conclusive, these correlations bear further investigation. 
Discussion 
 Next generation sequencing provides the opportunity to address complex problems in 
an unbiased way, often resulting in unexpected and exciting results. In Chapter 4, we found 
that the more obvious pathways, such as Shh signaling, proliferation or apoptosis, are not 
affected by FA fortification. RNA-seq revealed that FA fortification alters the transcriptional 
landscape, even in wildtype embryos. Interestingly, F3-supra diet mutants from both Ift88null 
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and Intudtm lines had increased gene dysregulation compared to their respective F3-supra diet 
wildtype embryos. This suggests a possible mechanism by which FA may increase variability 
of gene expression and ultimately account for changes in phenotypic penetrance. In an 
otherwise heathy or wildtype system, variable gene expression would be buffered and thus 
would not cause an observable phenotypic response. In a system that already has an 
underlying genetic insult, the buffering ability of the organism may be compromised, thus 
altering the phenotypic outcome. This idea harkens to the Waddington model of canalization 
(or buffering) during development, in which the buffering ability of organisms during 
development allows for a consistent phenotypic outcome even when exposed to variable 
conditions351. As Waddington wrote351:  
The constancy of the wild type must be taken as evidence of the buffering of 
the genotype against minor variations not only in the environment in which 
the animals developed but also in its genetic make-up. That is to say, the 
genotype can, as it were, absorb a certain amount of its own variation 
without exhibiting any alteration in development. 
Thus in our system, one can argue that the underlying cilia mutations disrupt the buffering 
capacity of the organism, making the developing embryo more susceptible to FA-induced 
variability in gene expression. 
 Comparing Ift88null and Intudtm supports this theory. The Ift88null allele is a stronger 
allele than Intudtm, which is a hypomorphic allele of Intu. Embryos that are homozygous for 
Ift88null/null have reduced buffering capacity, and the increased gene dysregulation observed on 
the supra FA diet may be sufficient to increase the incidence of exencephaly. In Intudtm/dtm 
embryos, on the other hand, the buffering ability of the organism is sufficiently robust, and 
thus the incidence of NTDs is not altered in spite of the increased gene dysregulation 
observed on the supra FA diet. 
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 Given the role of FA in OCM, the fact that a phenotypic response to FA is not 
observed upon short-term fortification, and the proposed role of epigenetics in shaping 
Waddington’s landscape, we next looked at DNA methylation. It is, of course, possible that 
FA is not significantly affecting DNA methylation, but is still altering the epigenetic 
landscape. As we have chosen to start with DNA methylation, that will be discussed here, 
and alternative targets will be discussed in the final chapter. The analyses of the DNA 
methylation experiments are still in the very early stages, but there some intriguing eQTLs 
that have been identified, including DMRs near developmentally important genes like Vangl2 
and b-catenin, both of which are downregulated in Intudtm F3-supra diet mutants compared to 
F3-supra diet wildtype and F3-control diet mutants.  
Further evidence for epigenetically labile regions of the genome comes from the 
Feinberg lab, where it was shown that there is stochastic methylation in certain cancer-
specific DMRs. Variability of methylation in these DMRs was significantly higher in cancer 
cells than in wildtype cells, and the stochastic methylation was correlated with stochastic 
gene expression352. The authors suggest that the disease state – cancer – is a disease of 
generalized dysregulation as a result of stochastic noise. In our data, there did not appear to 
be a difference in the number of eQTLs found as a result of diet, nor did there appear to be an 
effect of diet on total number of DMRs, suggesting that FA fortification is not causing a 
generalized increase in stochastic methylation. However, the analyses are still very early, and 
in depth bioinformatic analysis may reveal interesting patterns of DMRs that correlate with 
specific regions of the genome. 
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Methods 
RNA and DNA isolation 
 Embryo heads were isolated (by cutting from the first brachial arch to just above the 
otic vesicle, Figure 5-1), flash frozen in liquid nitrogen, and stored at -80° C until RNA and 
DNA isolation. For Ift88null, both RNA and DNA were isolated from somite-matched (19-21 
somites, ~E9.5) Ift88null F3-control diet and F3-supra diet wildtype and mutant embryo heads 
using the QIAGEN AllPrep DNA/RNA Micro Kit (Cat. # 80284). For Intunull and Intudtm, 
DNA and RNA were isolated using the ZR-DuetTM DNA/RNA MiniPrep kit (Cat #D7001). 
Intunull DNA and RNA were isolated from somite-matched (20-21 somite, ~E9.5) embryo 
heads using a slight modification of the ZR-Duet kit. Specifically, instead of using the 
included Zymo-SpinTM IIIC column, I used the Zymo-SpinTM IC column (Cat.#C1004-50), 
which is specifically designed for extremely small amounts of DNA and allows for elution in 
as little as 6 µL. Prior to elution of DNA, the spin columns were incubated with 
DNase/RNase-free water at 65° C for 5 minutes. Unfortunately, I did not use this the lower-
elution spin column when I isolated the RNA that was ultimately used for RNA-seq, so I did 
not get any DNA from those embryos. Thus, the Intunull samples for RNA-seq and RRBS 
came from different embryos. However, I did isolate both DNA and RNA from the embryos 
used for RRBS, which will allow for follow-up qRT-PCR as needed. Intudtm DNA and RNA 
were isolated from somite-matched (31-33 somite, ~E10.5, one embryo was 33-34 somites) 
embryo heads following the standard ZR-Duet protocol (i.e. using the provided spin 
columns) with the addition of the 65° C for 5 min incubation of the DNA spin column to 
increase elution. All experiments were performed using 4 embryos for each condition (F3-
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control diet wildtype, F3-control diet mutant, F3-supra diet wildtype, and F3-supra diet 
mutant). 
RNA-sequencing 
 For Ift88null, barcoded RNA-seq libraries were made from 1 µg of RNA using the 
Illumina TruSeq RNA Sample Preparation Kit, v2, Set A (Cat. #RS-122-2001). Sequencing 
was performed on an Illumina HiSeq 2000 with single-end reads, 100 cycles (1 x 100) (4 
samples/lane). For both Intunull and Intudtm, barcoded libraries were generated from 1 µg of 
RNA using the TruSeq Stranded mRNA Library Prep Kit (Cat. #R2-122-2101), and 
sequencing was run on the Illumina HiSeq 2000/2500 HT Mode with V4 Chemistry, single 
reads, 50 cycles (1 x 50), 16 samples/4 lanes. I performed the bioinformatic processing for 
Ift88null with close supervision and assistance from Dr. Ken Jones. Ken Jones performed 
Bioinformatic processing for Intunull and Intudtm. Both DAVID and Ingenuity Pathway 
Analysis (QIAGEN) were used for pathway analysis. 
Reduced representation bisulfite sequencing (RRBS) to assay DNA methylation 
 Barcoded RRBS libraries were generated from 100 ng of input DNA following the 
NuGEN Ovation® RRBS Methyl-Seq System 1-16 kit (Cat. #0353). As with RNA-seq, 
libraries were generated from 4 embryos per condition (total of 16 libraries for each line). 
Paired end sequencing (2 x 125) was performed on the Illumina HiSeq 2000/2500 HT Mode 
with v4 Chemistry, with 16 samples spread across 4 lanes of sequencing. Dr. Ken Jones 




 CONCLUSIONS AND FUTURE DIRECTIONS 
NTDs are a complex and devastating disorder with both genetic and environmental 
risk factors. One of the best studied environmental risk factors is FA deficiency. The purpose 
of this thesis was to determine if mice with genetic mutations that affect cilia formation and 
function respond detrimentally to multigenerational FA fortification and to investigate the 
mechanism by which FA affects a response. As discussed in Chapter 2, four of the six mouse 
models studied showed a detrimental response to multigenerational FA fortification (F3-
generation: NTDs or polydactyly), but only one mouse model, Intudtm, showed a detrimental 
response upon short-term fortification (F1-generation), and this was not found to be 
statistically significant. Viewed in another light, more moderate levels of FA are beneficial to 
these cilia mutants. In vitro experiments recapitulated this beneficial response to lower levels 
of FA, as primary cells grown in lower levels of FA media had increased cilia number 
(MEFs) or increased cilia length (human JBTS fibroblasts). Two aspects of these data are 
striking. First, we provide strong evidence of a direct and detrimental response to FA 
fortification, adding to the growing body of literature linking supra levels of FA to negative 
outcomes. Second, we have shown that the length of exposure to FA fortification is 
important, and is certainly worthy of further study. 
This is not the first time FA supplementation or fortification has been implicated in 
negative outcomes in mouse or human studies. Previous work in this lab showed that the 
incidence of exencephaly increased 3-fold in the cilia mutant, 3Poly, upon multigenerational 
FA fortification, but was non-responsive to short-term FA fortification175. Multiple studies in 
mouse and humans have found increased risk of allergic airway disease in offspring strongly 
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correlates with high maternal FA intake288-290, and recent work has shown that FA 
supplementation can lead to developmental delay in wildtype mice285,286. Studies of cancer 
have shown that FA may be either protective or detrimental, depending on the dose and the 
presence of a preexisting neoplasm353. In some studies, FA was found to inhibit cancer 
progression and/or to be protective, while other studies have found that high FA 
supplementation may promote carcinogenesis in the presence of microscopic neoplastic 
foci354. It is also possible that the decline in human NTDs observed since mandatory FA 
fortification in the US is not purely a result of a protective effect of FA. In humans, NT 
closure is complete before women know they are pregnant, and one hypothesis that has been 
put forward is that the ‘protective’ effect of FA may be due in part to early spontaneous 
abortion leading to fetal loss177. Thus, in retrospect, it is perhaps not surprising that some 
genetic defects show a detrimental response to FA with respect to NTDs. 
The second important point from this thesis is that it addresses the duration of 
exposure to increased FA. Prior to these studies, only a handful of the more than 240 alleles 
implicated in NTDs in mice had been studied for responsiveness to FA60, and only two 
studies used a long-term, multigenerational fortification scheme175,176. Both of these studies 
found that multigenerational fortification increased embryonic lethality in mutants, and 
increased the incidence of exencephaly in remaining mutants. Although mutant loss was not 
observed as a result of FA fortification in any of the mouse models used in this thesis, 
exencephaly did increase upon FA fortification in both Ift88null and Intunull. Perhaps more 
intriguing is the fact that the incidence of double thumb in Intudtm/dtm embryos decreased after 
multiple generations on the control FA diet, which has approximately half the FA of what is 
found in the regular mouse chow.  
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The work in this thesis suggests that underlying cilia defects prime biological systems 
to respond adversely to long-term exposure to FA fortification. Given the prevalence of 
ciliopathies in the population (autosomal dominant polycystic kidney disease is estimated to 
affect as many as 1 in 1000 people355), the potential public health implications of FA 
fortification cannot be overestimated. There is no epidemiological data suggesting an 
increase in the incidence of ciliopathies in the years following FA fortification, though 
ciliopathy diagnoses have increased significantly in the past few decades as awareness of 
range of biological processes mediated by cilia has increased, making it difficult to determine 
whether any potential increased rates of ciliopathies are the result of improved medical 
diagnostics or FA fortification. Nonetheless, the potential for adverse effects on such a large 
percentage of the population certainly warrants further investigation into cilia-FA gene-
environment interactions. 
To further investigate how cilia and FA interact, it would be valuable to assay IFT 
trafficking in cilia mutants. Live imaging combined with fluorescently labeled IFT proteins 
could be used to study the rate of IFT trafficking in wildtype and ciliopathy cell lines grown 
in varying doses of FA media. Although primary cells lines, such as human patient 
fibroblasts and mutant MEFs, would be ideal for such studies, these have inherent 
drawbacks, as they are not as robust as immortalized lines and only permit a limited number 
of passages before quiescence and/or differentiation. Fortunately, the advent of CRISPR-
Cas9 gene editing technology295 makes it possible to study numerous human mutations in an 
immortalized, isogenic cell line. Using both primary and immortalized cell lines for live 
imaging experiments will provide a more complete picture of how FA is affecting trafficking 
in cilia. 
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This thesis has focused on primary cilia, but future work should also include studying 
FA responsiveness in motile and/or multiciliated cell systems. Multiciliated cells generate a 
directional fluid flow across tissues, and thus are important for movement of cerebrospinal 
fluid in the central nervous system, mucus clearance in the airway epithelia, and 
transportation of ova in the oviducts and fallopian tubes356. The multiciliated airway 
epithelium would provide an excellent system for studying the effects of FA. Mouse 
respiratory epithelial cells can be isolated and cultured from adult animals in varying levels 
of FA media to assay the effect of FA on wildtype and heterozygous animals357. Airway 
epithelia can also be induced from embryonic stem cells, which would be important for 
studying the effect of FA on multiciliated cells in homozygous animals, as most of the cilia 
mutations studied in this thesis are embryonic lethal. A combination of immunofluorescence, 
scanning and transmission electron microscopy would be needed to assay the effects on FA 
on cilia number and length, as single cilia in multiciliated cells can be difficult to visualize 
with light microscopy. 
It is also possible that FA is subtly altering the transcriptional and/or epigenetic 
landscape. Due to the natural buffering ability of organisms during development, these 
changes do not result in phenotypic changes in wildtype animals. In the presence of an 
underlying genetic insult, however, this buffering capacity is reduced, and FA-induced 
transcriptional fluctuations can lead to phenotypic responses, potentially accounting for the 
increased penetrance of NTDs and polydactyly observed in cilia mutants in this thesis. This 
does not account for why mutations affecting cilia respond adversely to FA, while other 
mutations can benefit from FA. As shown in Chapter 5, multigenerational FA fortification 
does cause diet-dependent changes in the transcriptome, with increased gene dysregulation 
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observed in Ift88null and Intudtm mutants compared to diet-matched wildtype embryos when 
maintained on the supra FA diet compared to the control FA diet. However, Intudtm does not 
show an increase in the incidence of NTDs, perhaps because the underlying genetic insult of 
the hypomorphic allele does not disrupt the buffering ability of the embryo as much as the 
null allele in Ift88null.  
FA fortification also causes changes in DNA methylation, though it is not yet clear if 
these changes are causative, as it seems that the number of DMRs identified across diets was 
comparable to DMRs observed as a result of just a genetic mutation. It must be noted, 
however, that the sequencing depth for the RRBS experiments was less than the ideal 
minimum of 10X coverage. Thus, additional sequencing reads will be necessary. 
Furthermore, the Ift88null line has yet to be subjected to DNA methylation analysis, and 
RRBS data from the Ift88null line will be valuable in correlating gene expression changes with 
DNA methylation changes. It is also possible that FA fortification does not affect a 
phenotypic response via altered DNA methylation, but is still affecting the epigenetic 
landscape. SAM acts as a methyl donor for numerous methylation reactions. FA fortification 
may alter histone methylation patterns, which could be assayed using ChIP-seq. Histone 3 
has several of the most-studied methylation sites, including lysine 4 (H3K4), H3K9, H3K27, 
H3K36, H3K79 and H3K20, and arginine H3R2, H3R8, H3R17 and H3R26358, though it is 
known that any basic residue can be methylated, and numerous methylation sites have been 
identified on other histones. It is also known that the extent of methylation can change the 
effect of histone methylation. For example, H3K4me3 (trimethylation) is generally 
associated with active transcription or genes poised for transcription, while H3K4me1 
(monomethylation) is associated with enhancer activity. However, the relationship between 
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methylation status and function is not clear cut, as H3K4me2 and H3K4me3, both marks 
normally associated with active transcription, can also be associated with transcriptional 
repression358. Similarly, H3K27me3, which is usually associated with transcriptional 
repression, has also been found to be enriched in the promoter regions of genes undergoing 
active transcription359. Furthermore, combinations of histone methylation modifications can 
alter the function. H3K4me3 and H3K27me3 appear to form a bivalent domain of expression 
that maintains important developmental genes silenced but poised for transcription360. 
Although there are many interesting histone methylation modifications, initial experiments to 
explore the effect of FA diet on these cilia mutants would likely start with H3K4me3 and 
H3K27me3. Additionally, it would be valuable to test changes in the phenotypic penetrance, 
gene dysregulation and the epigenome upon returning animals to the control diet from the 
supra diet. If FA is acting by altering the epigenome, we would expect to observe inheritance 
of epigenetic changes, and thus gene dysregulation, even after animals have been removed 
from the supra FA diet.  
Another avenue of exploration would be to perform similar multigenerational 
fortification experiments with the FA-responsive mouse lines using different methyl donors. 
Choline, betaine and methionine are also involved in one-carbon metabolism, and 
downstream metabolites of FA, such as folinic acid and even formate174,361, might provide 
insights as to what parts of the OCM cycle are most susceptible to changes. Additionally, it 
would be extremely useful to have folate metabolite data from embryos and dams maintained 
on the control and supra FA diets. Currently, we have been limited by the fact that 
concentrations of these metabolites in our samples are below the threshold of detection of 
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mass spectrometry, but new columns and technological advances should make folate 
metabolite profiling for our minute samples possible in the very near future. 
It is also possible that FA-related changes in gene expression are not causative, and 
that developmental buffering is not affected in a biologically meaningful way. FA acts as a 
methyl donor to generate SAM, and SAM acts as a methyl donor for numerous reactions. 
The importance of differential RNA methylation is only just coming to the forefront, and is 
worthy of further investigation. As mentioned above, recent work has shown that cilia 
disassembly in Chlamydomonas is dependent on the methylation of several ciliary proteins, 
including CCDC40 and CCDC65, both of which have been implicated in primary ciliary 
dyskinesia in humans274,275. Indeed, there are numerous other possible methylation candidates. 
Therefore, these thesis studies are just a step in understanding potential cilia-FA gene-
environment interactions. It is also possible that FA is affecting a different part of the OCM 
pathway, such as the biosynthesis of nucleotides. Altered nucleotide pools may affect gene 
expression and/or developmental fitness. Overall, a great deal of work remains to be done to 
understand how FA is affecting gene expression, the epigenome, and neural tube closure. 
However, the data presented in this thesis are the first studies, to our knowledge, implicating 
a set of genes important to a specific biological process – cilia assembly and function – that 
show a detrimental response to FA.  
Understanding the mechanism by which FA affects development is an ambitious 
undertaking. The first assumption for the cilia mutants was that FA would exacerbate a cilia-
signaling defect. However, FA does not appear to significantly alter gene expression in the 
Shh, b-catenin-Wnt or PCP/Wnt signaling pathways, nor does it affect proliferation or 
apoptosis in the developing neural tube. Interestingly, there is an effect of FA on cilia 
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number and/or cilia length, as shown in Chapter 3 in MEFs and human JBTS patient 
fibroblasts and in Chapter 4 in the embryonic kidney. New higher-resolution confocal 
microscopy technology will allow for assaying cilia number and, hopefully, cilia length in 
the developing neural tube, which may provide important insights as to whether FA directly 
affects cilia in vivo in affected tissues. Given the recent work in Chlamydomonas showing a 
requirement for protein methylation prior to ciliary disassembly274,275, and the phenotypic 
response observed in cilia in vitro, it is possible that FA fortification is directly altering cilia 
structure or function. Again, given the prevalence of ciliopathies and NTD-affected 
pregnancies in the human population, the public health importance of identifying and 
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APPENDIX A 
ANIMAL DIET INFORMATION 
Comparison of Control (2 mg/kg FA), Supra (10 mg/kg FA) and ‘regular’ mouse diets. 
Product # 







% Gram Gram Gram
Protein 19.2 19.2 19.1
Carbohydrate 67.3 67.3 47
Fat 4.3 4.3 6.5
Total 90.8 90.8 72.6
Energy Density (kcal/gm) 3.85 3.85 3.1
Ingredient Gram Gram
Casein, 80 Mesh 200 200 NA
L-Cystine 3 3 3
L-Methionine 5
Corn Starch 315 315
Maltodextrin 35 35
Sucrose  350 350
Cellulose, BW200 200 200
Soybean Oil 45 45 unk
Corn oil
t-Butylhydroquinone
Mineral Mix S10026 10 10
Mineral Mix S10022G
Zinc Carbonate
DiCalcium Phosphate  13 13
Calcium Carbonate  5.5 5.5
Potassium Citrate, 1 H2O  16.5 16.5
Vitamin Mix V10001 10 10




Choline Bitartrate 1 1 1.2




Diet information for Control (2 mg/kg FA, D05072702) and Supra (10 mg/kg FA, 
D05072701) Rodent Diet. D12450 is the baseline diet to which vitamins and minerals, 




 D12450B, D05072701, and D05072702
Rodent Diet With 10 kcal% Fat and Diets With 10 kcal% Soybean Oil 
With Either 10 ppm Folic Acid or 2 ppm Folic Acid
Product #
% gm kcal gm kcal gm kcal
Protein 19.2 20 19.2 20 19.2 20
Carbohydrate 67.3 70 67.3 70 67.3 70
Fat 4.3 10 4.3 10 4.3 10
Total 90.8 100 90.8 100 90.8 100
kcal/gm 3.85 3.85 3.85
Ingredient gm kcal gm kcal gm kcal
Casein, 80 Mesh 200 800 200 800 200 800
L-Cystine 3 12 3 12 3 12
Corn Starch 315 1260 315 1260 315 1260
Maltodextrin 10 35 140 35 140 35 140
Sucrose 350 1400 350 1400 350 1400
Cellulose, BW200 50 0 50 0 50 0
Soybean Oil 25 225 45 405 45 405
Lard 20 180 0 0 0 0
Mineral Mix S10026 10 0 10 0 10 0
DiCalcium Phosphate 13 0 13 0 13 0
Calcium Carbonate 5.5 0 5.5 0 5.5 0
Potassium Citrate, 1 H2O 16.5 0 16.5 0 16.5 0
Vitamin Mix V10001 10 40 10 40 10 40
Choline Bitartrate 2 0 2 0 2 0
Folic Acid 0 0 0.009 0 0 0
FD&C Yellow Dye #5 0.05 0 0 0 0 0
FD&C Red Dye #40 0 0 0.05 0 0 0
FD&C Blue Dye #1 0 0 0 0 0.05 0
  Total 1055.05 4057 1055.0590 4057 1055.0500 4057
D05072701   D12450B D05072702B
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Diet information for Teklad 2020X Rodent Diet: 
 
  
Teklad Global Soy Protein-Free Extruded Rodent Diet
Standard Product Form: Extruded
Macronutrients Vitamins
Crude Protein % 19.1 Vitamin A 
e, f
IU/g 15.0
Fat (acid hydrolysis) 
a





% 47.0 Vitamin E IU/kg 110
Crude Fiber % 2.7 Vitamin K3 (menadione) mg/kg 50
Neutral Detergent Fiber 
c
% 12.3 Vitamin B1 (thiamin) mg/kg 17
Ash % 5.1 Vitamin B2 (riboflavin) mg/kg 15
Energy Density 
d
kcal/g (kJ/g) 3.1 (13.0) Niacin (nicotinic acid) mg/kg 75
Calories from Protein % 24 Vitamin B6 (pyridoxine) mg/kg 18
Calories from Fat % 16 Pantothenic Acid mg/kg 33
Calories from Carbohydrate % 60 Vitamin B12 (cyanocobalamin) mg/kg 0.08
Minerals Biotin mg/kg 0.40
Calcium % 0.9 Folate mg/kg 4
Phosphorus % 0.7 Choline mg/kg 1200
     Non-Phytate Phosphorus % 0.4 Fatty Acids
Sodium % 0.1 C16:0 Palmitic % 0.6
Potassium % 0.4 C18:0 Stearic % 0.1
Chloride % 0.4 C18:1ω9 Oleic % 1.1
Magnesium % 0.2 C18:2ω6 Linoleic % 2.6
Zinc mg/kg 60 C18:3ω3 Linolenic % 0.3
Manganese mg/kg 80 Total Saturated % 0.8
Copper mg/kg 15 Total Monounsaturated % 1.1
Iodine mg/kg 6 Total Polyunsaturated % 2.9
Iron mg/kg 200 Other
Selenium mg/kg 0.23 Cholesterol mg/kg -- 
Amino Acids
Aspartic Acid % 1.1













Lysine % 0.9 f 1 IU vitamin A = 0.3 µg retinol
Histidine % 0.4
g
 1 IU vitamin D = 25 ng cholecalciferol
Arginine % 0.8 For nutrients not listed, insufficient data is available to quantify.
Tryptophan % 0.2
0915
Product Description-  2020X is a fixed formula, non-autoclavable 
extruded diet manufactured with high quality ingredients and designed to 
support gestation, lactation, and growth of rodents. 2020X does not contain 
alfalfa or soybean meal, thus minimizing the occurrence of natural 
phytoestrogens. Typical isoflavone concentrations (daidzein + genistein 
agylcone equivalents) range from non-detectable to 20 mg/kg. Exclusion of 
alfalfa reduces chlorophyll, improving optical imaging clarity. Absence of 
animal protein and fish meal minimizes the presence of nitrosamines. Also 
available certified (2020XC) and irradiated (2920X). For autoclavable 
diet, refer to 2020SX (Sterilizable).
Ingredients (in descending order of inclusion)- Ground wheat, ground corn, 
corn gluten meal, wheat middlings, soybean oil, calcium carbonate, dicalcium 
phosphate, brewers dried yeast, L-lysine, iodized salt, magnesium oxide, 
choline chloride, DL-methionine, calcium propionate, L-tryptophan, vitamin E 
acetate, menadione sodium bisulfite complex (source of vitamin K activity), 
manganous oxide, ferrous sulfate, zinc oxide, niacin, calcium pantothenate, 
copper sulfate, pyridoxine hydrochloride, riboflavin, thiamin mononitrate, 
vitamin A acetate, calcium iodate, vitamin B12 supplement, folic acid, biotin, 
vitamin D3 supplement, cobalt carbonate.
d
 Energy density is a calculated estimate of metabolizable energy  based on the 
  Atwater factors assigning 4 kcal/g to protein, 9 kcal/g to fat, and 4 kcal/g to 
  available carbohydrate. 
e
 Indicates added amount but does not account for contribution from other 
  ingredients.
© 2015 Envigo
Teklad Diets + Madison WI + envigo.com + tekladinfo@envigo.com + (800) 483-5523
a
 Ether extract is used to measure fat in pelleted diets, while an acid hydrolysis 
  method is required to recover fat in extruded diets. Compared to ether 
  extract, the fat value for acid hydrolysis will be approximately 1% point higher.
b
 Carbohydrate (available) is calculated by subtracting neutral detergent fiber
  from total carbohydrates.
c
 Neutral detergent fiber is an estimate of insoluble fiber, including cellulose, 
  hemicellulose, and lignin. Crude fiber methodology underestimates total fiber.
Nutrient data represent the best information available, calculated from 
published values and direct analytical testing of raw materials and finished 
product. Nutrient values may vary due to the natural variations in the 
ingredients, analysis, and effects of processing.
Teklad Diets are designed and manufactured 
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A Hypomorphic Allele Reveals an Important Role of
Inturned in Mouse Skeletal Development
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Background: Cilia are important for Hedgehog signaling in vertebrates and many genes that encode proteins involved in cilio-
genesis have been studied for their roles in embryonic development. Null mutations in many of these genes cause early
embryonic lethality, hence an understanding of their roles in postnatal development is limited. Results: The Inturned (Intu)
gene is required for ciliogenesis and here we report a recessive hypomorphic mutation, resulting in substitution of a con-
served hydrophobic residue (I813N) near the C-terminus, that sheds light on later functions of Intu. Mice homozygous for this
Double-thumb (IntuDtm) allele exhibit polydactyly, retarded growth, and reduced survival. There is a moderate loss of cilia in
IntuDtm/Dtm mutants, and IntuI813N exhibits compromised ability to increase ciliogenesis in cultured Intu null mutant cells.
IntuDtm mutants show rib defects and delay of endochondral ossification in long bones, digits, vertebrae, and the sternum.
These skeletal defects correlate with a decrease in Hh signaling. However, patterning of the neural tube and planar cell polar-
ity appear to be normal. Conclusions: This hypomorphic Intu allele highlights an important role of Intu in mouse skeletal
development. Developmental Dynamics 244:736–747, 2015. VC 2015 Wiley Periodicals, Inc.
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Introduction
Vertebrate embryonic development is a complex process that
requires the integration of numerous molecular and cellular com-
ponents under genetic control. This complexity is reflected in a
diverse array of birth defects resulting from disruptions of core
developmental signaling pathways, such as Wnt, Notch, FGF,
TGFb, and Hedgehog (Hh) pathways. Ciliopathies comprise a
plethora of human birth defects such as Polycystic Kidney Dis-
ease (OMIM 173 900), Bardet-Biedl (OMIM 209 900), Joubert
(OMIM 213 300), Meckel (OMIM 24900), and Kartagener (OMIM
244 400) Syndromes. The common cellular bases of all ciliopa-
thies are defects in the biogenesis or function of the cilium, a
microtubule-based cell surface extension present in most post-
mitotic cells in vertebrates (Baker and Beales, 2009). Understand-
ing the genetic and molecular basis of ciliogenesis and the role of
the cilium in embryonic and postnatal development is critical for
proper diagnosis and treatment of ciliopathies.
Many developmental defects in ciliopathies are attributed to
abnormal Hh signaling. The Hh signaling pathway is essential for
embryonic development, patterning, and growth (Briscoe and
Therond, 2013). There are three Hh family members in the mouse:
Sonic Hedgehog (Shh), Desert Hedgehog (Dhh), and Indian
Hedgehog (Ihh). Shh affects cell proliferation, axis formation, and
patterning in many tissues, including the neural tube and limb
buds. In the developing neural tube, a decreasing ventral-to-
dorsal Shh gradient regulates the expression of various genes
encoding homeobox and bHLH transcription factors (Briscoe and
Therond, 2013). The subsequent antagonistic interactions among
these transcription factors sharpen gene expression boundaries in
the neural tube and promote neuronal differentiation (Briscoe
and Therond, 2013). Shh is also transiently expressed in posterior
mesenchyme of the limb buds known as a zone of polarizing
activity (ZPA). Both gain and loss of function analyses show that
Shh is critical for the establishment of the anterior/posterior
polarity of the limb buds and proper formation of digits (Zeller
et al., 2009).
Ihh signaling is predominant in endochondral ossification, a
process in which developing cartilage expands, calcifies, and is
then replaced by bone tissue (Lai and Mitchell, 2005). The devel-
opment of the long bones begins with the condensation of mes-
enchymal cells and differentiation into chondrocytes, which
secrete cartilaginous extracellular matrix (ECM), proliferate, and
undergo hypertrophy. Terminally differentiated hypertrophic
chondrocytes deposit calcified ECM and undergo apoptosis. This
is followed by the invasion of osteoblasts and osteoclasts, which
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CHROMOSOME SCREENSHOTS WITH ALL DYSREGULATED GENES 




KEY TO TRACKS: 
For each chromosome, the top track shows all genes expressed at E9.5 (black, generated 
from E9.5 wildtype embryo RNA-seq data).  
 
The next 4 tracks display dysregulated genes in Ift88null comparisons (all embryos were 19 – 
21 somites): 
Blue: F3-control diet wildtype versus F3-control diet mutant 
Pink: F3-supra diet wildtype versus F3-supra diet mutant 
Sea green: F3-control diet wildtype versus F3-supra diet wildtype 
Purple: F3-control diet mutant versus F3-supra diet mutant 
 
The next three tracks show genomic CpG methylation data from unexposed WT mice from 
the Li et al experiment with wildtype mice maintained on high methyl diets and mapped onto 
the mm10 genome148 – these tracks are shown for reference: 
Orange control (F0)  
Dark orange WT mice fed methyl-rich diets for 1 generation (F1) 
Red WT mice fed methyl-rich diets for 6 generations (F6) 
 
Differentially expressed genes and DMRs for each of the four Intunull comparisons (all 
embryos were 20-21 somites): 
Comp1 = F3-control diet wildtype versus F3-control diet mutant  
Comp2 = F3-supra diet wildtype versus F3-supra diet mutant 
Comp3 = F3-control diet wildtype versus F3-supra diet wildtype 
Comp4 = F3-control diet mutant versus F3-supra diet mutant 
 
Differentially expressed genes and DMRs for each of the four Intudtm comparisons (all 
embryos were 31-33 somites): 
Comp5 = F3-control diet wildtype versus F3-control diet mutant  
Comp6 = F3-supra diet wildtype versus F3-supra diet mutant  
Comp7 = F3-control diet wildtype versus F3-supra diet wildtype 
Comp8 = F3-control diet mutant versus F3-supra diet mutant  
 
Dark blue = All genes (both UCSC and RefSeq)  
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